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Abstract

A n analysis is presented of the molecular mechanisms involved in
maintaining the liver specific transcriptional profile of the rat and mouse
serum albumin genes. Using DNA transfection and recombinant viral
infection, the minimal rat promoter and mouse enhancer elements were
identified, functionally dissected and shown independently to be hepatocyte
specific elements. Based on these studies, multiple cis-acting DNA regulatory
regions were elucidated and the cognate proteins which interact with them
characterized and where possible their identity determined. It was found that
the promoter proximal -156 nucleotides of the rat albumin gene were
necessary and sufficient to insure albumin transcriptional specificity.
Furthermore, the transcription factors involved in insuring this effect
included several liver enriched proteins and others of a more ubiquitous
cellular distribution. It is therefore, the interaction of several factors (only
some of which are liver specific or enriched) which dictates the liver
specificity of this promoter.
The albumin enhancer element was localized much farther upstream
(-10.5 to -8.43kbp) and shown to consist of both positive and negative
regulatory domains. Two of the proteins which interact with the albumin
enhancer are newly described, NLS1 and ANF, a positive and negative acting
protein respectively, which interact in a modular fashion to stimulate the rate
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of albumin transcription. N L S 1 (non-liver specific 1) D N A binding activity is
present in all cell types, yet it stimulates albumin transcription only in the
liver. ANF (albumin negative factor) negates the action of NLS1 and can act
upon heterologous promoter and enhancer elements in this same fashion.
This negative factor is present ubiquitously, but its activity is overridden in
the liver by a third protein factor. This protein was determined to be C/EBP, a
liver enriched transcription factor, which for the enhancer element performs
this novel modulatory role. The biological action of these different factors
was subsequently evaluated by correlating their relative levels with both the
specificity and rate of albumin gene transcription in a series of rat hepatoma
cell lines, which each transcribe the albumin gene at a different rate. An
analysis of the expression of the rat transthyretin gene was also included in
this series of experiments, and the question of coordinate hepatocyte gene
control was addressed. Lastly, the control of some of these transcription
factors themselves were analyzed by measuring both their transcription rate
and protein binding activity in the rat liver and several hepatoma cell types.
These factors are regulated in a complex fashion, involving both
transcriptional and post transcriptional mechanisms.
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Chapter 1

Introduction

The process of cellular differentiation, which occurs during the
development of a multicellular organism, involves a multitude of regulatory
events. These include the turning on and off of specific cellular genes that
encode proteins which together contribute to the attainment of each
developmental stage (Darnell, 1985; Gehring, 1987; Maniatis et al, 1987). The
differentiation of the mammalian hepatocyte from a single pluripotent
precursor cell early in embryonic development is a well-studied process, and
has been shown to involve the sequential and coordinated expression of a
large number of genes many of which are activated in a tissue specific fashion
(Greengard, 1969; 1970; Greengard et al, 1972; Powell et al, 1984; Panduro et
al, 1987a). The initial events which set this complex process into motion,
referred to as developmental commitment, manifest themselves at the
earliest stages of embryonic life, when a limited number of cells exist, making
it difficult to study this process experimentally (Gardner and Rossant, 1976).
The end product of these determinative events, however, is differentiation;
the patterned expression of a specific set of cellular gene products that serves
to embody a cell with its own unique phenotypical characteristics.
By examining the normal expression of tissue specific mRNAs in the
adult, during development, and as the result of certain pathophysiological
states (ie. regeneration and neoplasia), it is possible to explore the
mechanisms involved in their regulation. Numerous genes expressed
mainly in hepatocytes have been identified and shown to be differentially
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and/or coordinately expressed at various times during the developmental
process, many as a result of transcriptional control (Derman et. al, 1981;
Tilghman and Belayew, 1982, Cistanzom et. al, 1983; Powell et al., 1984;
Ciliberto et al, 1985; Darnell 1985; Clayton and Darnell, 1983; Panduro et al,
1987a). The transcriptional control of an individual liver specific mRNA and
the means by which multiple genes are expressed in a concerted fashion to
produce the differentiated hepatocyte therefore represent fundamental
developmental decisions.
My thesis has been directed towards obtaining a better understanding of
the cis-acting DNA sequence elements and the trans-acting cellular regulatory
factors that contribute to cellular differentiation in the rodent liver. To
accomplish this task, I have focused upon a single gene, that for serum
albumin, which is transcribed in a liver specific manner. I examined the
transcription of albumin in numerous cell types and tissues (e.g. the mouse
and rat liver, human and rat hepatoma cells, CWSV1 rat cells and primary
hepatocytes) which each express albumin to a different extent. For each of
these experimental systems, I have addressed a set of questions, which
includes the following:

I. What is the rate of albumin transcription?

II. What are the cis-acting DNA sequence elements involved in the
control of albumin transcription?
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III. H o w m a n y trans-acting factors interact with these regulatory
elements? Are these factors liver specific or ubiquitous? D o they
resemble any other k n o w n transcription factors? H o w is cell-type
specific transcription maintained?

IV. Are these factors shared among different genes and involved in
coordinate gene control? H o w are these factors themselves regulated?

I. Tissue specific gene expression: A general overview
Differentiated cells, such as hepatocytes, pancreatic acinar and islet
cells, lens cells, blood cells and lymphocytes, all produce characteristic
proteins because the genes encoding them are specifically expressed in that
cell type and not elsewhere, despite the fact that all cells maintain identical
DNA complements (Derman et al, 1981; Edlund et al, 1985; Boulet et al, 1986;
Davis et al., 1987; Lenardo et al, 1987; Scott and Carol, 1987; Maniatis et al,
1987). The regulation of the production of cell-type specific products which is
the distinctive characteristic of a differentiated cell, must therefore result
from modulations at some point along the complex pathway which generates
a functional protein from a DNA encoded gene sequence. These alterations
can occur at any one of several different levels of gene control.

Levels of gene control
The production of a specific cellular protein begins with the process of
transcription, in which an RNA molecule is copied from a DNA template by
the enzyme RNA Polymerase II. This nuclear precursor is then modified via
6

several processing steps which are nearly always required for the production
of a functional mRNA. These include the addition of methylated GTP
residues to the 5' end of the RNA (capping), addition of 100-200 adenosine
residues (the Poly A tail) to the 3' end of the molecule and splicing in which
parts of the RNA (the intervening sequences) are removed (for reviews see
Darnell, 1982; Green, 1989). This messenger RNA is then transported from
the nucleus to the cytoplasm where it is translated into protein. The
regulation of this process can occur at any or all of the above steps and in
addition by changing the stability of the various cellular intermediates (i.e.
RNA half life; Darnell, 1982). The study of many tissue specific genes in a
variety of systems, however, has shown that the primary level of regulation
responsible for maintaining cell type specific gene control is transcription
(Derman et al, 1981; Tilghman and Belayew, 1982; Gillies et al, 1983; Walker
et al., 1983; Darnell, 1985; McKnight and Tjian, 1986; Maniatis et al, 1987; Liu
et al, 1988; Mitchell and Tjian, 1989), and an investigation of this process is
the central focus of this thesis. It should be kept in mind, however that
posttranscriptional mechanisms do occur either as a primary mechanism or
in combination with a variable degree of transcriptional modulation. Notable
examples of this are the regulated splicing of the genes which dictate the
sexual phenotype of Drosophila (Boggs et al, 1987; Nagoshi et al, 1988), or the
gene which is involved in the production of calcitonin and its related protein
CGRP in a tissue specific fashion (Amara et al, 1982).
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Cis-acting D N A sequence elements regulate transcription
Why are specific DNA sequences chosen for transcription in one cell-type
and not another? The advent of cloning procedures and the techniques for
introducing genes back into cells has enabled a functional characterization of
the regulatory elements involved in dictating both the specificity and the rate
of transcriptional initiation (Cassio et al, 1981; Ott et al, 1984; Ciliberto et

1985; Boulet et al, 1986; Friedman et al, 1986,1987; Babiss et al, 1987; Hay et al
1987; Grayson et al, 1988a; Godbout et al, 1986, 1988a). Cis-acting DNA
regulatory elements have been defined which are necessary and sufficient to
permit transcription of tissue specific genes in cell types in which the
endogenous genes are normally expressed, and conversely to prevent their
expression in inappropriate cell types. These sequences often represent
DNase I hypersensitive or methylation free DNA domains, suggesting that
these regions are maintained in a transcriptionally active state, with their
DNA suitably decondensed and accessible to the transcriptional machinery
(Stadler et al, 1980; Weisbrod, 1982; Serfling et al, 1985; Cedar, 1988; Morse
and Simpson, 1988).

Protein transcription factors interact with DNA regulatory regions
Trans-acting proteins which bind to these cis-elements have been
identified by using in vitro DNA binding assays (e.g. DNase I footprinting, gel
shift and exonuclease III analysis), and numerous DNA-binding proteins,
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m a n y widely distributed and a few that are cell-specific (cell-enriched), are
currently being studied to delineate their roles in transcriptional regulation
(Briggs et al, 1986; Babiss et al, 1987; Bodner and Karin, 1987; Cereghini et al,
1987; Courtois et al, 1987; Lenardo et al, 1987; Fletcher et al.,1987; Ko et al,

1988; Herr et al, 1988; Costa et al, 1988b, 1989; Hai et al, 1988; Ptashne, 1988).
Most of the binding sites for these factors are clustered in DNA regions
(enhancers or promoter-proximal sequences) that when deleted or mutated
lead to a failure of gene expression: these binding proteins or groups of
binding proteins are assigned a positive role in transcription (Jones et al,

1987; Lee et al, 1987; Mitchell et al, 1987; Costa et al, 1988b, 1989). In a smalle
number of cases, however, DNA regions have been identified that when
deleted appear to release a gene into activity or at least to allow higher
expression based on the activity of the remaining positive acting regions.
These elements presumably act in a negative capacity (Brand et al, 1985;
Goodbourn and Maniatis, 1986; Muglia and Rothman Denes, 1986;
Colantuoni et al, 1987; Imler et al, 1987; Hay et al, 1989; Kakkis et al, 1989;
Levine and Manley, 1989; Scheuermann et al, 1989)
Evidence from the analysis of many elements has suggested that the
promoter (usually found within 100-200 nucleotides of the RNA start site;
Maniatis et al, 1987; Dynan, 1989) and enhancer elements (which may be
located far upstream, downstream or within the coding sequences of a gene
(Banerji et al, 1981; Fromm and Berg, 1982; Gilles et a/.,1983; Queen and
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Baltimore, 1983; McKnight and Tjian, 1986) are multifaceted genetic elements
containing DNA sequence motifs (7-20bp of DNA), each of which represents a
potential site of interaction with a protein transcription factor (Herr and
Clark, 1986; Zenke et al, 1986; Wirth et al, 1987; Dynan, 1989; Mitchell and
Tjian, 1989; Johnson and McKnight, 1989). A schematized picture of a typical
gene regulatory region is shown in Figure 1.1.
The promoter elements of most protein coding genes, though not all,
contain an A/T nucleotide rich region found 20-30 nucleotides from the start
site of RNA transcription known as the TATA box, which is important for
directing the first steps in the formation of an active transcription complex
(Horikoshi et al, 1988; Dynan, 1989; Hahn et al 1989). A protein factor, TFIID,
interacts with this TATA region, the importance of which is attested to by the
fact that it has been functionally conserved from yeast to man. It has recently
been demonstrated that the yeast TFIID can functionally complement a TFIID
deficient Hela cell transcription system (Buratowski et al, 1988; Cavallini et
al, 1988), and this protein has now been cloned (Buratowski et al, 1988). This
evolutionary conservation has also been demonstrated for at least one other
component of the basic transcriptional machinery (TFIIA; Hahn et al, 1989) as
well as for the activating domains of a wide number of DNA binding proteins
(Struhl, 1988; Webster et al, 1988; Ptashne, 1988; Guarente, 1988). This
suggests a strong conservation exists in the protein-protein interactions
dictating the cellular transcriptional mechanism.
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Figure 1.1. A schematized representation of a eukaryotic regulatory element
depicting D N A binding proteins interacting with an upstream enhancer
element. O n e possible activation mechanism in which upstream factors
interact with the TFIID protein is suggested by this diagram and is described in
the text, (from Darnell, 1989).
1 1

Mechanism of transcriptional initiation
Studies on the mechanism by which these factors influence
transcription are still in their infancy but several models have been
developed. One current theory suggests these upstream sequence elements
and their cognate proteins increase the functional TFIID binding to the
promoter proximal sequences, thereby facilitating transcription (Figure 1.1;
Ptashne, 1988; Horikoshi et al, 1988; Nakajima et al, 1988). This model is
based on the in vitro observation that numerous core promoter elements
(containing the TATA box and the cap site alone) are capable of activating
transcription in HeLa cell nuclear extracts (Horikoshi et al, 1988). In the cell,
however, this is not the case, most probably because TFIID is present in a
limited concentration relative to the number of available DNA templates. It
therefore has been suggested that upstream sequence elements and their
associate factors function by assisting TFIID in the formation of the initiation
complex (Horikoshi et al, 1988). These factors could either increase the
affinity of TFIID binding to the TATA box or alternatively modify the activity
of the protein in such a way as to affect its interaction with the DNA or any of
the other components of the initiation complex (Simon et al, 1988; Mitchell
and Tjian, 1989). A recent study by Horikoshi et al (1988), demonstrated the
latter to be the case for the adenovirus E4 gene. They showed that the
upstream transcription factor ATF, qualitatively influences the binding of the
TFIID factor upon the E4 promoter proximal sequences (increasing the region
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protected from D N a s e I digestion; Figure 1.1; Horikoski et al, 1988, V a n D y k e
et al, 1988). Furthermore, this change correlated with increased in vitro
transcriptional activity, strongly implicating this interaction as a mechanism
involved in transcriptional activation (Horikoshi et al, 1988). This, however,
represents only one example of an upstream factor interaction, and mounting
evidence suggests that these upstream factors might also interact with the
large RNA polymerase molecule itself, or any of the at least five associated
protein components of the basic transcription complex (Matsui et al, 1980;
Samuels et al, 1982; Davison et al, 1983; Reinberg and Roeder, 1987; Mitchell
and Tjian, 1989).
For the more upstream DNA regulatory regions, models which include
DNA bending and looping have been evoked to explain their ability to
interact near the RNA start site (Ptashne, 1986; Schleif, 1986), and studies of
the protein-protein interactions surely involved in regulating these effects are
being performed for a number of systems (Ptashne, 1988). In any case, it
appears that the modular organization of these regulatory elements allows
transcriptional regulation to occur in response to a diverse group of cellular
signals. Although the interplay between the various proteins is not yet fully
understood, it is believed that combinations of cis acting elements arranged in
unique configurations confer upon each gene an individualized
transcriptional program (Mitchell and Tjian, 1989).

13

Sequence-specific D N A binding proteins
These transcriptional proteins can be purified based upon their strong

affinity for specific DNA binding sites. (Briggs et al, 1986; Mitchell et al, 198
Scheidereit et al, 1987; Kawakami et al, 1988). Protein sequence is then
obtained and these genes can be cloned by preparing oligonucleotide probes or
antibodies for use in screening cDNA libraries. Additionally, in recent years
several of these proteins have been cloned using the technique of Singh et al.
(1988) which employs the DNA binding sequence to directly screen Xgtll
cDNA expression libraries. Examples of proteins cloned in this way include
the H2TF1 and ATF transcription factors (Singh et al, 1988; Hai et al, 1989).
Once cloned, the DNA binding and activating domains of the protein
can be functionally dissected. From recent studies is has become evident that
several distinctive protein structures are often associated with the DNA
binding proteins such as the homeodomain, POU domain, zinc finger, and
leucine zipper ( reviewed in Mitchell and Tjian, 1989; Johnson and McKnight,
1989). Furthermore, common activating regions are emerging as well,
(reviewed by Ptashne 1988; Mitchell and Tjian, 1989), usually consisting of
specific classes of amino acids (ie. acidic, glutamine or proline rich groups).

Regulation of transcription factors
In light of their importance in activating transcription, the cellular
control of these proteins certainly represents an important developmental
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decision. The study of a large number of these factors has demonstrated that
they can either be constitutively present (Briggs et al, 1986; Jones et al, 1987;
Mitchell et al, 1987; Chodosh et al, 1986; Mermod et al, 1988), tissue specific
(Bodner and Karin, 1987; Scheidereit et al, 1987; Kawakami et al, 1988; Frain
et al, 1989) or inducible in their distribution (Fletcher et al, 1987; Wu et al,
1987; Lenardo and Baltimore, 1989). Also, it has become apparent in recent
years that many of these transcription factors require some specific
modifications to become functionally active. For example certain factors have
been shown to be glycosylated (Jackson and Tjian, 1988), and included in this
group is the ubiquitous factor SP1. This glycosylation is not required for DNA
binding, and therefore, the ability to activate transcription could possibly be
regulated by the extent of this modification in a specific cell type (Mitchell and
Tjian, 1989). Another example of an activated factor is that responsible for
transducing the signal for heat shock in yeast. This factor will bind DNA in all
cells but must be phosphorylated to be functionally active (Sorger et al, 1987).
Conversely, while the above two factors will bind DNA in the absence of
modification, the adenovirus E4f factor requires modification of its precursor
(by El A) to efficiently bind DNA and thereby exert its transcriptional effect
(Raychaudhuri et al, 1988).
Additionally, a group of factors has been described which are present in
the cytoplasm of all cells but in an quiescent form (ie NFKB; Lenardo and
Baltimore, 1989). In response to an extracellular signal (LPS) the NFKB
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disassociates from its inactivator 1Kb in the cytoplasm, assumes its active
configuration and is transported to the nucleus. The steroid hormone
receptor family functions in a like fashion (Beato, 1989).
Lastly, some activating proteins such as the adenoviral El A protein or
the VP16 protein of herpes virus do not bind to DNA directly but rather
activate transcription by interacting with or modifying other proteins (which
bind the DNA; Kovesdi et al, 1986; Raychaudhuri et al, 1988; Simon et al,
1988; Triezenberg et al, 1988). Hence, the regulation of the transcription
factors can occur in several ways, and it is not merely the presence or absence
of a factor, but rather its correct state of modification and the extent of its
protein-protein interactions which determines its ultimate transcriptional
activity.
How do these factors generate the tissue specific transcriptional profile
of a differentiated tissue? Are specific factors involved in each process, or do
these genes make use of unique combinations of common cellular factors.
Furthermore, how are these factors themselves regulated during
development. The approach to these questions calls for the study of a group
of genes all active in a specific cell type, from which an analysis of regulatory
regions and an identification of the transcriptional proteins might reveal
important elements involved in their control. These questions can be
approached by studying coordinate expression of a set of genes in hepatocytes,
the cell-type that carries out the differentiated functions of the liver.
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II. Liver gene gypr?ggion

Advantages of using the mammalian liver to study development
The liver is the second largest organ (the skin is the largest), and due to

its large size, the developing liver can be studied at an early stage of growth,
for it always represents a good source of cellular material, whether it be DNA,
RNA or protein. The liver constitutes approximately 1-2 percent of the weight
of adult animals and as much as 10 percent of the weight of the fetus.
(Doljanski, 1960; Jones and Spring-Mills, 1983) Furthermore, the liver is a
homogenous tissue composed almost entirely of one parenchymal cell type,
the hepatocyte. About 50% of the nuclei in liver are hepatocytes and due to
their large size they constitute as much as 80-90% of the volume of the liver
(Figure 1.2; Greengard et. al, 1972). In addition, since most hepatocytes are
tetraploid, perhaps as much as 90% of the transcription in the liver occurs in
hepatocytes(Greengard et al, 1972).
The liver is the center for a multitude of endocrine and exocrine
functions and hepatocytes are intricately involved in the maintenance of
normal metabolism, detoxification, and in the production of many other
tissue specific enzymes and serum proteins of major physiological
importance (Greengard, 1969; Jungerman and Katz, 1982). Perhaps more cell
specific products are synthesized by hepatocytes than any other cell type
(Darnell, 1985). Since many genes which encode these cellular proteins are
expressed at high rates, a large number have been cloned and analyzed with
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respect to their expression during hepatocyte development. This allows an
analysis of the process by which a set of cell-type specific genes are expressed
coordinately in a single cell type.
A schematized representation of the adult liver is shown in Figure 1.2,
depicting cords of hepatocytes juxtaposed to their blood supply. The liver
lobule has been defined to consist of small functional units termed acini
(Rappaport, 1976; Jones and Spring-Mills, 1983). These acini are divided into
three zones based upon the hepatic microcirculation, and it is now known
that several genes in the liver are transcriptionally regulated in a position
dependent fashion (e.g. glutamine synthetase; glutathione-s-transferase; Kuo
et al, 1988). The serum albumin gene, however, which represents the focus of
these studies, is transcribed by all hepatocytes (Bennett et al, 1987).

General approaches to the study of hepatocyte gene expression
To approach the question of hepatocyte-specific gene expression during
development and hepatocyte differentiation, several groups isolated cDNA
clones representing abundant liver gene mRNAs (Derman et. al, 1981;
Tilghman and Belayew, 1982; Cistanzom et. al, 1983). These clones were then
used as molecular hybridization probes for the quantitation of mRNA
accumulation and an analysis of gene transcription rates in both liver and
non-liver tissues using the in vitro nuclear run-on assay. This assay involves
isolating nuclei from various tissues, and elongating previously initiated

18

Figure 1.2.

A

schematized representation of the morphology of the

mammalian liver. Depicted are hepatocytes, the major cell type in the liver,
juxtaposed to their blood supply. Structures are as marked. (From Elias and
Sherrick, 1968).
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R N A polymerase II transcripts in the presence of labeled nucleotides. Since
no new initiation reactions occur, this method allows a determination of the
relative rates of transcription for any gene in a given cell-type (Weber et al,
1977; Hofer and Darnell, 1981). The transcriptional signals for a group of the
cDNA clones (a dozen or so) studied were higher in liver nuclei as compared
to brain or kidney nuclei while the relative rates of transcription for clones
representing genes transcribed in most all cell types (e.g. actin and tubulin)
were similar (Derman et al, 1981; Powell et al, 1984).
From these results, several basic conclusions have emerged. First, it
has become evident that two general groups of liver specific transcripts exist:
those expressed exclusively in the liver and others preferentially expressed in
the liver (though at 100-1000x greater levels; Derman et. al, 1981; Powell et al,
1984; Darnell, 1985). Furthermore, the major level of regulation for many of
these genes appears to be transcriptional initiation, for the transcriptional
decrease in non-liver tissues completely accounted for the lower levels of
accumulated RNA (Derman et. al, 1981; Tilghman et. al, 1982; Cistanzom et.
al, 1983; Powell et. al, 1984; Panduro et. al, 1987a). Interestingly, for the
common cellular genes analyzed (actin and tubulin) a major component of
their regulation appeared to occur posttranscriptionally, since their levels of
cytoplasmic RNA were found to be higher than could be accounted for by the
transcription rate alone (Powell et al, 1984) The transcription rate of albumin
has been evaluated in this fashion in both liver and non-liver cell types
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(Table 1.1; Tilghman and Belayew, 1982; D e r m a n et al, 1981; Powell et al,
1984; Liu et al, 1988). Albumin is among the most actively transcribed liver
specific genes.

Developmental Regulation of liver gene expression
Many of these liver-specific clones were subsequently used to measure
the relative rates of transcription and steady state mRNA accumulation at
different developmental stages (Tilghman and Belayew, 1982; Powell et al,
1984; Panduro et al, 1987a). Interestingly, two of the most abundant liver
specific mRNAs, albumin and a-fetoprotein, are developmentally regulated
in a reciprocal fashion. Figure 1.3 shows a time course of albumin and afetoprotein messenger RNA accumulation during mouse development
(Tilghman and Belayew, 1982). Both genes are transcriptionally activated at
prenatal day 16 with a-fetoprotein expression quickly reaching its maximal
level while albumin expression increases more slowly. At birth, afetoprotein levels rapidly decrease while albumin steadily increases to its
maximum level which is obtained at two weeks of age. At that point, many
other "adult" liver genes are expressed at their maximal rates including
contrapsin, tyrosine aminotransferase, and cytochrome P450 (Panduro et al,
1987a), along with the genes encoding proteins involved in the pathway of
gluconeogenesis. These observations (for albumin and a-fetoprotein) have
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Liver

100%

HepG2

10%

Fao

10%

CWSV1

50%

C2
C2rev7

0.5%

Hela
Brain
Kidney

Table 1.1. Relative albumin transcription rates in different cell types. Nuclear
run o n transcription analysis w a s used to measure the relative albumin
transcription rates in rat and h u m a n hepatoma cell lines and tissues (as
described in the text).
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Figure 1.3. Developmental regulation of albumin and a-fetoprotein m R N A
levels. At various stages of mouse development, livers were excised, R N A
was purified and hybridized to filters containing the albumin (filled-in circles)
and A F P (open circles) c D N A clones. These values were then plotted (vertical
axis) as a function of the time point in liver development (horizontal axis).
(From Tilghman and Belayew, 1982).
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been confirmed at the level of transcription (Powell et al, 1984.)
Interestingly, the decrease in a-fetoprotein mRNA following birth
coincides with the cessation of cellular DNA replication (which is a
characteristic of terminally differentiated hepatocytes), as measured by
thymidine incorporation (Tilghman and Belayew, 1982). In fact, the relative
levels of albumin and a-fetoprotein is often used as a standard for defining
the state of differentiation of hepatocytes. Alphafetoprotein has been shown
to increase by as much as 1000 fold in hepatomas, carcinomas, embryonal
germ cell tumors, and following liver injury, suggesting that the previously
differentiated hepatocytes have dedifferentiated to a more fetal stage
(Petropoulos et al, 1983; Panduro et al, 1987b). In many of these situations,
the transcription rate of albumin either decreases or stays the same,
depending on the exact nature of the inducing stimulus (Petropoulous et al,
1983; Panduro et al, 1986, 1987a). Hence, a high rate of transcription of
albumin, in the absence of a-fetoprotein, is characteristic of the end stage,
differentiated hepatocyte.
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III. In vitro systems for the study of hepatocyte development
differentiation

and

Primary hepatocyte cell culture
Liver differentiation and hepatic gene expression can be studied using a
variety of in vitro systems. The most obvious choice would be to maintain
primary hepatocytes in culture and to use these cells to analyze the regulation
of expression of the endogenous and newly introduced liver preferential
genes (by DNA transfection or recombinant virus infection). It is possible to
perfuse, disaggregate and culture hepatocytes from rodent liver or human
surgical biopsies (Clayton and Darnell, 1983; Reid and Jefferson, 1984), using
collagenase and the chelating agent EDTA to disrupt the junctions between
neighboring hepatocytes. However, under standard serum supplemented
culture conditions these primary cells rapidly loose their hepatocyte
morphology and with increasing time in culture, do not transcribe their liverspecific genes (Clayton and Darnell, 1983; Reid and Jefferson, 1984). Freshly
plated hepatocytes (0-2h in culture in plastic dishes) maintain high rates of
liver gene expression, comparable to liver hepatocytes. In contrast, at 24h the
rate of transcription of the liver specific, but not common genes (actin and
tubulin), decreases dramatically (1-10%) compared to the levels observed in
freshly excised liver tissue (Clayton and Darnell, 1983). The liver-specific
mRNA levels persist significantly longer (2-5 days), eventually declining as
the tissue specific character is lost (Clayton and Darnell, 1983; Jefferson et al,
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1984). This suggests a preferential stability of these liver m R N A s which
persist in culture. Since the transcriptional rates of this entire series

is dramatically lowered in a coordinate fashion, the involvement of a gene
signal is implied. It has been suggested that certain substances such as

hormones, nutrients and metabolic products, present in situ are lacking in

the culture system (Clayton et al, 1985a, 1985b). Alternatively hepatocytes

might need their normal cell-cell contacts as a signal which enables them

coordinately activate a group of characteristic functions (Reid and Jeffer
1984; Clayton et al, 1985b). This is suggested strongly by work on tissue

sections which shows that liver specific gene transcription is maintained
much longer periods of time (Clayton et al, 1985b). Certain experimental

systems have tried to extend the period of liver specific gene expression

better mimicking the in vivo situation (ie, culture on collagen, media wit
DMSO) with limited success (Reid and Jefferson, 1984). What these studies

suggest; however, is that the expression of a wide variety of unrelated li

specific genes is probably controlled by a limited number of liver-specif

transcription factors. Therefore, after disaggregation of hepatocytes, the

production of any of these regulatory factors would affect the expression
many related genes.

Hepatoma cell lines
Numerous hepatoma cell lines have been isolated as tumor explants

from both rodent and human liver (Reuber, 1961; Knowles et al, 1980). Many
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clonal cell lines established from these tumors either do not express specific
liver genes or more often express specific liver genes at diminished rates (See
Table 1.1). This most probably is a reflection of the state of cellular
differentiation of the individual hepatoma cell lines. This variability can be
both advantageous and disadvantageous from an experimental point of view.
For example, the albumin gene is transcribed in human HepG2 cells at only
10% the rate observed in adult liver hepatocytes (Table 1.1; Clayton et al,
1985a; Friedman et al, 1986). While HepG2 cells are easy to maintain and are
amenable to transient expression assays, the lack of a fully differentiated
hepatocyte phenotype might lead to an inability to detect all levels of livergene regulation (particulary the regulatory events responsible for
maintaining the rate of transcription of any liver-specific gene). Despite this
drawback, however, these cells have been used to characterize the expression
of the tissue specific albumin promoter element which I describe in this thesis
(Friedman et al, 1986; Babiss et al, 1987) and those of other liver specific genes
expressed in hepatocytes including the transthyretin (TTR; Costa et al, 1986;
Costa et al, 1988a), a 1-antitrypsin (Ciliberto et al, 1985) and a-fetoprotein
genes (Godbout et al, 1986, 1988a), each maximally expressed at distinct
developmental stages for which the hepatoma cell represents a suitable but
non-optimal cell choice.
However, this transcriptional variability can become a benefit since
each tumor cell line represents a fixed genetically stable stage of hepatocyte
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development.

For example, the F a O cell line (Deschatrette et al, 1974;

Deschatrette et al, 1980) has been shown by several groups to transcribe the
albumin gene at only 10-20% the rate observed for intact hepatocytes (Cassio
et al, 1981; Clayton et al, 1985a; Friedman et al, 1987), suggesting it is only
partly maintaining the differentiated liver phenotype. A subclone of FaO
cell, however, the C2 cell line (Deschatrette et al, 1974; Deschatrette et al,
1980), was subsequently selected based upon its inability to divide without
glucose (this being indicative of an absence of the hepatocyte specific
gluconeogenic enzymes; Bertolotti et al, 1987). These cells express few if any
liver specific functions (determined at the level of transcription), and are
considered to be dedifferentiated (Deschatrette et al, 1987; Clayton et al,
1985a).
Additionally, a C2 revertant (C2rev7), was selected based on its ability to
again grow in glucose free medium (indicating reexpression of liver specific
gluconeogenic enzymes), and it accumulates cytoplasmic albumin mRNA to
the same levels observed in the FaO cell line, but unlike FaO cells, transcribes
the albumin gene at barely detectable levels (Friedman et al, 1987). Therefore,
although this cell line is synthesizing albumin, it has not fully reverted back
to the same state of cellular differentiation as the FaO cell line, for its recovery
of albumin gene expression is based mainly on post-transcriptional events
(Friedman et al, 1987). Hence, as will be shown in chapter 8, these stable cell
lines can be used to correlate the levels of the different transcription
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regulatory factors with the transcriptional rate of albumin (and for that matter
other liver specific genes), thereby evaluating their biological roles.
Furthermore, additional experiments using somatic cell hybridization
techniques have shown that when hepatoma cells are fused with a variety of
other cell types, liver-specific functions are most always "extinguished"
(Weiss and Chaplain, 1971; Fougere and Weiss, 1978; Mevel-Ninio and Weiss,
1981; Killary and Fournier, 1984). This suggests that diffusible factors are
involved in the coordinate control of liver-specific gene expression, and
implys that negative regulation is involved. This will be discussed in chapter
7, when a negative element present in the albumin enhancer is described.

CWSV1 Cells
Immortalization of adult hepatocytes with DNA tumor viruses
(Adenovirus and SV40), has recently lead to the isolation of several cell lines
which express liver specific genes, including albumin, at levels approaching
that of normal adult liver cells (Table 1.1; Woodworth et al, 1986;
Woodworm and Isom, 1987; Zaret et al, 1988). Like the hepatoma cell lines;
however, it appears as though the rate of albumin transcription cannot fully
account for the levels of cytoplasmic albumin mRNA observed, again
suggesting a change in post-transcriptional regulation exists (Woodworth et
al, 1986). Furthermore, since some of these cell lines (ie. CWSV1) are
maintained in a chemically defined medium, a more precise analysis of
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paracrine substances (ie hormones and growth factors) which m a y have
significant effects on hepatocyte differentiation can be measured
experimentally.
CWSV1 cells are SV40 immortalized rat hepatocytes which have been
selected for on the basis of albumin production, and they transcribe albumin
at 50% the rate of the intact rat liver (Woodworth et al, 1986). Furthermore,
like hepatoma cells, these cell lines can be used in transient expression assays,
and they have been employed in this thesis to investigate the albumin gene
enhancer. The fact that they have the highest level of endogenous albumin
transcription of any continuous cell line makes them a good choice for study
in cases where rate enhancement is under investigation.

Transgenic mice
Transgenic mice have been used to study gene expression during
development in different tissues (Palmiter and Brinster, 1986). By introducing
a transgene containing specific amounts of upstream regulatory sequences
into the developing mouse embryo, it is possible to assay the expression of
this gene in tissues throughout development. This method has been used to
define several cis-acting DNA elements that contribute to both the specificity
and rate of liver-gene expression, including the al-antitrypsin, albumin and
a-fetoprotein genes (Hammer et al, 1987; Pinkert et al, 1987; Camper and
Tilghman, 1989). While time-consuming and technically difficult to prepare,
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the major advantage of this approach is that the gene of interest can be
studied in the context of chromatin structure, which as already discussed
represents an important level of gene control. While corrections must be
made for copy number (multiple copies of the endogenous gene might be
present) and chromosomal location considered, this approach obviates many
problems associated with the hepatoma cell studies, including the potential
identification of cis-elements that contribute to transcriptional rates.

In Vitro Transcription
Liver specific gene transcription can also be achieved using cell free
nuclear extracts (Gorski et al, 1986). Transcriptionally active liver extracts
can be made which transcribe liver gene templates more efficiently than
non-liver extracts. The studies of Gorski et al. demonstrated that the mouse
albumin gene is transcribed at a higher rate in extracts prepared from liver,
than in brain or spleen extracts. Similar in vitro liver specific transcription
has since been observed by investigators using other liver specific genes, and
the regulatory regions determined (via deletional analysis) correspond well
with those uncovered by transient analyses (Cereghini et al, 1988; Lichtsteiner
et al, 1987; Monaci et al, 1988). Now that multiple liver specific factors are
both purified and cloned, this in vitro method will allow the analysis of a
reconstituted liver gene transcription system, in which the mechanistic
interactions of the separate components can be precisely analyzed.

31

IV. T h e serum albumin Gene
Serum albumin is involved in the maintenance of osmotic pressure
and in the transport of many substances throughout the bloodstream
(Rothschild et al, 1988.) The substances transported by albumin vary widely
from hormones to fatty acids, toxic waste products, bilirubin, fatty acids and
exogenous drugs. Serum albumin is known to have a single, unmodified
peptide chain of 580 to 585 amino acids, depending on the species, and its
secondary structure has a unique pattern of double loops held together by
disulfide bridges. Albumin protein levels in the serum are maximal
following birth (Rothschild et al, 1988).
Albumin is very similar to the a-fetoprotein gene with respect to
genomic structure and protein function. The proteins exhibit nearly identical
ligand binding properties and have significant amino acid sequence
homologies, suggesting that they might have arisen because of a gene
duplication event early in evolution (Gorin et al, 1981; Jagodzinski et al,
1981; Kioussis et al, 1981; Law and Dugaczyk, 1981; Ingram et al, 1982).
Furthermore, an even greater homology is observed between their DNA
sequences especially in the promoter regions which interact with crucial
regulatory proteins. Both genes are found on the same chromosome
(chromosome 5, 14, and 4 in mouse, rat and human ), with the albumin gene
located 5' to the a-fetoprotein gene, separated by 13-14kbp (Figure 1.4
Tilighman and Belawew, 1982; Gorin et al, 1981; Ingram et al, 1982; Urano et
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Figure 1.4. Genomic structure of the albumin and a-fetoprotein genes. These
genes are very similar with respect to their genomic structure and protein
functions. Both genes are found on the same chromosome (chromosome 5,
14, and 4 in mouse, rat and human, respectively), with the albumin gene
located 5* to the a-fetoprotein gene and separated by 13-14kbp.
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al, 1984; Gal et al, 1985; Tilghman, 1985, Nahon, 1987). Each is transcribed
with the same polarity, so it is possible that albumin transcription could
extend into the a-fetoprotein gene domain. Further, the mRNAs encoded by
both genes are very similar with respect to the complexity of their
exon/intron organization. However, as stated earlier, the expression of these
genes is regulated in a reciprocal manner; this happening at the level of
transcriptional initiation (Tilghman and Belayew, 1982; Powell et al, 1984;
Nahon et al, 1987).

Transcriptional regulation of albumin
The serum albumin gene has been cloned and analyzed from many
species. The rat gene is composed of 35kbp of contiguous DNA sequence
containing 14 exons and 13 introns (Sargent et al, 1979), and the mouse clone
is quite similar (Tilghman and Belayew, 1982; Tilghman, 1985). A strong
sequence conservation exists 5' to the capsite of the rat, mouse, chicken and
human albumin genes, extending to 250bp upstream, suggesting functional
importance for these sequences, and the factors which interact with them
(Figure 1.5; Cereghini et al, 1987). As will become evident in chapter 3 of this
thesis, this was proven to be the case.
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Figure 1.5. Sequence homology between the 5' upstream promoter regions of
the rat, mouse and h u m a n albumin genes. The regions of greatest homology
are boxed, and these conserved elements will be s h o w n in chapter 3 to
represent sites for binding of regulatory factors, (from Cereghini et al, 1987).
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A l b u m i n chromatin structure
Perturbations in the chromatin structure are usually associated with
regions of active transcription. It is currently believed that DNase I
hypersensitivity indicates DNA sequences upon which the interaction with
histones is affected in such a way as to facilitate the accessibility to the
transcriptional machinery (Morse and Simpson, 1988). This could be the
result of either the complete absence of nucleosomes or alternatively might
reflect changes in the composition, conformation or the extent of interactions
between different histone proteins (Stadler, 1980; Wu, 1980; Weisbrod, 1982;
Roche et al, 1985; Morse and Simson, 1988; Ceder, 1988). Furthermore, these
regions of hypersensitivity often contain identified cis-acting regulatory
sequences, with corresponding cellular transcription factors bound to them
(Jongstra et al, 1984; Zaret et al, 1984), and recent in vitro experiments have
shown that the formation and stabilization of transcription initiation
complexes with sequence specific factors can competitively exclude histones
and prevent the inhibitory effect of nucleosomes (Workman and Roeder,
1987). This latter result strongly suggests it is the presence of specific
transcription factors at the time of DNA replication that might designate
chromosomal regions for potential transcriptional activity. In this way, a
gene is committed to the active state and the information contained in the
chromosome stably transmitted (Brown, 1984).
Additionally, in many cases methylation has been observed to correlate
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with tissue specific gene expression, and treatment of cells with azacytidine, a
potent demethylating agent, activates a host of cellular genes (Davis et al,
1987; Ceder, 1988). Methylation therefore represents another mechanism by
which genetic information can be passed along during cellular replication, for
that is the time when the DNA is methylated. For albumin, it has been
shown that decreased methylation correlates with its increased expression as
shown in hepatoma cell lines, their variants and extinguished hybrids
(Orlofsky and Chasin, 1985). All these studies demonstrate that chromatin
organization is a fundamental level of gene control, which in concert with
the transcription factors, works to create the potential for transcriptional
activation.
Therefore, as an early approach to identifying DNA regions which
might contribute to the specificity and rate of albumin gene expression,
chromatin structural studies were performed on the rat albumin gene
upstream sequences. For this study, DNA was analyzed from cells which did
not express albumin [Hela and C2 cells, spleen, kidney, and brain tissues and
late cultured (for 24-96h) hepatocytes], express intermediate levels of albumin
[FaO and C2rev7 cells, and early cultured (2-24h) hepatocytes] or express the
albumin gene at a high rates [liver tissue]. The nuclei from these different
cell types were prepared and DNase I hypersensitive sites were mapped
(Babiss et al, 1986).
The DNase I hypersensitivity pattern of the rat albumin gene sequences
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between -7.3kbp to +2.26kbp (relative to the start site of albumin transcription)
was first examined in liver and kidney cells and in cells (ie. early and late
primary hepatocytes, hepatoma cell lines) which express albumin to varying
extents (Babiss et al, 1986). The major conclusion of this work was that three
hypersensitive sites were present in liver nuclei at roughly -0.05, -0.2 and
-2.8kbp relative to the start site of albumin transcription, which were liver
specific. In cultured hepatocytes (24-96h in culture) or hepatoma cells (FaO),
where albumin transcription is 10 - 20% of that in the intact liver, the two
more promoter proximal hypersensitive sites were present while the -2.8kbp
site was lacking. Therefore, it was reasoned that the hypersensitive sites
between -0.05 and -0.2 kbp were involved with the tissue-specific expression
of the albumin promoter while the hypersensitive site at -2.8kbp was
necessary to maintain high rates of albumin expression. The C2 hepatoma cell
line, which does not express the albumin gene, had a unique hypersensitive
sites at -1.5kbp, and this site was absent in the C2rev7 cell line, which regained
albumin promoter activity. It is still unclear whether this site is responsible
for the suppression of albumin gene expression in the C2 cell line.
Liu et al. (1988) conducted a similar type of study for the mouse
albumin gene, extending their analysis as far upstream as 15kbp and as far
downstream as +16.5kbp. They found many hypersensitive sites present only
in the liver, including sites at -O.lkbp, -3.5kbp -10.8kbp and -13.7kbp. Pinkert
et al also described hypersensitive sites in this region (one at -10.4kbp; Pinkert
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et al, 1987). The presence of these multiple hypersensitive sites implicates
both the promoter proximal and far upstream sequences for involvement in
the regulation of albumin expression.

The albumin promoter
The albumin promoter proximal sequences have been studied by
numerous groups and shown to be necessary for tissue-specific expression

the albumin gene. This was initially analyzed both by plasmid transfectio

studies using hepatoma cells (Ott et al, 1984; Heard et al, 1987), or by u
non-replicating adenovirus vectors containing the rat albumin gene

sequences extending from -441 to +957 (exons Z and A) and infecting human

(HepG2) and rat (FaO) hepatoma cells (Friedman et al, 1986). The studies o

Friedman et al, using the viral vector system, are the basis for the albu
promoter analysis which is described in chapter 3. It was shown that the
albumin containing viruses direct expression in HepG2 cells, but not in

mouse myeloma cells. No such activation in HepG2 cells was observed by th
mouse immunoglobulin and mouse p-globin promoters also present on

adenoviral genomes, the former of which (with its cell-specific enhancer)
active in myeloma cells (Friedman et al, 1986).
When the rate of albumin-viral (exogenous) transcription and
endogenous HepG2 cell albumin transcription were compared, however, that

from the viral albumin promoter was lower (Friedman et al, 1986). Therefor
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while the promoter proximal element w a s sufficient for maintaining
albumin tissue-specificity, it did not fully reconstitute the rate of albumin
expression. This along with the chromatin structural analyses presented
above suggested that additional sequences might be important in this regard.

V. Transcription of additional liver specific genes - coordinate gene control
As already stated, a basic understanding of the mechanism(s) by which
a wide variety of unrelated genes are coordinately expressed is the liver is a
long-range goal. From studies on the regulatory regions of several genes
transcribed preferentially in the liver (ie. Transthyretin, al-antitrypsin and of
course albumin), four liver specific (or enriched) transcription factors have
been extensively described. These factors (HNF1, C/EBP, HNF3 and HNF4 )
will be briefly introduced here. However, since all but HNF4 interact with the
albumin regulatory sequences, they will be encountered again in later
chapters of this thesis.

HNF1
The HNF1 factor was first described by Courtois et al, (1987) and later
shown to bind to the promoter proximal sequences of a large number of liverspecific genes including, albumin, al-antitrypsin, p-fibrinogen, TTR and afetoprotein (Courtois et al, 1988; Hardon et al, 1988; Monaci et al, 1988;
Feuerman et al, 1989), all of which represent promoters highly active in
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hepatocytes. In each case the deletion of the H N F 1 binding site produces a
large decrease in transcription. Since this protein is present almost exclusively
in the liver (though trace amounts are also present in the kidney), it was
named hepatocyte nuclear factor 1 (HNF1) by Courtois et al. (1987).
The transcriptional role of the HNF1 factor has also been demonstrated
in vitro where depletion of rat liver nuclear extract of HNF1 by
oligonucleotide competition, lead to a specific decrease in albumin promoter
function (Cereghini et al, 1988; Lichtsteiner and Schibler, 1989). Additionally,
a nuclear extract derived from spleen nuclei can become competent to
support albumin gene transcription solely upon the addition of purified
HNF1 protein, attesting to the vital role this protein must play in conferring
the liver specific phenotype (Lichtsteiner and Schibler, 1989).
HNF1 binds a palindromic consensus sequence containing two 6bp
inverted repeats separated by a single nucleotide. It has been purified and
shown to be a glycosylated protein with a molecular weight of 80-90kd
(Courtois et al, 1988, Frain et al, 1989; Lichtsteiner and Schibler, 1989).
Interestingly, a faster migrating variant (as determined by gel-shift analysis)
can be detected in dedifferentiated hepatoma cell lines that do not express any
liver specific functions, though the origin (same or different gene) and exact
role of this product is unclear (Baumheuter et al, 1988; Cereghini et al, 1988.)
The HNF1 factor has now been cloned (Frain et al, 1989) and sequence
analysis reveals it to belong to the homeodomain set of proteins (Ghering,
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1987), and it contains homology to the recently described P O U subfamily of
binding proteins (Herr et al, 1988; Frain et al, 1989). HNF1 is a highly liver
specific protein and its mRNA seems to be restricted to the liver (Frain et al,
1989). Preliminary transcriptional analysis, however, using a cloned cDNA
has detected transcription in several different mouse tissues (Xanthopoulos et
al, unpublished observations). This would suggest that a posttranscriptional
component is involved in HNF1 gene regulation.

C/EBP
The C/EBP protein was first identified by virtue of its binding to the
LTR of Murine Sarcoma virus and the CAAT box of the Herpes Virus TK
gene (Graves et al, 1986). It was purified from rat liver ( Johnson et al, 1987)
and demonstrated to interact with several enhancer and promoter elements
(SV40 enhancer, al-antitrypsin and TTR enhancer and promoter; Costa et
al, 1988b), as well as to CAAT box motifs, and hence, its name C/EBP
(CAAT/Enhancer Binding Protein). The C/EBP gene has been cloned from
the rat and mouse (Landshulz et al, 1988a; Xanthopoulos et al, 1989), and has
been found to be an intronless gene possessing the leucine zipper motif,
which is indicative of the ability of this factor to interact with DNA sequences
as a protein dimer (Landshulz et al, 1988b).
C/EBP is a liver enriched factor and it is present to lesser amounts in
fat and kidney tissue (Birkenmeier et al, 1989; Christy et a/.,1989; Kuo,
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Xanthopoulos and Darnell, In Press). Additionally, C / E B P has been shown to
be regulated at the level of transcriptional initiation (Xanthopoulos et al,
1989). Furthermore, the transcription rate of C/EBP decreases in late cultures
of mouse hepatocytes in a fashion similar to that for many genes regulated by
the C/EBP protein (Xanthopoulos et al, 1989). This suggests that the
coordinate expression of liver genes during liver development, and
suppression of liver-gene expression observed by cultured hepatocytes is
controlled to some extent by the level of this factor.
When oligomerized C/EBP directs liver transcription in vitro (Marie et
al, 1989), implicating it as a positive acting transcriptional protein. Friedman
et al (1989) have recently also shown that cotransfection and overexpression
of C/EBP in hepatoma cells can boost the transcriptional levels of an albumin
reporter gene (which is known to have C/EBP binding sites; Babiss et al, 1987;
Cereghini et al, 1987; Lichtsteiner et al, 1987; Chapter 3) by 50 fold.
Interestingly, in a similar experiment conducted in fibroblasts, the same
C/EBP clone produced no activation of the albumin construct. This cell type
dependance suggests that C/EBP might require an additional liver specific
protein or a liver specific modification in order to be functionally active
(Friedman et al, 1989).
A related protein, DBP, has recently been described which binds to the
same sequence as C/EBP (Marie et al, 1989). This factor was cloned by
Schibler and colleagues by screening a cDNA expression library with an

43

C / E B P binding site. Like C/EBP, D B P stimulates the in vitro transcription of
albumin and functions in cotransfection experiments as above, but in contrast
to C/EBP it is not a leucine zipper protein and it appears at later times in
embryonic development (Schibler, 1989). Furthermore, DBP, while a liver
specific protein, is transcribed in all tissues and hence unlike C/EBP,
posttranstscriptional mechanisms are involved in regulating its tissue
specificity. The ability of multiple proteins to bind the same DNA sequence is
not uncommon for transcription factors and similar situations are observed
for example in the cases of the octomer and CAAT binding factors (Dorn et
al, 1987; Herr et al, 1988).

HNF3 and HNF4
Two additional liver specific factors HNF3 and HNF4 have been
identified from studies on the TTR and al-antitrypsin genes (Costa et al,
1989). HNF3 was initially found by deletional analysis of the mouse
Transthyretin (TTR) promoter and specific point mutagenesis of this HNF3
site blocked transcription in HepG2 cells (Costa et al, 1989). Additionally,
oligomerization of the HNF3 binding site stimulated p-globin gene
transcription only in liver derived cell lines. This factor has been purified and
shown to be a 50kd protein. It has recently been cloned and preliminary
analysis suggests that it is transcribed in a liver specific fashion (Lai,
Xanthopoulos and Darnell, unpublished observations).
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F1NF4 sites were identified in both the T T R proximal and T T R
enhancer elements, again by transfection analysis, and the binding site of
factor very closely resembles the AF-1 factor described by Leff et al, 1989.
HNF4 is a 54kd protein which sequence analysis reveals belongs to the zinc
finger class of binding proteins. It has also been cloned and its tissue specific
regulation appears to be transcriptional (Sladek, Xanthopoulos and Darnell,
unpublished observations).

VI. Plan of the thesis
This thesis is divided into three major sections. The first involves a
study of the rat albumin promoter (Chapter 3). Recombinant adenoviral
vectors were used to introduce the albumin gene into human hepatoma cells.
This simplified the identification of the DNA sequences which were both
necessary and sufficient for dictating albumin cell-type specificity. An analysis
of the multiple DNA-protein interactions which occur upon this promoter
element was performed and the significant findings are presented in relation
to published reports by other groups who have also analyzed this much
studied regulatory region.
In the second section of the thesis, a functional characterization of the
far upstream mouse albumin enhancer element is presented (Chapters 4-7).
This sequence element was functionally demonstrated in CWSV1 cells to play
a critical role in the maintenance of the high rate of albumin transcription,
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and I have elucidated both positive and negative regulatory domains
involved in producing its tissue specific effect. Two novel regulatory proteins
have been identified, NLS1 (Non-Liver Specific protein \, Chapter 6) and
ANF (Albumin Negative Factor, Chapter 7), which along with the liver
enriched transcription factor C/EBP (Chapter 5), will be shown to function
combinatorally to dictate the liver specificity of the enhancer.
Lastly, in the third section of the thesis (Chapter 8), I explore the
question of how these transcription factors combine to modulate the
transcription of specific genes in different cell types, and also investigate how
the transcription factors themselves are regulated. Taking advantage of the
fact that the four liver enriched transcription factors just described have now
been cloned, the expression of these factors (at both the transcriptional and
post-transcriptional level) was assayed in several hepatoma cell lines and
their dedifferentiated variants. The levels of the factors were then correlated
with the transcription rates of two of their dependent genes, albumin and
transthyretin. These experimental findings help to further elucidate the
molecular mechanisms important for maintaining coordinate gene
transcription in hepatocyte derived cell-types.
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Chapter 2

Materials and Methods

Cells and Viruses
Monolayer cultures of human HeLa and 293 cells (Grahm et al, 1977)
were maintained in Dulbeccos modified Eagle's medium supplemented with
10% fetal calf serum. Human and rat hepatoma cells (HepG2, H4II, FaO, C2,
C2rev7 and H5) were all grown in monolayer culture in Ham's F12 media
supplemented with 5% fetal bovine serum, lx essential amino acids (GIBCO
laboratories) and 25^g of garamycin per ml (Schering corp; Ham, 1960;

Knowles et al, 1980; Clayton et al, 1985a). Primary cultures of rat hepato

were prepared by perfusion of rat livers in situ with EDTA and collagenas

using the procedure previously described for mouse hepatocytes (Clayton a
Darnell, 1983). Primary cells were cultured in Eagle's medium containing
10% fetal calf serum, lOfig/ml of hydrocortisone and lOug/ul of insulin.
CWSV1 cells were grown in serum free RPMI media which was

supplemented as described by Woodworth and Isom, 1986. This media (1 lite
contained 330ml RPMI (GIBCO), 15ml 7.5% NaHC03/4ml Hepes (1.5M), 40ml
BSA solution, 4ml Pen-Strep (lg Penicillin + 1 g Streptomycin/100ml) and
4ml lOOx trace metals. The BSA solution was prepared by mixing 320mg of
fatty acid free BSA to 8 ml of PBS (phosphate buffered saline), and

subsequently adding 160ul linolenic acid (5.4ul/ml absolute ethanol), and

160U-1 of ethanolamine (lOul/ml) dropwise. After stirring for 12hr at 4°C
400ul transferrin (lOOmg/ml PBS), 24u.l insulin (lmg/ml), 40ul
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dexamethasone and 14ul glucagon (lmg/ml) were added. The mixture of
trace metals was first prepared as separate solutions (A and B). Solution A (lx)
consists of 0.5nM MnCl2 4H20, 0.5nM (NH4) MO7O244H2O, 0.25nM NiSO46H20,
15.0nM Na2Se03, 0.25nM SnCl2.2H20, 2.5nM Na3V04, and 50nM CdS04 while
solution B consists of 250nM Na2Si03 .9H20. These two solutions were mixed
together immediately before use to prepare the lOOx stock. While routinely
grown in the above serum free medium (SFM), CWSV1 cells were split into
SFM containing 5% fetal bovine serum (Hazelton) for 4-6 hours until the cells
adhered to the plastic dish. At that time, SFM without serum was again used.
Viral stocks were obtained by infection of monolayer cultures of 293 cells and
the preparation of crude cellular lysates by repeated cycles of freezing and

thawing (Babiss et al, 1984). Titers of viral stocks were determined on 293 cells
by fluorescent focus assay (Thiel et al, 1967) with antiserum raised in rabbits
against cesium chloride-banded purified virions.

Preparation of plasmid DNA and clone Analysis
Plasmid bearing bacteria (usually the strain HB101) were grown
overnight in 500ml N broth (lOg bactotryptone, lg yeast extract, 8g NaCl, lg
Glucose and 0.3g CaCl2 per liter). The turbid cell suspension was spun at
3500rpm for 25min, resuspended in 30ml of Solution I (50mM Glucose,
25mM TrisCl, lOmM EDTA and 2mg/ml lysozyme), and allowed to stand at
room temperature for 5min. At that time, 40ml of solution II was added
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(0.2N N a O H , 1 % SDS), and the mixture was gently swirled. U p o n clearing,
40ml of Solution m was added (5M KAc pH 4.8, 57.5ml glacial acetic acid, 145.5
ml H20), with vigorous shaking. The flocculent white precipitate was
removed by centrifugation in a JA-14 rotor for 20min at 4°C, and filtration
through two layers of cheesecloth. The filtrate was then combined with 70ml
of isopropanol for 15 minutes at room temp. This was centrifuged in JA-14
rotor at 8000rpm for 30min, and the resulting pellet was dissolved in 9ml of
TE (lOmM Tris pH 8, ImM EDTA) to which was added lOg of CsCl, and 0.5ml
ETBr (lOmg/ml). This was added to an ultracentrifuge tube and centrifuged
in a VTI65 rotor at 45K for 16hr. Plasmid containing DNA bands were
harvested and purified by n-butanol and phenol/chloroform extraction
followed by ethanol precipitation.
A mini-prep procedure was used to prepare small quantities of plasmid
DNA for clone analysis. Bacteria were grown overnight on N broth plates (N
broth + 15mg/liter BBL granulated agar) containing the appropriate antibiotic.
A large number of cells was picked with a toothpick and dissolved in 80ul of
STET buffer (50mM Tris pH 8.0, 8% sucrose, 5% triton X-100, 50mM EDTA), to
which 5ul of a fresh lOmg/ml lysozyme solution was added. This suspension
in a 1.5ml microcentrifuge tube was boiled for 40 seconds and then
centrifuged (in a microcentrifuge) for 15 min. The pellet was removed and
the supernatant extracted with 60ul phenol/chloroform (24:1 v/v isoamyl
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alcohol). Following this separation, 20p.l of the aqueous phase was added to a
fresh microcentrifuge tube containing 40^.1 of ethanol. The DNA was

precipitated, subjected to a single 70% ethanol wash, desiccated and ana
by restriction endonuclease digestion.

Plasmid and recombinant adenovirus construction
Recombinant adenoviruses were constructed which contained variable
amounts of albumin promoter proximal sequence. To accomplish this, rat
albumin DNA sequences from -441 to +957 were cloned into pGeml as a
Hindlll - EcoRI fragment. This included 441bp of albumin promoter
sequence, the RNA start site and the A and Z exons (Sargent et al, 1979;

Sargent et al, 1981). Sequences were serially removed by linearizing this

plasmid (using either a Hindlll site at -441 or a BstEII site at +47) an
performing sequential deletion using the exonuclease Bal31 (Legerski et
1978). These digestions were routinely performed by incubating the DNA

(1.5pmoles ends) with O.lunit of Bal 31 (Boheringer Mannheim) in a buffe
containing: 20mM Tris pH 7.4, 600mM NaCl, 12.5mM CaCl^ 12.5mM MgCl2,

and ImM EDTA. Reactions were conducted at 30°C for a period of 1-5 min at
which point a lOuT aliquot was removed and added to 90ul of
precipitation/stop buffer (200mM NaCl, lOmM Tris pH 7.4 and 20mM EDTA).
Following phenol chloroform extraction and ethanol precipitation these
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albumin promoter containing fragments were B a m H I linkerized and cloned
using standard procedures (Maniatis et al, 1982) into the Bgl II site of the
plasmid construct AdBgl6 (Friedman et al, 1986) which contains adenovirus
sequences from 0 to 15.5 map units (1 map unit = 365bp) with the nucleotides
from 194 to 3320 deleted (Figure 2.1).
Plasmid DNAs were prepared, linearized at adenovirus nucleotide 3320
and mixed with the subgenomic adenovirus DNA (a fragment containing
from 3.85 to 100 map units). This adenovirus segment was prepared by
digesting the IN340 viral genome (Hearing and Shenk, 1983) with Clal which
cuts uniquely at 3.85 map units. This generated linear viral DNA that was
almost completely free from infectious molecules. Intracellular
recombination between the 3.85 to 100 map unit segment and each of the
plasmids resulted in the various adenoviruses described in the text. This
method of overlap recombination is described in greater detail elsewhere
(Babiss et al, 1984; Friedman et al, 1986).
The alb 194 virus series contained the left-end terminal 194 nucleotides
of the type 5 adenovirus genome followed by the rat albumin promoter
region (-441 to +957) and the first two exons of the albumin gene fused within
an intron to viral E1B sequences. This is performed in such a fashion that
the 3* E1B exon and E1B poly A+ site allow the formation of a stable mRNA
from the recombinant transcription unit (see Figure 2.1). Also included
within the E1B region is the adenovirus protein IX transcription unit.
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Figure 2.1. Genomic maps of the recombinant albumin adenovirus. In A
(top), the left end of the adenovirus genome is depicted with a diagram of the
R N A molecules produced from the El A and E1B regions. The angled lines
represent sequences which are spliced out of the mature m R N A s . Shown are
sequences from 0 to 15.5 map units of type 5 adenovirus (1 map unit = 365bp).
In A, bottom, is shown the cloning vector AdBgl6 (see text) in which
sequences from nucleotides 194 to 3320 were removed (represented by the
dotted line) and a Bgl II site created. This plasmid served as the recipient for
the deleted albumin promoter clones (containing upstream promoter region
(up to 441 base pairs) and 3' sequences to +957. In B, is diagrammed the
genomic m a p of the parent 441 base pair containing recombinant albumin
adenovirus. The dotted lines represent the albumin sequences. Note that
either the 13S or 22S E1B messages can be produced by the fusion
albumin/ElB gene (prepared by an intron fusion; Friedman et al. 1986).
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Construction of Mouse Albumin Enhancer Containing Expression Plasmids
Plasmid constructs with shortened versions of the mouse albumin

enhancer sequences placed at the -300bp position of its promoter proximal
region were prepared. These constructions were derived from a BamHI DNA
fragment containing albumin upstream sequences from -12.0Kbp to -8.43kbp
fused to the -300 mouse albumin promoter element and extending to +22 of

the albumin first exon (alb.EB.hgh, a gift of R. Palmiter, Pinkert et al,

that were cloned into the Bgl II site of the expression vector AdBgl6 whi

was described in the previous section (Friedman et al, 1986). This plasmid

(pRLl) was then digested with Hindlll (cuts at -10.5Kbp) and Sail (cuts a

nucleotide 5780 of the adenovirus sequence), and ligated into the polylink
of the pGEMl vector cleaved with the same enzymes. This plasmid (pRL2)
was the parent for the CWSV1 transfection constructs.
5' deletions were produced from the Hindlll site using the exonuclease
Bal31 and verified by sequence analysis (Maxim and Gilbert, 1980). The

enhancerless control was constructed by placing the -300(PstI) to +22(Bam
fragment from the mouse albumin DNA into the Bglll site of AdBgl6, and

subsequently subcloning the -300 (now a Bgin site) to Sail (nucleotide 57

adenovirus) fragment into the polylinker of pGEMl (this plasmid was named
pRL3).
Sequences were removed from the 3' end by taking advantage of

known restriction endonuclease sites (Ace I -9.9kbp Bgl II -8.9kbp; Pst -

54

while the 5' end was resectable by digestion with the endonuclease Hindin.
The DNA polymerase repaired termini were subsequently EcoRI linkerized
and the gel isolated fragments were placed in position 5' to the albumin
promoter and the orientation determined by restriction endonuclease
analysis.

Heterologous Mouse Albumin Enhancer Constructs
Heterologous constructs were designed using the mouse Transthyretin
(TTR) promoter. The TTR parent contains 202 base pairs of TTR upstream

sequence (of the RNA start site) along with the first two TTR exons, fuse
the SV40 large T antigen 3' end and poly A+ addition sites (Costa et al,

1988a). A unique Xbal site at -202 was used for insertion of the fragments

which were then appropriately oriented by restriction endonuclease digest
The TTR minimal enhancer sequences (a fragment taken from -1.96 to

-1.86Kbp upstream of the cap site) were fused immediately upstream of thi

promoter element at this same location (Costa et al, 1986). Fragments from
the albumin negative region (coordinates as described in chapter 7) were

generated by restriction endonuclease digestion, end repaired using kleno
polymerase, Xbal linkerized and placed between the promoter/enhancer
construct in either orientation as marked (+ or -). These fragments were
subcloned into pGeml and subsequently sequenced (Sanger et al, 1977).
Additional heterologous constructs were also designed using the
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m o u s e p-globin (Konkel et al, 1978) promoter. Albumin enhancer fragments
were cut with the appropriate enzyme and inserted in either orientation 341
nucleotides upstream from the p-globin mRNA start site. The SV40 enhancer
(Zenke et al, 1986) was inserted in this same location using Hindlll linkers.
This plasmid served as a positive control in the transfection assays.
Recombinant adenoviruses were isolated as previously described from
plasmids which contained either the mouse albumin promoter (-300
nucleotide upstream of the start site) alone or the albumin promoter with the
mouse albumin enhancer sequences from -10.5 to -8.43kbp placed
immediately upstream. The method of overlap recombination was again
used.

Plasmid Transfection, Adenovirus Infection and RNase T2 analysis of
Expression Constructs
Mouse albumin promoter and enhancer-containing plasmid DNA
(50|ig) along with the SV40 enhancer containing p-globin internal control
(20ug) was co transfected into CWSV1, HeLa, or HepG2 cells at 40% confluency
using the calcium phosphate-DNA co-precipitation procedure. Transfections
employing Hela and HepG2 cells were performed in DME containing 10% calf
serum, changed 3-4 hours prior to the procedure. CWSV1 cells were
transfected in Lebovitz L-15 media (GIBCO) containing 8ml of BSA solution
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(lOgBSA/100ml H 2 0), 4ul lOOx glucagon (150mg/ml), 5ml Pen-Strep, 8ml
NaBicarbonate and 20ml of fetal calf serum (Hazelton).
DNA to be transfected was resuspended in lOOul TE (lOmM Tris pH8.0,
ImM EDTA). Precipitates were prepared by adding the DNA to 800ul of 1/2

TE and lOOul 2.5M CaCl2 in a 15ml conical tube. Subsequently, 1ml of 2x HB
(50mM Hepes 7.2, 280mM NaCl, 1.5mM Na2HP04) was slowly added while

vortexing constantly. This was allowed to stand at room temperature for l

prior and then added to each plate. Four hours following transfection, the
cells were incubated for lmin with PBS containing 10% glycerol. The
PBS/glycerol solution was removed and the cells were washed two times

with Hank's buffered salt solution and fresh media added. The next day th

media was changed to Hams F12 for the HepG2 cells and serum free media fo
the CWSV1 cells. Cytoplasmic RNA was harvested from transfected cells at
48 hours after the transfection.
The cytoplasmic RNA was isolated using the method of Nonidet-P-40

(NP-40) lysis (Friedman et al, 1986), The media was removed from the cells

and they were washed with 5ml of ice cold PBS, The cells were then scrape

into 8ml of PBS and spun at 2000g for 5min at 4°C. Cells were resuspended

320ul of lysis buffer (0.14M NaCl, 1.5mM MgCl2, lOmM Tris pH 8.6) and 25ul

of 0.5% NP-40 was added. Nuclei were removed by centrifugation for 2 min,
and the supernatant was added to 300ul of 2x PK buffer (0.2M Tris pH 7.5,
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2 5 m M EDTA, 0.3M N A C L , 2 % w/v SDS) and 200ug/ml proteinase K at 65°C
for 30min. This was extracted 2x with phenol/chloroform and the RNA
precipitated in ethanol. This cytoplasmic RNA was scored for the
accumulation of the albumin-adenovirus hybrid mRNAs by protection
against nuclease digestion of labeled antisense RNA probes.
RNA probes were generated using either SP6 or T7 RNA polymerase

(Melton et al, 1984; Hart et al, 1985), as indicated in the specific figure

corresponding text. Total cytoplasmic RNA (20 ug) was hybridized to a spec

probe 7.5 x 105 total cpm and after RNase T2 digestion (55U/ml) at 30° C f

the products were sized on denaturing polyacrylamide gel. Multiple 5' or 3

assays were used through this thesis and they will be identified appropria
as they appear.
HepG2 cells were infected with the appropriate recombinant

adenovirus at 50pfu/cell for 24h in the presence of AraC (40fig/ml) to pre

viral DNA replication (Friedman et al, 1986, Babiss et al, 1987). Following
infection, cytoplasmic RNA was harvested, The poly (A+) containing RNAs
were isolated by oligo (dT)-cellulose chromatography (Nakazato and

Edmonds, 1974). Oligo (dT) was equilibrated in sterile loading buffer (20mM
Tris pH 7.6, 0.5M NaCl, ImM EDTA and 0.1% SDS, and a 1 ml column was
poured and washed with 0.1M NaOH, 5mM EDTA followed by 2-3 volumes
of sterile H20. The pH was monitored and maintained less than 8. RNA was
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dissolved in sterile water and heated to 65°C, allowed to cool and loaded twice
over the column. Poly A+ RNA was eluted with 2-3 volumes of sterile
elution buffer (lOmM Tris pH 7.5, ImM EDTA and 0.5% SDS), and

precipitated by adding sodium acetate. The production of stable cytoplasmi

RNAs from the fusion E1B gene in virus-infected cells was again scored usi

an RNaseT2 protection assay. The Viral E2a gene activity was measured as a
internal control for viral infectivity.

Cell and Tissue extracts
Adult male sprague Dawley Rats (Charles river; between 10-14 weeks of

age) were used to prepare nuclear extracts. Rat tissue (lOg; liver, spleen

kidney) was dissected at 4°C and immediately placed into 50ml of buffer on
(lOmM Tris pH 8; 0.35M NaCl). The TN buffer was decanted off (in a cold
room) and the tissue was finely minced and transferred to a 50ml motor
driven dounce homogenizer. containing 10ml homogenization buffer (0.32M
sucrose, 5mMCaCl2, 2mM MgOAc, O. IM EDTA, ImM DTT, lOmM Tris, pH
8.0 and 0.5mM PMSF), and subjected to 10 strokes The homogenate was then
filtered through 2 layers of cheesecloth, dounced ten times on ice (hand

dounce B pestle) and a sample analyzed for cellular breakage using a phase
contrast microscope. This homogenate was next combined with 2 volumes of
a solution containing 2M sucrose, 5mM MgOAc, O.lmM EDTA, lOmM
Tris-HCl,pH 8.0, ImM DTT, and layered over a 10ml cushion of the latter
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solution in a S w 2 7 tube. This was centrifuged at 13,000 rpm for 45 min. in a
Beckman L2-65B preparative ultracentrifuge.
The resulting nuclear pellet was resuspended and partially lysed in
20mM Hepes, pH 7.9, 25% glycerol, 0.42M NaCl, 1.3mM MgCl2, 0.2mM EDTA,
0.5mM PMSF, 0.5mMDTT (at a 2 to 1 ratio buffer to nuclei). This mixture was
then manually dounced ten times (Type A pestle, loose fitting), and nuclear
proteins were extracted over a 45 min. period at 4°C with mild shaking. The
viscous mixture was centrifuged at 25,000 rpm for 30min, using a Sw40 rotor.
Ammonium sulfate precipitation (0.3gr/ml) and dialysis of the nuclear
extracts was performed in BC100 buffer (lOOmM KC1, 25mM HEPES (N-2hydroxyethylpiperazine-N'-2-ethanesulfonic acid), pH 7.9), 20% glycerol and
0.1 M EDTA).
Cultured cell extracts (CWSV1, HepG2, and HeLa) were made according
to the procedure of Dignam et al. (1983), and these extracts were concentrated
by ammonium sulfate precipitation. Extract was stored frozen at -70° C in
BC100 buffer. Extracts from the rat hepatoma cells FaO, C2, C2Rev7 and H5
were prepared according to the procedure of Shapiro et al (1987) which
differed from the above chiefly in that the nuclei were quickly centrifuged
through sucrose prior to extraction. Protease inhibitors used included PMSF
(0.5mM final), pepstatin (lp.g/ml), Benzamidine HC1 (ImM final) and
leupeptin (0.5ug/ml final). Heparin agarose columns (5mg of protein per ml
of resin) were performed according to the procedure of Briggs et al, (1986).
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All extracts were examined to assess their equivalence (for both
protein amount and integrity) by performing gel shift assays using an
oligonucleotide containing a known binding site for the transcriptional
protein AP-1, which is found in most all cell-types (Lee et al, 1987). The
specific binding site used consisted of oligonucleotide B site from the alantitrypsin enhancer (Oligo B, Grayson et al, 1988a). An example of this
analysis is shown in Figure 2.2. This demonstrates that the extracts (prepared
in this case from HeLa cells or rat liver, brain or spleen tissue), contained
roughly equal amounts of nuclear proteins and that the integrity was
comparable.
In addition, these liver extracts have been shown to be transcriptionally
active (Figure 2.3). Using a G-less cassette system (Sawadogo and Roeder,
1985) templates containing either the mouse albumin promoter (650 or 50
nucleotides of 5' upstream sequence), the adenovirus major late promoter
(400 base pairs) or the p-globin promoter (341 base pairs) were assayed in a
reaction containing 45% liver nuclear extract (as described in Gorski et al,
1986). The final transcription buffer contained 25mM Hepes pH 7.6, 50mM
KC1, 0.6mM ATP, CTP, 35um UTP, O.lmM 3'-0-methyl-GTP, 12% glycerol and
1 ^1 of RNasin. As shown in Figure 2.3, each template generated a specific
transcriptional band, which could be inhibited by the inclusion of a-amanitin
(data not shown). Furthermore, the addition of albumin sequences (from -50
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Figure 2.2. A P I gel shift of nuclear extracts. A s described in the text, the
integrity of different nuclear extracts w a s compared by subjecting them to a gel
shift assay using a labeled probe containing an A P I binding site (Oligo B, alantitrypsin enhancer). For each lane, lng of labeled probe w a s incubated with
8jig of nuclear extract in the presence (+) or absence (-) of a 30 fold molar
excess of unlabeled A P I oligonucleotide. The arrow denotes the specific
retarded complex.
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In vitro transcription using liver nuclear extract prepared as

described in the text. Nuclear extracts from adult rat livers were used to
transcribe the m o u s e albumin gene (the sequences including -650 to +10
relative to the A L B capsite or a deletion to -50bp ) which had been cloned into
a vector that allows direct measurements of the rate of transcription
initiation, the G-less cassette. Also included is the p-globin promoter and an
adenovirus major late promoter G-less construct as described in the text. The
reactions are performed in the absence of exogenous G T P , which prevents
RNA

polymerase II elongation from occurring anywhere but at the

appropriate cap site.
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to -650 nucleotides upstream) provided a stimulation of transcription,
demonstrating that upstream trans-acting factors we present and able to
activate transcription in these extracts.

In Vitro DNA-protein binding assays
Gel mobility shift assays were used to identify DNA-protein

interactions in crude nuclear extracts (Fried and Crothers, 1981; Garner

Revzin, 1981). These assays were performed by incubating lng of end label

restriction fragment or synthetic oligonucleotide with 8-1 Oug of nuclea
extract in a 20ul binding reaction (containing 4ug of poly (dl-dC): poly
(Pharmacia), in 20mM HEPES pH 7.9, 40mM KC1, 2mM MgCl2, ImM DTT,
0.5mM EGTA and 4% ficoll) for 30min at room temperature. Following

incubation, 4ul of this mixture was electrophoresed on a native acrylami

gel (the percentage varying with the size of the probe) in 50mM TBE. Whe

used, an excess of cold competitor DNA or duplex oligonucleotide DNA was
employed (the precise fold excess is described with each individual
experiment).
Exonuclease in stop reactions were also used to explore DNA-protein

interaction (Wu 1985), essentially according to the protocol of Kovesdi e

(1986). For all reactions, 1 jxg of 5' end labeled DNA probe (uniquely la

using T4 polynucleotide Kinase) was combined with 30ug of nuclear extrac
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and 4jxg of poly d (I-C) which was included as a nonspecific competitor of
DNA-binding. Following ExoIII digestion (100U per reaction, BoehringerMannheim Biochemicals), the products were analyzed on 8% denaturing
polyacrylamide gels.
DNase I footprinting studies were also employed (Galas and Schmitz,
1978). These were performed using liver nuclear extract prepared as above
which had been fractionated on a heparin agarose column using a KC1 salt
gradient and Hela extract which had been fractionated on a PI 1 column using
KC1 steps (0.25M KC1 for liver and 0.4M step for Hela, respectively). The
fractions were dialyzed against BC100 buffer and a gel shift reaction was used
to determine the fraction possessing maximal binding activity. Subsequently,
a lng sample of
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P labeled probe was incubated with 5-30 ug of extract, 5ug of

poly (dl-dC) and 4% polyethylene glycol in a buffer containing lOmM Hepes
(pH 7.9), 7 mM MgCl2 and 0.75mM Dithiothreitol at 0°C for 60min. DNase I
was added for 3-4min and the reaction was terminated by the addition of
proteinase K (200|ig/ml) and sodium dodecyl sulfate (0.5%) The DNA was
extracted with phenol and ethanol precipitated, and the labeled fragments
were analyzed on an 8% denaturing acrylamide gel.

Methylation protection experiments
High specific activity 3' end-labeled probes were prepared by filling in a
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DNA

restriction site with lOOuXi of all four 32p deoxynucleotides ( N e w

England Nuclear Corp; 3,000 Ci/mmol) with the klenow fragment of DNA
polymerase 1 (Maniatis et al, 1982) followed by phenol-chloroform extraction
and ethanol precipitation. The DNA was recut with a second restriction
enzyme and the fragments were gel purified on a low melting-point agarose
gel (Bethesda Research laboratories). The methylation protection (footprint)
experiment involved incubating 20ng of this probe with lOOug of HepG2
extract in a 400ul reaction mixture under the same conditions as the gel shift
reaction. This mixture was subsequently treated with 2ul of dimethyl sulfate
(DMS) for 2 min and immediately loaded on a nondenaturing preparative
acrylamide gel (6%). The specific bands were localized by autoradiography
and eluted from the acarylamide and deproteinized by phenol-chloroform
extraction. The eluted DNA bands were then cleaved with piperidine and
analyzed on a denaturing 8% acrylamide gel to reveal G residues which had
been protected from DMS methylation by specific protein interactions.

Oligonucleotides
In many of the experiments described in this thesis synthetic
oligonucleotides were used as probes for gel shift reactions or as competitors
in any of the different in vitro protein assays described above. Five of these
double stranded oligonucleotides are shown in Figure 2.4. They are named
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Figure 2.4. Sequences of the oligonucleotides used as probes and competitors
in gel shift assays. Each is identified on the left by the n a m e of the protein
factor k n o w n to interact with it. The origin of each binding site is described in
the text.
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-103
-74
M M r - f AACAAACTGTCAAATATTAACTAAAGGGAG
n l M r I TTGTTTGACAGTTTATAATTGATTTCCCTC

C/EBP

-1,898
-1,869
ATCAGTAGTTTTCCATCTTACTCAACATCC
TAGTCATCAAAA.GGTAGAATGAGTTGTCGG

HNF3

-115
-85
TCGAGTTGACTAAGTCAATAATCAGAATCAG
AGCACAACTGATTCAGTTATTAGTCTTAGTC

HNF4

-66 -88
GCGCTGGGCAAAGGTCACCTGCTCGA
CGCGACCCGTTTCCAGTGGACGAGCT

NLS1

-10,015
-9,900
CATGCAGAAAGAAGTTTGGACTGATC
GTACGTCTTTCTTCAAACCTGACTCT

according to the cognate protein which is known to interact with their

sequence. Each oligonucleotides contains a four base pair overhang on eac

ends which was used for 3' end labeling. The sources of the oligonucleoti

are as follows: HNF1, P-fibrinogen promoter -103 to -74bp (Courtois et al
1987); C/EBP, mouse TTR promoter, -1,898 to -1,869 bp (Costa et al, 1988);
HNF3, mouse TTR promoter, -115 to -85 (Costa et al, 1989), HNF4, human

ApoCm gene, -66 to -88bp (Reue et al, 1988; Leff et al, 1989) and NLS1, m
albumin enhancer, -10.015 to -9,900 base pairs (Herbst et al, 1989).

Nuclear-Run On Transcription
Nuclear run-on analysis was performed to measure relative
transcription rates (Weber et al, 1977; Hoffer and Darnell, 1981). Nuclei

different tissues or cell lines were isolated according to the procedures

outlined earlier for the preparation of nuclei for extraction. After wash

transcription buffer lacking nucleotides (20 mM Tris, pH 7.9. 20% glycerol
mM KC1, 10mMMgCl2 and ImM DDT at 4°C) on ice, the nuclei were
resuspended in 100 jxl of complete reaction mix (ImM each ATP, CTP and
GTP, 0.3 to 0.5 mCi a-32p UTP (3000Ci/mmole; New England Nuclear). The

nuclei were then incubated for 15min at 30°C with gentle swirling to chai

elongate previously initiated RNA. At the end of the reaction, the synthe

of nascently labeled RNA was terminated by the addition of 2ml of HSB (50
mM NaCl, 10 mM Tris, pH 7.4, 50mM MgCl2, 2mM CsCl2 and 0.1ml DNAse
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(Worthington lmg/ml stock) at 25°C for 5' with occasional vortexing.

Following the addition of SDS (200ul of a 20% solution), EDTA (lOOul of 0.
and 3ml ETS (lOmM tris7.4, lOmM EDTA, 0.2% SDS), nuclear RNA was

isolated by hot phenol extraction (heated to 65°C) and ethanol precipitat
Unincorporated triphosphates were removed by precipitation of RNA with

trichloroacetic acid (Groudine et al, 1981). The total labeled RNA average
ct/min per cell nucleus.
Following RNA extraction, labeled RNA was hybridized to an excess of

cloned denatured DNA affixed as slots to 0.45 urn nitrocellulose (Kafatos
1979), and after RNase digestion, autoradiography was used to detect
hybridized RNA. pGem 1 plasmid was always included as a measure of non-

specific hybridization. These cloned DNAs were slotted onto nitrocellulos

(5(ig/dot) and prehybridized for 6h at 65°C in 2x TESS, 5x Denharts solut
(0.02% (v/v) Ficoll, 0.02% (w/v) bovine serum albumin, 0.05% (v/v)

polyvinylpyrollidone and 500ug yeast tRNA/ml. Nuclear hybridization (15 x
107 cts/ml) was conducted for 40h in 2x TESS (4x TESS stock: 0.1M TES pH
0.6 M NaCl, 0.02 M EDTA, 0.4% SDS), 5x Denharts, O.lmg/ml yeast tRNA,
0.1% sodium pyrophosphate in a final volume of 1 to 3ml. After extensive

washing (2x SSC at 65°C), filters were treated with ribonuclease at 37°C (

units/ml pancreatic RNase) in 2xSSC, blotted dry and exposed to Kodak XAR
X-ray film at -70°C with an intensifying screen for 16-72 hrs.
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D N A and Genomic Clones Employed
Spotted DNA included a clone for albumin, a 2400bp genomic fragment

(rat B genomic clone, Sargent et al, 1981), TTR, a 440 bp fragment of the r
TTR Gene (Dickson et al, 1985); HNF1 a 3Kb fragment M6 (Frain et al 1989)
(gift of R. Cortese); C/EBP (500bp pPSTl clone, Xanthopoulos et al, 1989);
HNF 3 and 4 were cDNAs of 655 and lOOObp respectively (Lai, Sladek and
Darnell, unpublished). A Chicken p-actin clone was used as a control
(Cleveland et al, 1980)

DNA sequencing
Most DNA sequencing was performed using the chemical sequencing
method (Maxam and Gilbert, 1980). 5ug of each DNA fragment was 5'

dephosphorylated using 1 unit of bacterial alkaline phosphatase in lOmM Tr

pH 8 for lh at 65°C, phenol extracted and ethanol precipitated. This DNA w

then end labeled using 1 unit of T4 kinase for lh at 37°C in a buffer cont
(0.5M Tris pH 7.6, 0.1M MgCl2, 50 mM DTT, ImM spermidine, ImM EDTA
and 32p yATP). The DNA was cut at a second site with a restriction
endonuclease and this now uniquely end labeled DNA was isolated using low
melting point agarose. In some cases, pGem cloned DNA was sequenced
using the enzymatic method employing the SP6 or T7 sequencing primers
(Sanger et al, 1977).
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Chapter 3

The Rat Albumin Promoter

It had previously been shown that the 441 nucleotides upstream of the
start site of the rat albumin gene can, when inserted into an adenovirus
vector, stimulate cell-specific expression (Babiss et al, 1986; Friedman et al,
1986; Friedman et al, 1987). In the absence of viral DNA replication, cellspecific expression of the albumin promoter is maintained. Rat hepatomas
(H4II and FaO), human hepatoma cells (HepG2), and primary mouse
hepatocytes all support exogenous albumin transcription from these
recombinant viruses (Friedman et al, 1986). In contrast, a number of nonliver derived cell types did not generate exogenous albumin expression.
These included myeloma cells (MPC11), HeLa cells, 293 Cells (human) and
CREF cells, a rat fibroblast cell line, indicating that this 441 nucleotide region
was both necessary and sufficient for maintaining liver specific gene
expression (Friedman et al, 1986). Similar conclusions had been reached by
Ott et al (1984), by transient transfection analysis of this same promoter
element into rat hepatoma cells.

Deletional Analysis of the Rat Albumin Promoter Element
To identify the precise upstream sequence elements that confer tissuespecific expression, Bal31 exonuclease digestion of a segment of the rat
albumin promoter was carried out, followed by cloning of the deleted DNA
into plasmids, to yield a series of promoter deletions (described in chapter 2).
Initial attempts at using DNA transfection to introduce these plasmids in
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H e p G 2 cells gave extremely low signals (below the level of quantitation),
even from the largest (441 nucleotide) albumin promoter construct.
Therefore, these promoter deleted constructs were introduced into the
adenovirus vector system described above (Babiss et al, 1986; Friedman et al,
1986; Chapter 2). These viruses, containing portions of the promoter, yielded
stable RNAs generated by transcription initiation at the albumin start site
followed by splicing of the albumin Z and A exons, the adenovirus Elb exon
and poly A addition sequences. The virus constructs which have deletions 5'
to their RNA start sites are named according to the nucleotide at the 5' end
of the albumin promoter sequence (Figure 3.1).
Human HepG2 cells were infected at a multiplicity of 50pfu/cell for 24h
in the presence of cytosine arabinoside (40|ig/ml) to prevent viral DNA
replication. Cytoplasmic RNA was isolated and the Poly(A+)containing
mRNAs were selected. The accumulation of albumin E1B fusion mRNAs
was measured using 32p-labeled sp6 antisense riboprobes, which recognize the
5' ends of the mRNA. The results of the assay are shown in Figure 3.1 (left
panel) and demonstrate that albumin promoter sequences extending to
position -156 are sufficient for maintaining albumin expression in HepG2
cells. Further deletion of 5* sequences to nucleotide -43 caused a complete loss
of albumin expression (the autoradiogram in Figure 1 was purposely
overexposed to show the lack of promoter activity from the albl94 (-43)
virus). To control for variations in the virus infection and RNA quantitation
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Figure 3.1. Functional analysis of the rat albumin promoter by viral
infection in H e p G 2 cells. Adenoviral recombinants containing the rat
albumin promoter sequences extending in the 5' direction relative to
the known start site for transcription to positions -441, -180, -156
and -43 and in the 3' direction to +957 were isolated by overlaprecombination in 293 cells .(as described in methods). Filled-in
boxes

show

exon

regions, open

parentheses

depict

promoter

deletions extending towards the cap site, and slanted parallel lines
indicate D N A sequences not shown between viral sequences at 9.6
m a p units and 100 m a p units (1 m a p unit = 365bp). H e p G 2 cells were
infected for 24hr with 50 pfu/cell of the appropriate virus in the
presence

of AraC

(40|ig/ml) to prevent viral D N A replication.

Cytoplasmic poly (A+) m R N A was isolated and 9\xg was hybridized with the
sp alb 5' riboprobe and 3ug was hybridized with the sp E2a riboprobe. The
protected R N A s were separated on a 5 % denaturing polyacrylamide gels. The
autoradiographic exposure was 12hr for the alb 5' assay and 20min for the E 2 A
assay. As shown in the bottom of the figure, the full-length labeled sp6 alb 5'
probe of 515 nucleotides is protected for 74 nucleotides while the E 2 A
riboprobe of 374 nucleotides is protected for 240 nucleotides. For comparison,
rat liver R N A (5ug) was also assayed using the sp alb5' riboprobe.
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prior to hybridization, a riboprobe assay for the viral E2a m R N A

was

performed on each of these samples. Since all the viruses led to formation of
equivalent amounts of E2a mRNA, the lack of viral-albumin expression from
the alb 194 (-43) virus was surely not due to an inability of this virus to infect
HepG2 cells (Figure 3.1, right panel). In experiments not shown, the 194 (-156)
virus was also active in rat hepatomas (H411 cells), but not in Hela cells (R.S.
Herbst and L. E. Babiss, unpublished observation). Thus the sequences
between -156 and -43 are able to dictate cell specific expression.
Two additional points should be made that relate to the use of 5' and 3'
assays for scoring albumin mRNA expression and for expression analysis in
general. First, the larger of the two protected hybrid bands shown in Figure
3.1 (using the 5' albumin assay) is most likely due to incomplete RNase T2
digestion. This does not to represent a second transcriptional start site or a
second splice acceptor site because primer extension analysis of the
recombinant viral-albumin mRNA (performed by extending an adenovirus
viral-albumin mRNA using an adenovirus E1B specific oligonucleotide)
revealed only one start site at the location indicated by the smaller (-74
nucleotide) sp6 band.
A second point is that the 3' assay on poly(A+) selected RNA from
infected HepG2 and Hela cells showed that the alb (-180) and alb (-156) viruses
accumulated RNAs containing the E1B sequence in both Hela and HepG2
cells (data not shown). However, analysis of these accumulated RNA
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molecules (using the 5' albumin sp6 riboprobe) showed that the transcripts
did not begin at the albumin start site but rather within the 194 nucleotides at
the left end of the adenovirus DNA. This activation of transcription might be
based on bringing the albumin initiation region close to the end of the viral
genome, which contains a potential enhancer element. Therefore, the only
valid measure of albumin promoter activity in the viral constructs was
achieved using the 5' sp6 assay scoring the first albumin exon. This is an
important point since very often the results of transient assays are reported
using assays which do not measure transcription from the actual RNA start
site (ie. CAT assays). Based on the above, such results must be interpreted
with caution, for they might not reflect transcripts generated exclusively by
the regulatory elements under study.

Detection of proteins that bind to albumin sequences between -156 to +47
Experiments were next designed to investigate the DNA-protein
interactions occurring on the albumin promoter. To determine if nuclear
proteins could physically interact with the albumin promoter sequences
between nucleotides -156 and +47, an assay was performed based on the
changed electrophoretic mobility of DNA when complexed with protein (the
"gel-shift" assay; Fried and Crothers, 1981). End labeled DNA fragments were
incubated with nuclear extracts in the presence of a nonspecific competitor of
DNA-binding proteins, such as salmon-sperm DNA, and the mixture was
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subjected to electrophoresis.

The slower mobility of any protein-DNA

complexes during electrophoresis was detected upon autoradiography of the
polyacrylamide gel When a 203-bp albumin DNA fragment (-156 to +47bp)
was reacted with proteins from HepG2 (7jig), HeLa (lOug) or primary
hepatocyte (7ug) nuclei, a slower moving DNA-protein complex could be
detected (Figure 3.2, data not shown). This shifted band was shown to be
specific since the labeled DNA-protein complex could be abolished if excess
unlabeled DNA of the same type (-156 to +47bp) was present in the
incubation, yet formation was not prevented by other regions of the albumin
promoter (sequences from -176 to -441 or -50 to +957), DNA from the mouse
prealbumin (TTR) promoter or the a 1-antitrypsin promoter (both of which
are expressed in hepatocytes; Costa et al, 1988a; Grayson et al, 1988a).
Additionally, fragments from the mouse p-globin promoter or from a series
of adenovirus promoters (EIA, E1B, E2A, E4) could not compete this shift.
The proteins capable of inducing the specific gel shift were also present
in HeLa cells (Figure 3.2). Since neither the endogenous nor recombinant
albumin promoter are able to activate transcription in HeLa cells, this result
was at first surprising. While this binding assay does not indicate that the
proteins from different cell types that produce a gel shift are necessarily
identical, this finding was the first indication that all or none differences in
the pattern of DNA-protein interaction between liver and non-liver cell types
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Figure 3.2. Factor binding to the rat albumin promoter sequences. A gel
mobility shift assay w a s performed as described in Materials and Methods,
using lng of end-labeled probe (sequences -156 to +957), salmon sperm D N A
(lug), and either H e L a cell nuclear extract (10ug) or H e p G 2 cell nuclear extract
(7ug) followed by electrophoresis through a low ionic strength polyacrylamide
gel. A s indicated above each lane binding reactions were done in the presence
of cold competitor D N A sequences at a 20 fold molar excess relative to the
labeled probe. The -50 to + 957 and -441 to -176 D N A fragments were rat
albumin sequences. The prealbumin (also referred to as T T R ) sequence spans
from nucleotide +40 to -202 and represents the region of that gene capable of
conferring cell-specific expression. The band resulting from the specific
interaction with the probe is indicated by an arrow.
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HepG2 extract
probe -156 to+47

Hela extract
probe-156 to+47

might not be responsible for the maintenance of liver specific gene
expression.

Localization of binding specificity
To further define the location of the DNA-protein interactions and the
distribution of albumin gene binding proteins in different cell-types, an
exonuclease III (exoHI) protection test was designed based on the experiments
of Wu (1985). This assay involves incubating a uniquely end labeled DNA
fragment with a nonspecific competitor (polydl-dC) and nuclear proteins
(30ug for each extract). The complexes that are formed are then exposed to
exoIII which digests duplex DNA in a 3' to 5' direction, stalling at regions
where DNA-protein interactions have occurred (exolllstop; Wu 1985; Kovesdi
et al, 1986). The partially digested DNA strands can then be analyzed by gel
electrophoresis.
When this type of digestion was carried out on DNA that was cut and
labeled at nucleotide +47, and then recut cut at nucleotide -156, a protein
binding region was detected with an upstream limit at position -123 (Figure
3.3, lower strand). Nuclear proteins from a wide variety of cell types:
hepatocytes, HeLa cells and kidney cells (data not shown) all produced an
exonuclease stop at this site. The protein(s) were preferentially bound to the
albumin promoter sequences as indicated by the suppression of the exoIII
stop band by a homologous competitor DNA ( RA-B; -176 to +47) and the
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Figure 3.3. Exonuclease III protection assays for the binding of albumin-gene
specific factors to albumin upstream sequences. Probes used for binding were
5' end labeled on the upper D N A strand (position -156 of strand equivalent to
the R N A ) or lower D N A strand (position + 47 of the strand complementary
to the m R N A ) of the probe. DNA-protein complexes were then incubated
with exonuclease IH, and partially digested labeled D N A was analyzed on 5 %
acrylamide denaturing gels. The lanes labeled "No ext" received no protein
and the lanes labeled "No exoIII" received no protein or exoIII. Thirty
micrograms of extract were used for each reaction. The origin of the extract is
s h o w n above each lane. R A - A (-441 to -176), R A - B (-156 to +47) and
prealbumin (-202 to +40) represent unlabeled D N A fragments which were
used as competitors in a 20 fold molar excess relative to the labeled probe in
reactions containing 30ug of liver nuclear extract. The exoIII stop fragments
are indicated by asterisks * and by their position relative to the albumin
transcription start site. A G + A sequence pattern is shown.
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failure of suppression by a non-homologous D N A competitor (RA-A.; -441 to
-176). Furthermore the -202 to +40 region of the prealbumin promoter did
not compete this stop. In addition to the exoIII stop at -123, a prominent
additional stop occurred at position -130 when extracts from cultured cells
were used. This included the Hela cell extract shown as well as the cell lines
H4II, FaO, C2 and C2rev7 (data not shown). This extra band was also observed
in extracts from the human hepatoma cell line HepG2 and hepatocytes
cultured for periods of either 4 or 48 hours. Remember from chapter 1 that
under the latter culture condition, albumin transcription declines at least 10fold. Thus some of the factors capable of binding to the albumin promoter
and producing the exoIII stop were still present in cultured cells that have lost
the liver specific transcription profile.
Exonuclease digestion experiments designed to determine the 3'
boundary of the protein binding region were also carried out with a probe
labeled at -156 and cut at +47 so that exonuclease digestion now proceeds from
downstream of the putative binding sites (in the opposite direction). ExoIII
stops were observed (Figure 3.3, upper strand) indicative of protein binding,
and again extracts from different cell-types gave similar protection results. A
strong exoIII stop site was observed at -106 and weaker bands were found
between -111 and -117. The site at -106 did appear to be stronger when extracts
came from early cultured hepatocytes (Figure 3.3: Upper strand Liv-E vs. LivL), in this case correlating with albumin transcriptional regulation. Another
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strong exoIII stop site was present at position -90. However, this site, like the
-130 exoIII stop on the lower strand, was only present in cultured cell nuclei,
and does not correlate with albumin gene expression. Additional exoIII stops
are observed but they were present in all the samples, including those to
which extract was not added, presumably resulting from difficulty in exoIII
digestion of particular DNA sequences (ie. DNA secondary structures).

Protein footprinting of the albumin promoter
To provide evidence of specific sites of DNA-protein contact,
suppression of DNA digestion by DNase 1 and methylation by DMS were
assayed on DNA sequencing gels (Galas and Schmitz, 1978; Wildeman et al,
1986). HepG2, Hela, liver and kidney nuclear extracts were each tested and
incubated with the same uniquely end labeled probe (-156 to +47, labeled on
either end), prior to DNase I or DMS treatment.
The DMS footprint on both strands of DNA is shown in Figure 3.4. On
the lower strand the only protection observed was at the G residue at position
-115. In addition a band at -110 (corresponding to an A residue) was rendered
more sensitive to cleavage by all the extracts (Wildeman et al, 1986). An
approximately equal effect was afforded by proteins in all extracts, although
note that different quantities of each extract was used; HeLa (25 ug), HepG2
(2ug), kidney (20 ug), and liver (lOug). Hence less liver or HepG2 protein is
required to produce this protection than protein from non liver cell-types.
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Figure 3.4.

Methylation protection experiment to define the albumin D N A

sequences that interact with nuclear factors. The -156 to +47bp D N A fragment
was labeled on the upper or lower D N A strand and incubated with various
concentrations of the following nuclear extracts; H e p G 2 (20ug), HeLa (25ug),
kidney (20ug) and liver (lOug). The mixture was treated with D M S and the
reaction products separated on an 8 % polyacrylamide-urea gel; (see methods).
Complete and /or partially protected G residues are indicated by an asterisk*
and labeled according to their position relative to the albumin cap site. A
(G+A) sequence reaction of the D N A fragment was electrophoresed along
with each D M S protection experiment.
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O n the upper strand no G residues were completely protected but
several G residues were partially protected against methylation by all four
extracts (e.g., those at -116 and -117). However, none of the G residues
between nucleotides -116 and -97 were protected even though the exoIII stop
studies indicated that proteins were bound in this region. Of course proteins
might bind to only one side of the DNA, leaving G residues on the opposite
side free to react. Also it should be pointed out that the DMS footprint assay
could fail to detect interactions if only a limited number of the DNA
molecules (e.g. 1/2) react with protein, since unreacted molecules would be
free to interact with DMS and thus produce a band in the assay. This contrasts
with the exo III assay where protein bindings to only some molecules will still
lead to an observable result, for this assay scores for the presence as opposed
to the absence of a specific signal.
DNase I footprinting studies were carried out using crude extracts
derived from liver and kidney tissues as well as HepG2 and HeLa cells
(Figure 3.5A) In all liver extracts three regions of protection were observed: a
weak region -46 to -70 (just downstream from the CAAT; see Figure 3.6); -85
to -106 (upstream element 1, UE1; just upstream from the CCAAT) and -109
to -135 (upstream element 2, UE2). Additionally, on this same lower strand
hypersensitive sites were observed at -108, -107 and -81. Figure 3.5B represents
a separate DNase I footprint experiment on the same lower DNA strand. The
coordinates of the protected sequences in these DNase I protection
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Figure 3.5. Panel A: DNase I footprints induced by nuclear extracts on the rat
albumin promoter. The -156 to +47 albumin promoter fragment labeled on
the lower strand was incubated with 20ug of the extract shown above each
lane. DNA-protein complexes were digested with D N a s e I at various
concentrations depending on the extract used [HepG2 (5 and 15ug/ml), HeLa
(15 and 20ug/ml), and liver (2.5 and 5ug/ml)] and the products were analyzed
on 8 % acrylamide gels. For the no-extract reactions, D N a s e I was used at a
final concentration of 0.5 and lug/ml. A (G + A ) sequence reaction of the
D N A fragment is shown.

For each extract, the D N a s e I concentration is

increasing from left to right. Hypersensitive sites, D N A sequences that are
cleaved by DNase I to a greater extent than free probe (lanes labeled "No ext."),
are indicated by arrows and their position relative to the cap site for albumin
transcription is given. Solid vertical bars show regions of D N A that are
protected from cleavage by DNase I due to protein binding. Panel B: same as
above except the DNase I concentrations used were as follows: H e p G 2 (15 and
35ug/ml, kidney (10 and 20ug/ml, and liver (10 and 20ug/ml, from left to
right).
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Figure 3.6. Summary of the results of exonuclease III, DNase I footprinting
and DMS-methylation protection experiments on' the rat albumin upstream
promoter sequences. The D N A sequence of the relevant protein binding
regions Of the albumin promoter is shown. Solid horizontal lines with
arrows above the upper and lower D N A sequence show the direction of exoIII
cleavage and stop sites. Vertical arrows depict DNase I hypersensitive
cleavage sites. Asterisks above G residues show the position of protection
from D M S methylation. The sequences in boxes shows regions that are
protected from DNase I cleavage on both the upper and lower D N A strands
(the upper strand data was not shown). The upper and lower D N A sequences
indicate the m R N A non-coding and coding strands respectively.
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experiments and all the in vitro D N A binding reactions are summarized in
Figure 3.6. In all the experiments, the liver cell extract produced the clearest
DNase I footprint. The clear result from the two DNase I experiments shown
was that all three regions could be footprinted from both extracts as long as a
sufficient quantity of extract was used. In the experiments shown in Figure
3.5 and several others that are not shown, the amount of liver nuclear
extracts required to give protection was about one-fourth that from Hela or
kidney nuclear extracts.

Discussion
The 5' deletion analysis using recombinant adenoviruses defined a
region between -156 and -43bp that is required for function of the rat albumin
promoter in HepG2 cells. Since the intact promoter only functions in
hepatocytes or hepatoma cells, these sequences must include those
responsible for cell-specific transcription. Using four different in vitro
approaches, including gel mobility shifts, exoIII stops and "footprinting" with
DNase I and DMS, three regions of DNA-protein interactions were identified,
a summary of which is shown in Figure 3.6. The regions protected by liver
cell extracts are shown boxed in, and represent the average boundaries
obtained from experiments shown in Figures 3.3 - 3.5 and additional
experiments not presented.
While extracts from hepatocytes afforded the best protection, it was also
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clear that extracts from cells that either d o not express the albumin gene, or do
so at a reduced rate also contained factors that would at least partially protect
the same DNA sequences by both DNase 1 and DMS footprinting and would
interact to produce the same gel shift and exoIII stops. There are at least three
possible ways to interpret the apparent wide distribution of factors that can
interact with the albumin promoter. First, the proteins recognizing these
sequences in expressing cells versus non-expressing cells might be encoded by
similar but non-identical members of a multigene family with only the
member present in liver being capable of activating transcription.
Alternatively, it could be that these DNA-binding proteins are in fact the
same in the different cell-types but cell specificity is brought about by cellspecific modifications to or interactions with other regulatory proteins. These
modifications could also include the packaging the DNA in an accessible
chromatin form. Thirdly, it might be the case that the increased amounts of
several binding proteins, perhaps interacting cooperatively, are able to
combinatorily confer liver specific albumin transcription.

Studies by other laboratories of the albumin promoter
The mouse and rat albumin gene promoter sequences (which are
virtually identical in their DNA sequence and protein binding patterns) have
been well studied, and similar experiments to those described in this chapter
have been published by other groups (Cereghini et al, 1987; Lichtsteiner et al,
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1987; Cereghini et al, 1988; Lichtsteiner and Schibler, 1989; Marie et al, 1989;
Tronche et al, 1989). Using heparin agarose fractionated liver nuclear extracts
a more detailed account of the multiple factors that interact with the albumin
regulatory sequences has been obtained. Based on these results at least 6
regions of protection have been detected in addition to the TATA and CAAT
binding elements. The current picture of the multiple DNA protein
interactions occurring on the albumin promoter element is diagrammed in
Figure 3.7.
Two of the binding regions which have been described in this thesis
(UE1 and UE2) correspond to the C/EBP and NF1 binding sites depicted in
Figure 3.7, and the more promoter proximal site which was described
corresponds to the HNF1 site (Figure 3.7). The previous inability to observe
the other three sites is readily explainable. For one thing, the two additional
C/EBP sites have a much weaker affinity for the protein (greater than ten fold
less; Lichtsteiner et al, 1987), and hence are difficult to detect using crude
nuclear extracts. Additionally, the binding of the CCAAT and HNF1 have
been shown to be mutually exclusive (Lichtsteiner et al, 1987), and therefore
without using fractionated extracts it is difficult to observe DNase I protection
upon these elements.
The results from these other studies support the initial conclusion that
several of the factors which interact with the albumin promoter are present
in cells which either do or do not transcribe albumin, though at somewhat
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Figure 3.7. S u m m a r y of the k n o w n DNA-protein interactions that occur on
the m o u s e and rat albumin gene promoters. At the bottom of the figure is a
legend identifying each transcription factor. For a detailed explanation of this
figure see the text.
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reduced levels in the non-liver tissues. Hence the albumin promoter is a
multiprotein complex, with nearly every nucleotide bound by protein, and
these control regions coincide with the sequence blocks that have been highly
conserved throughout mammalian evolution (see Figure 1.5, Chapter 1). Of
the factors that bind the albumin promoter only one is highly liver specific
(HNF1), two are liver enriched (NF1 and C/EBP)i and the CAAT factor is
present in all tissues. Therefore hepatocyte restricted albumin transcription
seems to be controlled by several liver enriched binding factors interspersed
with several ubiquitous elements, which combinatorily produce cell type

specificity, for no single one of these factors is exclusively present in the liver.
Interestingly two of these proteins, C/EBP and HNF1 interact with the
regulatory regions of several other liver genes, and their possible
involvement in coordinate liver gene control will be addressed in Chapters 8
and 9 of this thesis.

1

The transcription factor N F 1 w a s originally described to be a
ubiquitous cellular protein (Jones et al, 1987). Recent studies, however,
suggest that a liver specific form of this factor exists, most probably generated
by alternative R N A splicing (Lichtsteiner et al, 1987; Paonessa et a/.,1988).
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Chapter 4

Functional Analysis of the Mouse Albumin Enhancer

Throughout the course of the rat albumin promoter studies described
in the previous chapter, it was observed that the rate of transcription of the
virally introduced albumin gene (containing a maximum of 441 base pairs of
upstream promoter sequence) was much lower than that for the endogenous
gene (Chapter 3; Friedman et al, 1986; Babiss et al, 1986b). This was
determined by performing nuclear run-on transcription analysis on the viral
DNA template and comparing it with the rate of transcription of the
endogenous albumin gene. The ability to perform this type of analysis
represents a major advantage of the viral vector system, as opposed for
example, to the transient transfection assay, where far too few cells take up
and express the introduced DNA to permit measurements of this type. (Babiss
et al, 1986b; Friedman et al, 1986). While albumin cell-type specificity was
observed, high rates of transcription, comparable to the endogenous gene in
HepG2 cells, were only scored at high multiplicities of infection (when
upwards of 300 copies/cell of template were used) or when enhancer
elements (ie. the EIA enhancer) were added to the viral template (Friedman
et al, 1986). Hence while 441 nucleotides upstream of the albumin mRNA
start site could dictate tissue specific transcription these sequences did not
generate quantitatively correct levels of albumin expression (Babiss et al,
1986b; Friedman et al, 1986).
This difference in transcription rate can be explained in several ways.
For one thing, it might represent an effect of localizing the albumin promoter
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on the viral genome since viral templates might lack the essential chromatin
structural configurations which play an active role in the regulation of the
endogenous gene. Alternatively, the presence of the albumin promoter on
the viral chromosome could itself lead to an inhibition of its expression.
Equally likely, however, is the possibility that this 441bp promoter region is
missing essential cis-acting DNA sequences involved in maintaining the
high rate of albumin transcription (Friedman et al, 1986; Babiss et al, 1987).
As mentioned in the introduction (Chapter 1), previous work from our
laboratory had identified a DNase I hypersensitive site at a position -2.8kbp
upstream of the rat albumin promoter which correlates with the maximal
rate of albumin transcription (Babiss et al, 1986a), and it was subsequently
determined that this region contains a binding site for the transcription factor
C/EBP. Recombinant adenoviruses were constructed which contained these
added DNA sequences and assayed for their expression in both HepG2 cells
and primary rat hepatocytes. In neither case, however, was any enhancement
observed from this region (even when the region containing the
hypersensitive site was moved immediately adjacent to the 441 bp promoter
element).
Concurrently, Richard Palmiter's laboratory was performing an
analysis of the mouse albumin gene using transgenic mice (Pinkert et al,
1987). By analyzing mice which either contained 300bp of the mouse albumin
upstream promoter element or as much as 12 kilobase pairs (kbp) of upstream
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sequence fused to the h u m a n growth hormone gene, they identified a far
upstream albumin enhancer element, capable of producing a 5-10 fold
stimulation of albumin promoter directed expression. By analyzing several
additional transgenic constructs, Palmiter's group further determined the
functional enhancer sequences to reside in a region between -10.4 and
-8.5kbp upstream of the RNA start site. Notably, removal of the most 3' part
of this region (from -8.5 to -9.3kbp) enabled the remaining DNA sequences
(-10.4 to -9.3kbp) to produce weak enhancement in certain non-liver tissues
(e.g. lung, spleen, kidney; Pinkert et al, 1987). This suggested that separate
domains might be involved in determining both the specificity and rate
enhancing functions of this enhancer.
I have examined this region of the mouse albumin gene that in
transgenic mice is needed for full hepatocyte specific expression. I was
interested in identifying the cis-acting elements and the proteins that might
bind to the enhancer region to compare them to those that interact with the
albumin promoter proximal region (Chapter 3), and to the known factors that
activate hepatocyte-specific expression in several other genes (e.g. TTR and cclantitrypsin). To perform this analysis, however, a transient transfection assay
was required, for transgenic mice are not an efficient means of assaying the
large number of constructs involved in this type of functional enhancer
dissection.
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Transient transfection of the mouse albumin enhancer in C W S V 1 Cells
To specifically localize the mouse albumin DNA sequences that
function to increase the rate of transcriptional initiation from the albumin
cap site, transient plasmid transfection assays using rat CWSV1 cells were
performed (Figure 4.1). Since these cells transcribe albumin at a rate about
50% of that in the rat liver, they seemed to represent a good choice for use in
studying the sequences involved in enhancing albumin transcription (see
Chapter 1; Table 1.1). By comparison, the HepG2 cell line which had been
used for the promoter analysis only transcribes its endogenous albumin gene
at 10% that of the liver gene (Clayton et al, 1985), and it was initially thought
that this might be due to an inability of the enhancer to function in these
cells.
The parental plasmid used contained albumin promoter proximal
sequences extending from -10.5 to -8.43kbp relative to the transcriptional start
site fused to albumin sequences from -300 to +22 nucleotides (Figure 4.ID).
The mouse albumin sequence (-10.5 to 8.43kbp followed by -300 to +22bp) was
then joined to the first two exons of the adenovirus Elb gene including the
polyA+ addition sequences needed for the production of a stable mRNA
(Figure 4.1D).
A 5' deletion analysis was performed using constructs beginning at
-10.5kbp (a nominal number because the entire 2 kilobase pair (kbp) upstream
region has not been sequenced) with a constant 3* boundary at -8.43kbp.
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Figure 4.1. Functional analysis of the mouse albumin enhancer element in
C W S V 1 cells. The parent construct (top, D) and deletions (marked by position
in kbp) were co-transfected into C W S V 1 cells with a control plasmid (an SV40
enhancer containing p-globin promoter (bottom, D) to standardize for
variations in transfection efficiency (see Materials and Methods, Chapter 2).
Assays for expression were carried out by protection of labeled sp6 probes
(shown in D) as described in the text. In all panels the lane marked 0.3 refers
to an enhancer-less mouse albumin promoter construct (containing the -300
proximal promoter element.). In Panel A, all constructs have a 3' boundary of
-8.43kbp and a 5' boundary as marked. In Panels B and C the introduced
enhancer sequences are as marked.
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Next, a 3' deletion set was constructed using -10.24kbp as a 5* boundary and
deleting sequence in the 3' direction as marked (Figure 4.1 B, C). These
plasmids were then tested for the effects of upstream enhancer sequence on
expression by transient transfection assay in the rat CWSV1 cells. All
transfection experiments included an independent plasmid containing a
SV40 enhancer driven p-globin promoter which was used to monitor
transfection efficiency (Figure 4.ID). Since the experimental and control
constructs protected similar sized fragments, expression from each was
assayed in separate reactions by hybridizing two different

32

P-labeled antisense

RNA probes to cytoplasmic RNA prepared from the transfected cells (25 ug for
the albumin assay and 10ug for the p-globin) followed by RNase T2 digestion
and electrophoresis of the T2 resistant RNA on a sequencing gel. The labeled
antisense RNA probe for albumin expression was protected over 205
nucleotides representing the fusion exon made up of the first 22 bases of
albumin gene added to 183 base pairs of the Elb first exon (see Figure 4.ID). A
smaller 50 nucleotide protected fragment (not shown) corresponds to part of
the adenovirus second exon. A 206 nucleotide band representing the second
exon of the p-globin gene was protected (see figure 4.1 D), along with a 143
nucleotide band corresponding to the first exon (not shown in Figure 4.1).
The autoradiograms of gels representing the RNase T2 analysis of three
separate experiments are presented in Fig. 4.1. The entire enhancer region
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stimulated albumin gene expression by at least 5 fold in these cells (Fig. 4.1 A,
-10.5 vs -0.3), a result similar to the 5 to 10 fold stimulation reported in
transgenic mice (Pinkert et al, 1987). This stimulation was lost when
sequences between -10.15 and -10.1 lKbp were removed (Figure 4.1 A),
implicating this region as having a major role in enhancer function.
The initial 3' deletion construct had a 5' boundary at -10.24kbp
(therefore containing the 5' activating region mentioned above) and an initial
3' boundary at -8.43kbp. Sequences were removed to -9.3kbp (EcoRI site),
-9.78kbp (Avail site) or -9.94kbp (AccI site; Figure 4.1 B). Following
transfection of CWSV1 cells, no effect was noted upon removal of these
regions. However, removal of sequence to -10.03kbp completely abolished
transcriptional stimulation, identifying an essential 3' sequence between
-10.03 and -9.94kbp (Figure 4.1B). This observation, along with the 5' analysis
described above, identified the minimal enhancer element as a nominal 210
nucleotide sequence (-10.15 to -9.94kbp; Figure 4.1B).
A detailed examination of expression from further recombinant
constructs within this region yielded a surprising result. A plasmid
containing sequences from -10.07 to -8.43kbp, lacking 80 nucleotides from the
essential 5' element delineated above, failed to generate any enhancer
function in CWSV1 cells (Figure 4.1 A, C). However, removal of 1550, 850 or
470 nucleotides at the 3' side of this segment (between -8.43 and -9.94kbp)
reactivated enhancer activity from the previously 5' deleted plasmid (Figure
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4.1C). Furthermore, return of the D N A sequence at the 5' side to -10.09,
-10.15 or -10.24kbp gave no boost above the already maximal transcriptional
level obtained from a plasmid whose 5' boundary was at -10.07kbp (Fig. IC).

Therefore , if at least 470bp of 3' sequence (from -8.9 to -8.43kbp) was deleted,
then complete enhancement in CWSV1 cells was obtained by the 130
nucleotides from -10.07 to -9.94kbp. Furthermore, this minimal element
could function in either orientation (data not shown) .

Summary of SV1 Transfection Analysis
These analyses established three DNA regions as contributing to the
function of the mouse albumin enhancer. Alone, Region II (-10.03 to
-9.94kbp) is capable of enhancing the albumin promoter. When Region III
-8.9 to -8.43kbp) is added to Region II the enhancement is negated. Region I

-10.15 to -10.11 kbp) alone is not active, but its addition restores the enhancer
activity that is blocked by Region III (see Figure 4.2 for a summary of these
three regions). Table 4.1 summarizes the functional consequences of the eight
possible combinations of these three elements. Over the course of many
experiments the mean enhancer effect was 5 fold. Hence, a value of 100% has
been given to constructs demonstrating maximal enhancement while a level
of 20% represents the enhancerless promoter construct.
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Figure 4.2. S u m m a r y of the three functionally important regions of the
m o u s e albumin enhancer as identified by C W S V 1 transfection analysis.
Three functional regions: I, II, and III (shown by the brackets below the line
drawing) were delineated. Region I (-10.15 to -10.1 lkbp) alone does not
contribute to the rate of albumin gene expression, but serves to override the
negative effect of region IE (-8.9 to -8.43kbp). Region II (-10.03 to -9.94kbp)
contains the D N A sequences that contribute positively to the increased rate of
transcription initiation from the albumin promoter.
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20%
100%
20%
100%

100%

20%

20%

Table 4.1. Combinatorial effects of the three functional enhancer regions in
C W S V 1 cells. Over the course of m a n y experiments, the average enhancer
effect was five fold which has been arbitrarily ascribed a value of 100%. The
basal level of transcription from the enhancerless m o u s e albumin promoter
(-300) is 20%. The transfection results upon which the results in this table are
based are all presented in Chapter 4 except the final permutation
(+, -/ +) which represents data not shown.
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T h e m o u s e albumin upstream enhancer can activate a heterologous
promoter in an orientation independent manner
Three properties usually ascribed to enhancers are the ability to
function at a distance (in a position independent fashion), an orientation
independence and the ability to function to activate a heterologous promoter
(Serfling, 1985; Maniatis et al, 1987; Guarente, 1988). The sanctity of this first
criterion seems assured, for the albumin enhancer is found greater than lOkbp
upstream of the albumin start site, where it was shown by Pinkert et al,
(1987), to function in transgenic mice. To test the remaining facets of
enhancer function in cultured cells, the -10.5 to -8.43kbp enhancer fragment
or a -10.5 to -8.9Kbp enhancer fragment (lacking the negative element
described above) was placed in both orientations in front of either a promoter
active in hepatocytes and hepatoma cells, the mouse transthyretin (TTR)
promoter (Costa et al, 1986), or the mouse p-globin promoter (Konkel et al,
1987), a promoter that is by itself minimally active in most all cells. These
constructs along with control plasmids were used to carry out transfections of
several cell types. The assay of the transthyretin (TTR) promoter depends on a
nominal 93 base pair RNase T2 protected band that is complementary to the
TTR first exon (Fig. 4.3A, bottom, Costa et al, 1986). The TTR -202 promoter
element functions without the albumin enhancer to give a messenger RNA
that protects a 93 and 92 nucleotide doublet following RNase T2 digestion plus
a small amount of a doublet several bases longer (nominally 95 and 96 bases).
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Figure 4.3. The m o u s e albumin enhancer can activate heterologous
promoters of both liver and non-liver specificity following transfection into
rat C W S V 1 cells. In Panel A, the mouse albumin enhancer sequences from
either -10.43 to -8.43kbp or -10.5 to -8.9kbp (the region between -8.43 to -8.9kbp
is the negative region) were placed in either orientation (designated +/-), 5' to
the -202 position of the previously described m o u s e Transthyretin (TTR)
promoter element (Costa et al, 1986,1988a). Also in this assay are a
-202 T T R promoter construct (an enhancerless control), and this same
construct containing the 100 nucleotide T T R upstream enhancer element
(Costa et al, 1986, 1988a). The sp6 R N A probe specific to the 5" end of the
T T R m R N A s , protected a 93 nucleotide R N A as depicted below. A SV40
enhancer containing m o u s e p-globin promoter construct is included as an
internal control (see figure 1), and the 206nt second exon is shown. In B, these
same sequences are placed 5' to the p-globin promoter, in either orientation
(+/-). A n enhancerless construct p-glo -341 along with the SV40 enhancer
containing construct are also assayed. For this series, the T T R -202 promoter
construct is used as an internal control.
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The albumin enhancer, in either orientation (+ or -), with and without the
DNA sequences of region III between -8.9 to -8.43kbp, did not affect the
promoter function that gives the 92 or 93 nucleotide bands but did increase by
five-fold the message from starts that occur just upstream. This partial
activation of the TTR promoter by the albumin enhancer contrasts with the
complete lack of effect in the CWSV1 cells of the TTR enhancer element on its
own promoter (Figure 4.3A, lane 3 compared to lane 2). Thus, the TTR
enhancer element from the mouse gene that functions in human hepatoma
cells (Costa et. al, 1986, 1988a) does not function in CWSV1 cells, indicating
that these CWSV1 cells may not engage in completely normal hepatocyte
transcription.
Figure 4.3B proves that the albumin enhancer is also capable of
stimulating transcription of a foreign (non-liver) promoter in CWSV1 cells.
Either the complete enhancer (-10.5 to -8.43kbp) or the Region I plus Region
II fragments alone in either orientation, inserted at the -341 promoter
position increased p -globin expression by five-fold (Fig. 4.3B).

The mouse albumin enhancer will function in HepG2 cells
While CWSV1 cells were used to analyze the regulation of the
albumin enhancer, most studies of this kind have used rodent and human
hepatoma cell lines (including FaO and HepG2). One problem with hepatoma
cells, however, is that they only transcribe their endogenous albumin genes at
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roughly 1 0 % the level found in the rat liver (Clayton et al, 1985; Babiss et al,
1987; Friedman et al, 1987, Table 1.1), suggesting the possibility that the
albumin enhancer may not be contributing to the rate of albumin
transcription in these cells. I was interested in addressing this question but as
perviously described, the albumin promoter region gives very weak signals
upon transient transfection into HepG2 cells (Chapter 3, Babiss et al, 1987).
The enhancer was therefore tested in HepG2 cells using a recombinant
adenovirus construct containing the albumin upstream enhancer (-10.5 to
-8.43kbp) fused to the albumin promoter and an adenovirus reporter gene
(the E1B promoter; Figure 4.4A). In addition, plasmids were prepared for
transfection that had the albumin enhancer driving the promoter of the
mouse transthyretin gene which is known to be active and susceptible to
stimulation by its own enhancer in HepG2 cells (Figure 4.4B).
The promoter alone (-300 to +22) or the promoter plus the -10.5 to
-8.43kbp enhancer element were separately inserted into an adenovirus
vector as previously described (Chapter 2; Babiss et al, 1986; Friedman et al,
1986). Upon infection with recombinant viruses, the mouse albumin
regulatory sequences resulted in production of a stable RNA species generated
by transcription initiation at the albumin start site followed by splicing of the
fusion albumin-Elb exon (Figure 4.4, bottom). Expression from these
plasmids was scored using an antisense RNA probe specific for the first two
exons of the adenovirus E1B gene (probe sp641, Friedman et al, 1986). The
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Figure 4.4. The mouse albumin enhancer functions in human hepatoma
cells (HepG2 cells). Panel A represents infections (50pfu/cell for 24h in the
presence of AraC using recombinant adenoviruses containing the albumin
-300 promoter (Alb - enh) or the same construct containing the -10.5 to
-8.43Kbp enhancer sequence (alb + enh) into HepG2 cells. Following isolation
of cytoplasmic R N A , the accumulation of exogenously expressed
albumin-viral m R N A is scored using the probe depicted in the diagram.
Expression of the viral E2A gene was also quantitated to monitor variations
in virus uptake (Babiss et al, 1987). In panel B, the same mouse albumin
enhancer/TTR heterologous constructs (50ug) depicted in Figure 4.3 are
transfected into human H e p G 2 cells, with the SV40 enhancer containing
p-globin plasmid (lOug) as an internal control. Sequences are again placed 5' to
the TTR -202 nucleotide and the 3' boundary of mouse albumin enhancer
sequence is labeled above each lane.
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enhancer containing construct produced a five to ten fold stimulation
compared to the construct beginning at -300 of the albumin gene (Figure
4.4A). As an internal control, expression of the viral E2a gene was measured
in each infection.
Additionally, HepG2 cells were transfected with plasmid constructs
containing the TTR promoter plus either the albumin or TTR enhancers (the
chimeric albumin enhancer/TTR promoter constructs are identical to those
described in the previous chapter). The clear result was that the albumin
enhancer did stimulate TTR transcription in these cells and the stimulation
was from both RNA start sites, enhancing equally the 93-94 and 95-96
doublets, in a fashion nearly equivalent to that achieved by the TTR enhancer
itself. Thus, HepG2 cells can surely use the albumin enhancer sequences to
increase TTR and albumin promoter activity five fold as was the case in the
CWSV1 cells (Fig. 4.4 A, B).

The mouse albumin enhancer is cell-specific
While the albumin enhancer can function in both CWSV1 and HepG2
cells, it did not function in HeLa cells. The plasmid constructs containing the
albumin enhancer plus the p -globin promoter or the p-globin promoter
alone were introduced into HeLa cells (Figure 4.5) Neither the complete
enhancer sequences (-10.5 to -8.43kbp) nor any part of the enhancer including
Region I and II together or II alone (-10.5 to -8.9kbp and -10.07 to -9.94kbp )
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Figure 4.5. The m o u s e albumin enhancer does not function in Hela cells. This
figure depicts transfection of different portions of albumin enhancer sequence
(boundaries shown) placed 5' to the m o u s e p -globin promoter (at base pair 341) into Hela cells. The specific p-globin protected R N A is 206 nucleotides as
s h o w n in figure 4.1 (the second exon). The glutathione-S- transferase Y A gene
which is active in Hela cells is included as an internal control, and produces a
66 nucleotide protected R N A as shown.
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resulted in a decrease in p-globin expression. These constructs were also
introduced into MC cells, a neuroblastoma line, with like negative results
(data not shown). These transfections were internally controlled by the
inclusion of a construct which contained the glutathione-S-transferase YA
promoter which has been shown to be active in HeLa cells (Paulson et al, In
Press). It was assayed by and RNase T2 protection assay which protected a
RNA of 66 nucleotides (Figure 4.5, bottom). Hence each part of the albumin
enhancer functions in a cell-type specific fashion, including the region II
sequences, which alone can produce the entire positive enhancer effect.

Discussion
The functional analysis of the albumin enhancer has shown it to be a
complicated genetic locus containing both positive and negative regulatory
elements. The modularity of this element is similar in many respects to
other complicated regulatory regions such as those found in the yeast haploid
specific genes (Herskowitz, 1989), the c-myc gene (Hay et al, 1987, 1989) and
the SV40 enhancer region (Zenke et al, 1986; Herr and Clark, 1986).
Furthermore, the SV40 enhancer has recently been demonstrated to contain
individual modules termed "enhancons" each of which interact with a single
protein, and these units function in pairs (which in some cases require
specific partners) to facilitate the diverse transcriptional effects of that
regulatory element (Herr and Clark, 1986; Ondek et al, 1988). The albumin
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enhancer regions could function in the same way.
The ability of the enhancer to function in hepatoma cells is deserving
of special note. Albumin is an adult liver specific gene, only reaching its
maximal level of expression several weeks following birth in the rodent
(Camper and Tilghman, 1989) In fact, Tilghman and coworkers have
suggested that the albumin enhancer does not function in the fetus and that
instead the albumin gene is activated during fetal development by the
neighboring a-fetoprotein enhancers. While the a-fetoprotein enhancer
could still play role, the fact that the albumin enhancer functions in these
partially differentiated HepG2 cells demonstrates that the albumin enhancer
can work to some extent in more fetal cell types.
Thus as was the case for the promoter (chapter 3), multiple regulatory
elements are involved in regulating the enhancer, yet the two differ
significantly since the albumin enhancer contains a negative region and a
unique type of modulatory element. Having identified these three important
regions, I proceeded with an in-vitro DNA protein binding analysis to
identify the transcription factors which interact with them, with the goal of
better understanding the mechanism by which this enhancer exerts its liver
specific effect. Chapters 5-7 sequentially present the results of protein binding
studies on each of these regions.
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Chapter 5

Albumin Enhancer Region I

A s described in the preceding chapter, three regions of functional
importance were identified based on a deletion analysis of the albumin
enhancer in CWSV1 cells. From these studies, the enhancer was shown to
consist of both positive and negative regulatory sequences: a negative region
(III) that suppresses an otherwise positive, liver-specific enhancer element (II)
and a third region that by itself is inactive but in conjunction with the
remaining elements overrides the effect of the negative region (I). To gain a
better understanding of the mechanism by which these cis-acting elements
function, each of these regions was analyzed for DNA-protein interaction
using a combination of in vitro binding analyses. Region I, the overriding
element is described here while the other elements are presented in
successive chapters.

Two nuclear protein-binding sites within the mouse albumin enhancer are
recognized by C/EBP, a previously identified liver enriched transcription
factor
The search for protein binding sites within the enhancer began with a
35 nucleotide probe (-10.15 to -10.115) containing the functionally acting Region
I sequences (deletion of DNA sequence from -10.15 to -lO.llkbp completely
ablated enhancer function; see chapter 4). Protein binding was first explored
using the gel retardation shift assay which takes advantage of the fact that
end-labeled DNA complexed with protein migrates more slowly than
free-DNA (Fried and Crothers, 1981; Garner and Revzin, 1981). When mixed
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with hepatocyte extract the labeled -10.15 to -10.115Kbp probe produced three
gel shift bands (Fig. 5.1A). Interestingly, these bands were competed during
DNA-protein interaction both by an unlabeled, homologous DNA fragment
and by an oligonucleotide representing a binding site in the TTR enhancer
known to bind the liver enriched transcription factor C/EBP (TTR
oligonucleotide 3, Costa et al, 1988a). No competition, however, occurred
when the labeled -10.15 to -10.115kbp Region I probe was competed with an
oligonucleotide binding site for hepatocyte-specific nuclear HNF1.
Furthermore, the binding activity in Region I was heat stable (80° C), a known
characteristic of the C/EBP protein (Johnson et al, 1987; Costa et al, 1988b).
Lastly, purified C/EBP/p-galactosidase fusion protein (gift of S. McKnight)
produced a gel shift with this probe that was competed by TTR
oligonucleotide 3, but not by oligonucleotides binding sites for HNF1 or
HNF3 (Figure 5.IB). Hence, all these lines of evidence strongly implicated
C/EBP as the protein which is interacting with the Region I sequences,
although point mutagenesis of these binding sites in conjunction with a
functional analysis of the mutants is certainly warranted to confirm this
model.

DNase I footprinting of the C/EBP binding site (s)
To more precisely locate the C/EBP binding site within Region I, a 210
nucleotide fragment (-10.240 to -10.030kbp) was end labeled and a DNase I
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Figure 5.1. Definition of a C / E B P site(s) within the mouse albumin enhancer
Region I. In panel A the m o u s e albumin Hindlll/Rsal fragment (-10.15 to
-10.115kbp, lng) was 3' end labeled and incubated with lOug of liver nuclear
extract, and 4ug of poly (dldC): poly (dldC) in the absence (-) or presence (+) of
homologous unlabeled D N A (50 fold molar excess). The binding reaction
(30min at 20°C) was then analyzed for gel retardation on an 8 % acrylamide
gel. The unbound and hence faster migrating probe is shown at bottom while
a doublet of specific retarded bands are depicted in the region flanked by the
arrow. Oligonucleotides (in 50 fold molar excess) representing a k n o w n
C / E B P binding site (0L3) and a binding site for H N F 1 , were assayed for
competition as well. The lanes labeled 80°C represent reactions where the
liver extract was heated prior to incubation with the probe. In panel B, the
same probe is assayed but n o w using a C/EBP/p-galactosidase fusion protein
(gift of S. McKnight; see text), in the presence (+) or absence (-) of specific
competitor. Again, oligonucleotides representing binding sites for C / E B P
(OL3) and H N F 1 were used in addition to an oligonucleotide with a site for
H N F 3 . In C, D N a s e I footprints of C / E B P binding sites in the mouse albumin
enhancer, using either oligonucleotide affinity purified C / E B P protein (lanes
2 and 3 ) or C / E B P p-galactosidase fusion protein (lane 4). For this probes
labeled uniquely at the 5' end spanning from the Hindlll site at -10.24kbp to
the Styl site at -10.03kbp were incubated with buffer alone (lane 1), affinity
purified protein (lane 2- 5ng, lane 3, 20ng), or fusion protein (lane 4, enriched
bacterial extract), treated with DNasel, and the products analyzed by
polyacrylamide gel electrophoresis. T w o regions of protection from DNasel
digestion are denoted as A and B.
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footprint analysis was performed using protein purified by oligonucleotide
affinity chromatography [using oligonucleotide 2 of TTR (Costa et al, 1988a)]
or an the E. coli produced fusion protein containing a 20 KD segment of
C/EBP (as above). Two clear footprints designated sites A and B were observed
on both DNA strands, though only the results from the lower strand are
shown in Figure 5.2. Thus, not only did C/EBP bind within the 35 nucleotide
functionally important region used in the first gel shift experiment (the B site,
Figure 5.ID) but to a second site as well (the A site, Figure 5.ID). The
specificity of this second site for C/EBP was confirmed by a gel shift assay
which demonstrated that the complex was specifically competed with TTR
oligomer 2, another known C/EBP binding site (Figure 5.2, Costa et al, 1988a).
In addition, the binding activities interacting with both these sites were liver
enriched, producing retarded shift complexes with these probes only in liver
and not kidney, brain or spleen nuclear extracts (data not shown), as has been
previously described for the C/EBP protein (Grayson et al, 1988a; Costa et al,
1988a, 1988b). In light of this redundancy of C/EBP sites, Region I for the
discussion has been expanded to include both sites A and B.

Discussion

Sequence comparison of C/EBP binding sites
Sequence comparison of the footprint region showed a good match
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Figure 5.2. Identification of a second C / E B P site by gel shift analysis using a
D N A probe extending from -10.24 to -10.14kbp. This probe was uniquely end
labeled and subjected to a gel retardation assay as in figure 5.1. Several shifted
complexes are observed in the absence (-) but not in the presence (+) of a 50
fold molar excess of self competitor fragment. Competition assays using
specific D N A fragments were as previously described. T T R 012 represents a
k n o w n C / E B P binding site (Costa et al, 1988b).
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Figure 5.3 Summary of the DNA-protein interactions occurring on the
mouse albumin enhancer Region I. This region has two sites for the protein
factor C/EBP. The sequence of this region is shown and the footprintable
regions (labeled A and B) respectively are highlighted. Shown above each
region is the best homology match with other known C/EBP sites (Costa et al,
1988b).
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between Region I, site B, and the T T R oligonucleotide site 3 (Figure 5.3; 9 out
of 11 bases in the relevant region). Site A in Region I did not match well with
any of the C/EBP footprinted regions, the best match being a 7 out of 10 match
with the TTR oligo 2 site (Figure 5.3; Costa et al, 1988). This lack of a strong
consensus among C/EBP binding sites (Costa et. al, 1988b) is characteristic of
this protein, with the good match between TTR oligo 3 and site B in the
albumin enhancer being an exception (Costa et al, -1988b). This well
documented ability of C/EBP to bind to a wide array of divergent sequences is
like the situation observed for the hapl protein of yeast which binds to the
UAS elements of the cycl and cyc7 genes and is responsible for their Heme
inducibility (Pfeiffer et al, 1987). In that case it has been shown that the same
binding domain has somehow evolved to recognize two very different DNA
sequence regions.

C/EBP functions in a novel capacity in the mouse albumin enhancer
In all previously characterized functional situations C/EBP protein has
been demonstrated to have a positive effect on transcription (see chapter 1).
Past experience in our laboratory working with the mouse transthyretin
(TTR) and al-antitrypsin genes localized many C/EBP sites on both these
elements (Costa et al, 1988b; Grayson et al, 1988b), and removal of a site
produced a decrease in transcription, although some sites had only a modest
(20-50%) effect on expression. This latter fact, however, could have been due
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to the fact that H e p G 2 cells (in which most of these studies were done) have
reduced levels of C/EBP protein as compared to the liver (Freidman et al,
1989).
In the mouse albumin enhancer the C/EBP binding sites alone have no
demonstrable positive effect on transcription, and their addition to Region II,
in the absence of Region III, produced no transcriptional boost above that
previously observed from Region II alone. The C/EBP sites did (site B alone),
however, play an important modulatory role, counteracting the negative
effect of Region III. This is the first demonstration of C/EBP functioning in
this capacity.
The function that the C/EBP protein displays in the mouse albumin
enhancer resembles the role played by the al protein in yeast, which
specifically activates the a specific genes in haploid cells (Herskowitz, 1989).
It that system, it has been proven that al is not involved in transcriptional
stimulation directly, but acts by modulating the activity of a second factor
termed MCMI (also referred to in the literature as PTRF or GRM; Keleher et
al, 1988, Bender et al, 1987; Herskowitz, 1989) which binds to an adjacent
DNA sequence. It has been shown that the al protein increases the affinity of
MCMI for its binding site ( Jarvis et al, 1988; Herskowitz, 1989) and additional
studies have suggested that it also changes the MCMI protein conformation to
increase its ability to effect transcription (Tan et al, 1988). This precedent
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suggests a mechanism by which C / E B P might be functioning in the present
situation.
Exactly how the albumin C/EBP proteins(s) are influencing the other
albumin enhancer factors is an issue which still needs to be explored. A
thorough understanding of this will require a purification of the binding
activities which interact with all three regulatory regions and a careful
analysis of the exact nature of their protein-protein interactions. The fact,
however that the mouse albumin promoter contains three C/EBP sites
provides a clue concerning the mechanism by which the C/EBP site (s) are
functioning. For example, the transfection constructs which lacked Region I
were inactive for enhancement, although three promoter C/EBP sites (in the
300bp albumin promoter element, see chapter 3) were immediately adjacent
to negative Region III. The fact that these sites could not override the
negative effect might indicate that the C/EBP exerts its effect by interacting
with the neighboring Region II (the NLS1 protein, chapter 6).

C/EBP interacts with both the albumin promoter and enhancer elements
The presence of C/EBP sites in both the promoter and the enhancer of
the albumin gene, as well as at a site between the two (at -3.5kbp; Liu et al,
1988) is quite interesting, and suggests that this protein might in some way
act to facilitate communication between these disparate regulatory elements.
Additionally, both the mouse TTR and al-antitrypsin genes also have C/EBP
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sites in both their promoter and enhancer elements (Figure 9.1; Costa et al,
1988a,1988b; Grayson et al, 1988b) further implicating C/EBP in this type of
role. This theory becomes even more tenable with the discovery that C/EBP
possess the leucine zipper motif and therefore is able to dimerize.
Interactions between like proteins (ie. Ara C) are known to be important in
several prokaryotic systems to facilitate the interaction of DNA sequences
located large distances apart, since their interaction facilitates DNA looping
(Huo et al, 1988; Schleif et al, 1988). Hence while C/EBP has no positive
effect, perhaps it plays a dual modulatory role: counteracting the negative
region while also assisting these far upstream sequences to function. A
model for how C/EBP might work in insuring albumin tissue specificity will
be presented in the discussion of chapter 7, after all three regulatory regions
have been described.

122

Chapter 6

Albumin Enhancer Region II

The focus of this chapter is Region II, the positive acting, liver specific
enhancer element. It was this region which alone could provide complete
enhancement in CWSV1 cells. This same region, however, could not
stimulate transcription of the heterologous p-globin promoter in HeLa cells.

Region II binds proteins in extracts from liver and non-liver cell types
Region II (-10.03 and 9.94kbp) was fully active for enhancer function in
the CWSV1 transfection assays. Therefore, this 90 nucleotide DNA fragment
was analyzed for protein interactions by performing a gel shift using crude
liver and spleen extracts as well as extracts from HepG2, CWSV1 and HeLa
cells. Two retarded bands that could be specifically competed by unlabeled
homologous oligonucleotide were observed (Figure 6.1 A). These bands were
not competed, however, by a collection of binding sites representing
previously identified proteins. These include sites for two widely distributed
proteins, API and NF1 (Jones et al, 1987; Lee et al, 1987), C/EBP and the -8.9
to -8.7kbp portion of Region III, as well as sites for the recently described
hepatocyte enriched factors HNF 3 and HNF 4 that occur in the TTR and alantitrypsin regulatory regions (Costa et al, 1989). The protein binding region
of the 90 nucleotide region II probe was subsequently narrowed to the 40
nucleotides between -10.03 and -9.9kbp because this fragment produced an
identical gel-shift result as the entire 90 nucleotide fragment (Figure 6.1 B)
while the corresponding 50 nucleotide fragment from -9.99 to -9.94kbp did not
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Figure 6.1. The factor which interacts with Region II is present in extracts
from liver and spleen tissue and C W S V 1 , H e p G 2 and HeLa cells. In panel A,
a 5' labeled D N A probe (probe A ) spanning from -10.03 to -9.94Kbp (Region II)
was subjected to a gel retardation assay. A shifted doublet was observed in the
absence (-) but not the presence (+) of specific competitor. The additional
competitors have been described in the text. A second labeled probe was
prepared by truncating the fragment described in panel A at the unique
Sau3A site at -9.90 kbp (probe B), and its shift pattern is shown in Panel B.
This probe produces a similar gel shift pattern after incubation with extracts
derived from the cell lines and tissues marked above each lane.

125

A.

B.

Probe A

Probe B
LU

^

o
+

GO

I-I

+
H
LU

! g£!
- +

* - ~ »COO.
O H

I<

Eh

- +

— w ro 5T
U- n. U- U- -

OJ
I
>

co

£

o
a
a>
I

2 co z z a o - + - + -

a>
I

c
0)
0)
a

+ - +

I U J I K E

min

-10.03

Probe A * I —

-9.99
i

Sty I

Sou 3A

Probe B * I—

—I
Sou 3A

Styl

-9.94
—I
Ace I

bind any protein (data not shown). The protein(s) responsible for the gel shift
of the Region II probe were also found in lesser abundance in the CWSV1 and
HepG2 cells, where the enhancer was shown to function. However, nuclear
extracts obtained from HeLa cells and spleen tissue also produced gel shift
results similar to those obtained with liver extracts (Figure 6.1 B). Thus, DNA
Region II that clearly seems involved in enhancement in hepatoma (or liver)
cells but not in HeLa cells, can be bound by proteins from cells in which the
enhancement does not occur. For this reason, this newly described protein
was named NLS1 (non-liver_specific factor 1).

DNase I footprint analysis of NLS1 binding
To more precisely define the sequences which interact with NLS1, a
DNase I footprint experiment was performed. A DNA fragment extending
from -10.03 to -9.94kbp was uniquely 5' end labeled and subjected to a
footprint analysis using nuclear extract from either liver or HeLa cells. The
liver and HeLa nuclear extracts were fractionated over a heparin agarose
column and the maximal NLS1 binding activity was determined to be present
in the 0.4M KC1 peak for both. In the result shown, however, a 0.4M Pll
HeLa column step fraction was used which also has a high level of NLS1
binding activity (gift of X. Fu). The DNase I footprint(Figure 6.2) employed the
extracts just described or BSA as a control. Note that a nearly identical
footprinted region was observed for both extracts. The footprinted region is
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Figure 6.2 D N a s e I footprint of the Region II sequences. The functionally
active D N A fragment from -10.03 to -9.94 was 5' end labeled and subjected to a
D N A s e I footprint assay as described in the methods section of the text.
Heparin agarose purified liver fraction or Pll purified H e L a extracts were
used plus a B S A control. Either 3 or 6ug of extract w a s used (the left or right
lane respectively). The footprinted region is depicted at the bottom by the
brackets
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denoted by the black bar, and the protected D N A sequences are s h o w n at the
bottom of the figure depicted by a bracket (Figure 6.2, bottom). In an additional
DNase I experiment (data not shown), this same footprinted region could be
competed by a -10.03 to -9.9kbp albumin enhancer fragment, thereby proving
the specificity of this interaction. Therefore, no differences are observed
between the protected regions obtained with extract from rat liver where the
NLS1 could direct transcription, or HeLa cells where NLS1 was inactive.

Discussion

In contrast, to region I, Region II on its own did have enhancing ability,
but only in hepatocytes and not in HeLa cells. It was therefore somewhat
surprising to find the proteins that bound to Region II were widely distributed
in several cell types, including HeLa and spleen cells. It is possible that the
protein(s) binding to Region II might either be modified correctly only in
liver cells or alternatively that a second protein, present only in liver cells,
interacts with the NLS1 to produce gene enhancement. Additionally, NLS1
binding activity could represent a multigene family, with only the liver
version capable of activating transcription. Several previously identified
transcription factors have been shown to constitute multigene families (ie.
ATF, API, CAAT; Dorn et al, 1987; Hai et al, 1988) each member of which
might activate transcription in its own unique manner.
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Is N L S 1 modified specifically in the liver? A final answer to this
question will require the purification and cloning of this factor from liver and
at least on other cell source. The data above, however, suggests that no
differences exist in the DNase I protection pattern generated from two
different cell sources, and the shift mobility of complexes from several cell
types was similar.
Recently, however, a difference in the gel-shift has been detected
using an oligonucleotide constructed according to the footprint data (Figure
6.2) and the shifted complexes were analyzed by electrophoresis on higher
percentage acrylamide gels (10% as opposed to 8%). Under these newer
conditions (shown in Figure 6.3), the HeLa protein produced a shifted
complex with a slightly increased electrophoretic mobility. This difference
could be the result of a post transcriptional modification event (ie. cleavage or
phosphorylation) that might change the size or charge of the protein, or
perhaps indicates that the two proteins are products of different genes. Of
note, the Hela cells are a human cell line while the liver extract was prepared
from the rat, and hence a species difference might produce this effect. In any
event, this shift mobility difference is similar to the situation observed with
the ApoCIII gene where the positive acting factor AF-1 is present in two
different gel shift forms in expressing vs. non-expressing tissues (Leff et al,
1989), or for the factor HNF1, which exists as a faster migrating variant
(vHNFl) in dedifferentiated hepatoma cells (Cereghini et al, 1988). The
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Figure 6.3. Liver and Hela cell nuclear extracts produce N L S 1 gel-shifts of
different mobility. A n oligonucleotide representing the footprinted sequences
s h o w n in Figure 6.2 (bottom) was end labeled an subjected to a gel shift using
crude liver or H e L a cell nuclear extract, in the presence (+) or absence (-) or a
100 fold excess of unlabeled homologous oligonucleotide competitor, and
electrophoresed on a 1 0 % acrylamide gel. Under these condition, a difference
in gel shift mobility is observed using extracts from these two different celltypes
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analysis of the albumin enhancer N L S 1 site described

above is still

preliminary and as the protein(s) are purified these different alternatives can
be explored in greater detail.
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Chapter 7

Albumin Enhancer Region III

F r o m the functional studies described in chapter 4, Region III w a s
demonstrated to prevent the enhancing action of Region II, an effect that was
overcome by the presence of Region I. To characterize the nuclear factors that
might interact with the negative acting DNA sequences of Region III (shown
from the functional studies presented in Chapter 4 to lie between -8.9 and
-8.43kbp), and to determine the tissue distribution of any such factors, gel
retardation assays and DNase I footprint analyses of this region were
performed.

Multiple Factors Interact with Region III
From the CWSV1 transfection analysis, the region between -8.9 to
-8.43kbp was proven to have a negative effect. The sequences extending from
-8.9 to -8.43kbp were therefore divided into three segments (probes 1-3,
Figure 7.1), and subjected to separate gel shift analyses (it had previously been
determined by exonuclease III studies that the region between -8.9 and
-8.84kbp did not contain any sites of DNA-protein interaction, and hence,
they were not included for further study). By competition with unlabeled
oligonucleotides, two binding sites for known proteins were localized: NF1
which binds to probe 1 (Figure 7.2) and HNF3 which binds to probe 2 (Figure
7.4 and 7.5). The third probe bound several proteins for which no known
oligonucleotides could compete (probe 3, Figure 7.6).
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Figure 7.1. Restriction m a p of albumin enhancer Region III. Using the
restriction endonuclease sites shown, this D N A fragment w a s divided into
three different end-labeled D N A probes (denoted 1, 2 and 3) which were used
to assay for DNA-protein interaction. N o probe was prepared for the -8,900 to
-8,827bp segment for it had previously been shown not to interact with any
protein.
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The m o u s e albumin enhancer contains a N F 1 binding site
A 77 base pair fragment (-8.827 to -8.750kbp) was 3' end labeled and
subjected to a gel retardation shift assay. A protein binding site was detected,
which appears to be an NF1 site based on competition by an oligonucleotide
containing mouse albumin upstream elements DEI and DEII, but not by an
oligonucleotide containing DEI alone (Figure 7.2A). Since DEI represents an
C/EBP binding site and DEII a site for NF1 binding, this competition must
therefore be resulting from the NF1 site (Babiss et al, 1986; Cereghini et al,
1987; Costa et al, 1988.). Furthermore, a gel-shift of this region using nuclear
extracts prepared from various tissues and cell types showed this activity to
be generally distributed among the different extract sources (Figure 7.2B), as
has been previously shown for NF1, and a reasonable similarity is evident
with the known NF1 consensus sequence (Figure 7.3; Jones et al. , 1987). The
mouse albumin promoter also contains a binding site for NF1 (see chapter 3),
which has been shown to bind both the ubiquitous NF1 protein and a liver
specific form of this factor which results from alternative RNA splicing
(Paonessa et al, 1988). The albumin enhancer NF1 binding site presumably
binds both of these different forms of the factor, which are not readily
distinguishable by gel shift analysis (Lichtsteiner et al, 1987).

Region III contains and HNF3 binding site
The DNA fragment extending from -8.75 to -8.7kbp (probe 2) produced
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Figure 7.2. Identification of an N F 1 binding site in the m o u s e albumin
enhancer by gel- shift analysis. Probe 1 (-8,827 to -8,750bp; see Figure 7.1) was
end-labeled and lng was incubated with 8ug of liver nuclear extract (Panel A )
or 8ug of nuclear extract from H e L a cells, brain or spleen tissue (Panel B), in
the presence (+; self) or absence (-) of self competitor. Specific competitors
used include the -8.75 to -8.7kbp fragment of the albumin enhancer, m o u s e
albumin DEI + DEII or oligonucleotide 2 from the T T R enhancer (TTR O L 2 , a
C / E B P binding site; Costa et al, 1988a). The mouse albumin DEI is a C / E B P
binding site while DEII is a site of N F 1 binding (Cereghini et al, 1987).

136

A

B

&&V<#

.V

^

«*

Comp ' —<f
I - 1 1^— y ^ -e£ +

• •

l

Alul
A *B *-

Mnll

BamHI

Figure 7.3. D N A sequence of the -8.837 to -8,700bp portion of Region III
which contains the NF1 and H N F 3 binding sites. The D N A sequences
footprinted by purified H N F 3 are shaded and above each site is shown the
homology with known consensus sequences (Jones et al, 1987, Costa et al,
1989).
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a gel-shift band with protein from hepatocytes that w a s competed by itself (+)
and by an oligonucleotide containing the binding site for the liver specific
protein HNF3 which interacts with the TTR promoter proximal sequences
between -85 to -lllbp (Figure 74A; Costa et al, 1989). A series of additional
oligonucleotides, however, did not compete with the labeled probe. This
strongly suggested the existence of a HNF3 binding site in the mouse albumin
enhancer. Additionally, this binding activity is liver specific as shown in
Figure 7.4B, for the shifted complex is not present in nuclear extracts prepared
from kidney, spleen or brain tissue and HeLa cells have a single band of lesser
mobility which is always present in cultured cells but does not represent
HNF3 (Costa et al, 1989).
This HNF3 site was confirmed by using oligonucleotide affinity
purified HNF3 protein (gift of R. Costa; Costa et al, 1989) to footprint this
region. (Figure 7.5). Two different amounts of purified HNft\3 protein were
used (lanes 1 and 2: 5 or 10 ug respectively) plus a BSA control. A G+A DNA
sequence ladder is included for orientation. The protected nucleotides on
each DNA strand are depicted by the black bar in Figure 7.5 and interestingly
there exists a DNase I hypersensitive site in the middle of the footprinted
region (marked by a "*"). The footprinted DNA sequences are highlighted in
Figure 7.3 where it is shown that an 8/10 base homology exists with the
known HNF3 element. The mismatched bases are in a region which Costa et
al (1989) has shown dictates the affinity of the HNF3 protein for its DNA
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Figure 7.4. Identification of a H N F 3 site in the m o u s e albumin enhancer by
gel shift analysis. O n e ng of Probe 2 (-8,750 to -8,700bp; see Figure 7.1) w a s endlabeled and subjected to a gel shift analysis as previously described using
either 8ug of rat liver nuclear extract (Panel A ) Or 8ug of nuclear extracts
prepared from kidney, spleen, brain tissue and H e L a cells (Panel B), in the
presence (+, Alu) or absence (-) of self competitor. Specific competitors used
include oligonucleotides containing binding sites for C / E B P (TTr 012), H N F 3
(TTr -85 to -111), and DEI and DEII as described in Figure 7.2. A lOObp p G e m
fragment is also included as a competitor. M l and M 2 identify the two shifted
complexes which are characteristically observed for H N F 3
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Figure 7.5. D N a s e I footprint analysis of the H N F 3 binding site. A 5' end
labeled probe from -8,827 to -8,700bp was incubated with affinity purified
H N F 3 protein (approx. 1000 fold; Gift of R. Costa) prior to digestion with the
enzyme D N a s e I. The products were then analyzed on this 8 % denaturing
acrylamide gel. Lane 1 was incubated with B S A as a control and lanes 2 and 3
with 5 or lOug of the H N F 3 protein respectively. A (G+A) sequencing ladder
and markers (M) are included for orientation purposes. The footprinted
regions are denoted by the black bars. Note the appearance of several
hypersensitive sites including the most prominent in the center of the
footprinted region marked with a "*".
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sequence. This albumin sequence w a s subsequently demonstrated to be a
weak HNF3 binding site by gel shift analysis (data not shown).

Several Proteins interact with the sequences between -8.7 and -8.43Kbp
Probe 3 (-8.7 to -8.43kbp; Figure 7.6), by far the largest of the three
probes analyzed, produced at least two shifted complexes present in extracts
prepared from rat liver, CWSV1 and HeLa cells. At this point in the analysis,
however, it was unclear which of the DNA sequences in Region III might be
responsible for the negative, regulatory effect observed. Clearly the removal
of the described HNF3 and NF1 binding sites (with Region I intact) had no
affect on the overall level of mRNA accumulation, suggesting at least that no
positive role exists for these factors in the transient assay system. In any
event, none of these results served to precisely single out the proteins
responsible for the negative effect. It became apparent that settling this
question required a more detailed deletional analysis of this region coupled
with a functional analysis of the mutants. At this point, therefore an
additional functional analysis of the negative element was undertaken.

The negative acting sequences reside between -8.7 and-8.43kbp of the mouse
albumin enhancer
To specifically localize the DNA sequences which conferred the
negative effect on the mouse albumin enhancer, transient plasmid
transfection assays were again performed using rat CWSV1 cells (see chapter
141

Figure 7.6 Gel-shift analysis of protein binding to Probe 3 of albumin
enhancer Region III. Probe 3 (-8700 to -8,433bp) the largest of the probes w a s
end-labeled and subjected to gel-shift analysis with 8ug of nuclear extract from
liver tissue, C W S V 1 or H e L a cells in the presence (+) or absence (-) of self
competitor. Specific shifted DNA-protein complexes are shown by arrows.
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4, Figure 4.1). Agreeing with the results reported in chapter 4, a five-fold
stimulation in albumin promoter function was found when the entire
albumin enhancer was included (Fig. 7.7A; -10.5 vs. -0.3). Furthermore,
when sequences between -10.5 and -10.07kbp (which includes Region I) were
removed, a complete loss of enhancer function was observed (Figure 7.7A,
-10.07), owing to the absence of the enhancer modulating sequences. Also
shown in figure 7.7A, however, is a DNA fragment which contains the
negative element exclusively (sequences from -8.9 to -8.43kbp) placed 5' to
the -300 albumin promoter element. Interestingly, the Region EI sequences
did not suppress the basal level of albumin promoter function (compare lanes
marked -8.9 and -0.3, figure 7.7A). Therefore, the negative element would
seem to have no direct effect on the albumin promoter but rather appears to
exert its effect solely by negating the effects of the enhancer.
To define the functional boundaries of the negative element, a
plasmid containing mouse albumin regulatory domain II and III (-10.07 to
-8.43kbp) was used to make deletions from the 3' boundary using three
different restriction sites: PstI; (-8.7kbp), Bgl II (-8.9kbp); or Accl (-9.94kbp).
Plasmids with these deletions (maintaining a set 5' end at -10.07kbp) were
assayed in CWSV1 cells (Figure 7.7B). The plasmid construct with a 3'
coordinate of -8.43kbp (containing the entire -8.9 to -8.43 region), did not
show any enhancer function, due to the presence of the negative element. In
contrast, when 270bp were deleted to the site at -8.7kbp, full enhancer
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Figure 7.7 Additional functional analysis of the m o u s e albumin enhancer
element in C W S V 1 cells. In panel A the parent construct (bottom) and
deletions (marked by their 5' boundary in kbp) were co-transfected into
C W S V 1 cells with a control plasmid (bottom, a SV40 enhancer containing
(3-globin promoter) to standardize for variations in transfection efficiency (see
Materials and Methods, chapter 2). Assays for expression were carried out by
protection of labeled SP6 probes. The lane marked -0.3 indicates the
enhancerless albumin promoter plasmid containing 300bp of promoter
sequence. In panel B, the parent construct is assayed (-10.5 to -8.43kbp), along
with an additional construct as s h o w n which maintains a 5' enhancer
boundary of -10.07kbp while having a variable 3' end position as indicated
above each lane.
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function was restored, locating the functional, negative sequences of Region
HI between -8.7 and -8.43kbp. As observed previously, further 3' deletion of
DNA sequences to -9.94kbp resulted in identical enhancement, indicating that
no additional negative regulatory elements exist.

The negative element functions in HepG2 cells
An added experiment (Figure 7.8) showed that the negative acting
region of the albumin enhancer (Region EI) also produced an effect in HepG2
cells, in this case upon the heterologous TTR promoter. When the TTR
promoter alone was coupled with the activating part of the albumin enhancer
without the negating sequences (-10.07 to -8.7kbp), there was a stimulation of
the TTR promoter (Figure 7.8; lane marked -8.7; approx. 3-5 fold). This
stimulation, however, was blocked by inclusion of the sequences between -8.7
to -8.43kbp (Figure 7.8, lane marked -8.43), which includes the negative
region. Therefore, both the positive and negative, regulatory regions of the
albumin enhancer function in HepG2 cells (see Chapter 4). Subsequent
experiments aimed at delineating the exact location and function of the
albumin enhancer negative element have therefore used the HepG2 cell line.

The albumin negative element can act to down-regulate the TTR enhancer
I next wanted to determine if the negative element could act upon a
heterologous enhancer; in this case the TTR enhancer. The effect of the
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Figure 7.8 The mouse albumin enhancer negative region can function in
h u m a n hepatoma cells (HepG2 cells) upon the heterologous T T R promoter.
Albumin enhancer sequences as indicated were placed 5' to the T T R
promoter element at position -202 relative to the start site of R N A
transcription. These constructs were then transfected into h u m a n H e p G 2
cells, along with the SV40 enhancer containing p-globin plasmid as an
internal control. The RNase T2 assay used to score the T T R expression
protects a 93 nucleotide band as shown and is described in the text.
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negative region in abolishing the action of the T T R enhancer on its o w n
promoter was demonstrated by inserting various parts of the albumin
enhancer region between the TTR enhancer and promoter as shown (Figure
7.9, bottom). The assay of the transthyretin (TTR) promoter depends on a
nominal 93 base pair RNase T2 protected band that is complementary to the
TTR first exon (Fig. 7.9, bottom), although a band slightly larger is also
observed (nominally 95 and 96 bases) which is thought to represent either an
upstream start site or an RNase T2 artifact (see chapter 4). In any event, these
bands are usually proportional. The approximately 5 fold stimulation of the
TTR enhancer on its own promoter (Fig. 7.9, left most two lanes) was blocked
by the presence of the albumin negative region (Figure 7.9, -8.43 to -8.9). This
negative effect was mapped more precisely by dividing the negative element
into two roughly equal sized pieces (-8.9 to -8.7kbp) and (-8.7 to -8.43kbp).
The negative effect was contained entirely within to -8.7 to -8.43kbp region
which could exert its action when present in either orientation (indicated by +
or - in Figure 7.9). Similar experiments were performed by placing the same
negative region fragments between the SV40 enhancer-p-globin promoter
construct described previously, and assaying for expression in both HepG2
and HeLa cells (data not shown). In each case, no negative effect was
observed; either the SV40 enhancer is too potent to achieve suppression or
there are a limited group of enhancers that can be suppressed by this negative
element.
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Figure 7.9. Mouse albumin enhancer Region III can negate the function of
the TTR enhancer. Constructs were prepared as described in the methods
section and diagrammed at bottom, which placed portions of the mouse
albumin enhancer negative region (as marked above each lane). between the
TTR enhancer and promoter at a unique Xbal site as shown. These constructs
were transfected into human hepatoma cells (50ug) along with the
SV40/p-globin plasmid (20 ug) as an internal control. The TTR -202 promoter
containing plasmid and the TTR promoter/TTR minimal enhancer construct
are included as controls in both panels A and B, which represent separate
experiments.
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T w o binding sites for the same protein reside between -8.7 and -8.43kbp
Experiments were designed that would identify protein binding sites
within the 273 base pair portion of the albumin enhancer containing the
negative element. As shown earlier in this chapter, this region gives a
complex gel shift pattern suggesting that several proteins might be interacting
with these sequences (Figure 7.5). Therefore, to simplify the analysis, this
DNA fragment was bisected at a unique Asel restriction site (-8,651bp). Endlabeled DNA fragments from -8,700 to -8,652bp and -8,651 to -8,430bp were
prepared and mixed with nuclear extracts from either rat liver or HeLa cells.
Assays for DNA binding were carried out by gel retardation shifts using these
labeled DNA fragments. Both fragments bound protein from both extracts
and one particular complex (marked in Figure 7.10A with an arrow) was
specifically prevented from forming by including an excess of unlabeled
homologous oligonucleotide. Furthermore, the two parts of the negative
region (-8,700 to -8,562 and -8,561 to -8,430, probes 1 and 2, respectively)
showed cross competition with each other indicating a binding site in each
half for the same (or a similar) DNA binding protein (Figure 7.10B). Early
efforts at purification of this binding activity are consistent with this
conclusion, for upon fractionation with heparin agarose the peak binding
activity for both probes is found in the same fraction (data not shown). Since
the specific activity of the two probes was the same and probe 1 gave a
stronger gel shift band and was better able to compete for itself than an equal
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Figure 7.10. Definition of the A N F (albumin negative factor) sites within the
m o u s e albumin negative region -8.7 to -8.43kbp by gel-shift assay. T w o
roughly equal sized probes were prepared by restriction endonuclease
digestion at the unique Asel site as shown. These two end labeled probes
were then used in separate gel shift assays (Probe 1 and Probe 2, respectively).
In panel A the probes were 3' end labeled and incubated with liver or Hela
cell nuclear extract in the absence (-) or presence (+) of homologous unlabeled
D N A (50 fold molar excess) and the products analyzed by gel retardation on
an 5.5% native acrylamide gel. In Panel B the same two probes are used (as
marked) except n o w other competing fragments and oligonucleotides (also in
50 fold excess) are used. These include the entire -8.7 to -8.43kbp fragment
(represented by (+), unlabeled probes 1 and 2 as well a D N A fragment from
the retinol binding protein (RBP) gene promoter containing the functional
negative acting region (gift of R. Cortese). Oligonucleotides representing
binding sites for the factors N L S 1 and A P I are also included as competitors.

150

B
Probe 1

Probe 1

Probe 2

Probe 2

r-~
a6

Liver

HeLa

Liver

**

HeLa

J

06
CVJ

-

CM

OJ

©

_

co .a .a Q_ ,_
"* o o m Q_

^
^j

°? rx a. rr <

z

i-

•9 d ^

o So m Q_
tf
I °? Q. Q. DC <
"*

CO

IJ

m

m

m**%

«*•#

PstI

Asel

Pst

•8,561

•8,433

55
•8,700
probe 1
probe 2

Z

molar amount of probe 2, it appears that probe 1 binds this protein with a
higher affinity than probe 2. The specificity of this complex was further tested
by competition during complex formation with excess molar amounts of
several other oligonucleotides. No other oligonucleotide tested reduced
complex formation (Figure 7.1 OB). These unsuccessful competitors included
the previously described negative elements in the retinol binding protein
gene (RBP; Colantuoni et al, 1987) and a group of other positive acting factors
(shown in Fig. 7.10 are sites for API and NLS1, the protein that binds to the
activating region of the albumin enhancer; not shown but also with no effect
were oligonucleotides representing SP1, HNF1, 3, 4, C/EBP and Octl binding
sites (Courtois et al, 1988; Costa et al, 1988; 1989; Jones et al, 1988).

The albumin negative factor (ANF) is present ubiquitously
The cellular distribution of this newly identified protein which was
termed ANF for albumin enhancer negative factor was determined next.
The same amount of total protein from nuclear extracts from six different cell
sources were used in a gel shift reaction with negative region probe 2 (-8,651
to -8,430), shown in Figure 7.11. Each extract used was first subjected to a gel
shift reaction using a known API binding site to insure its integrity (data not
shown, chapter 2), and each was normalized tin this way. All the cell lines or
tissues contained similar amounts of the albumin negative factor except for
CWSV1 cells where the level was reduced by 50%. It was in these CWSV1
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Figure 7.11. The A N F binding activity is present ubiquitously. Probe 2 (see
Figure7.10) w a s end labeled and subjected to a gel shift assay with equal
protein amounts (8ug) of nuclear extracts prepared from the cell-types
identified above each lane. The arrow depicts the specific A N F complex.
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cells, however that the function of the negative element w a s first identified,
suggesting that this decrease might not be functionally significant. These
results illustrate that the factor recognizing the negative region of the
albumin enhancer is widely distributed, and is present in cell and tissue types
which do (liver, SV1 and HepG2) or do not (HeLa, Kidney and C2) transcribe
albumin.

The ANF binding site
To define the binding sites for the ANF proteins in each region of the
negative element two types of experiments were carried out, both of which
used end-labeled DNA probes. Each of the fragments (Probe 1 or Probe 2,
Figure 7.12) were uniquely 5* end labeled (as shown in Figure 7.12, bottom)
and subjected to their separate analyses. Note that only the results for one
DNA strand (the bottom strand for probe 1 and top strand for probe 2), are
shown in Figure 7.12, yet the data representing the results from both strands
are summarized in figure 7.13.
First, exonuclease III digestion of the labeled probe in the presence of
nuclear proteins showed blocks to digestion that were specifically competed by
the presence of excess unlabeled probe (Figure 7.12A and B). For each exoIH
analysis, lng of labeled probe was incubated with 30 ug of nuclear protein
(either liver, HeLa or kidney) for 30min and then subjected to exonuclease HI
digestion. The starred bands indicate specific, self-competable, exonuclease
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Figure 7.12. Exonuclease III stop and D N a s e I protection experiments to
delineate the boundaries of A N F binding. The two probes were 5' end labeled
at the position shown and subjected to the assays as described in.the methods
section. The ExoIII assays are shown in parts A and B for probe 1, and 2
respectively while C and D represent the D N a s e I footprints for the same two
probes. Note that in panel A the lane labeled (+) contains homologous self
competitor while the (-) lane contains an equal molar amount of p G e m l . In
B, however, the (-) lane contains no unlabeled non-specific competitor. This
control is instead n o w included in the lane labeled N S containing an equal
amount of p G e m l . The lanes labeled "No ext" received no protein extract
and the lanes labeled "No exoIH" received neither protein extract nor exoIII.
The exoIII stop fragments are indicated by asterisks and by their position
relative to the albumin transcription start site. A "G + A" sequence ladder is
included. The D N a s e I protection assay (C and D ) used the same probes
incubated with either B S A (as a control) or either Pll purified Hela extract, or
a heparin agarose purified liver protein fraction. These complexes were
treated with DNasel, and the products analyzed by 8 % denaturing
polyacrylamide gel electrophoresis as shown. Regions of protection from
DNasel digestion are denoted by the bar, with the coordinates as shown. See
Figure 7.13 for a s u m m a r y of the A N F binding sites and a sequence
comparison.
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stop sites presumably representing points of DNA-protein interaction. Using
probe 1 (Figure 7.12A), which contains ANF site A (the stronger binding site),
a predominant exonuclease stop was seen at nucleotide -8,598 with liver,
HeLa and kidney nuclear extract (Figure 7.12A). Lanes marked (+) contain a
30 fold molar excess of cold unlabeled self competitor while the lanes marked
(-) contain an equal fold molar excess of a pGem fragment to keep the total
amount of DNA constant.
For ANF site B, an exonuclease stop were observed with both liver and
HeLa extracts (Figure 7.12B). In these experiments the (+) again refers to a 30
fold excess of self competitor while the lane marked (NS) contains an equal
molar excess of pGem. The (-) lane contains no unlabeled DNA and hence, a
reduced amount of total DNA. A strong exoIII stop is observed at -8466 while
a much weaker stop is seen at nucleotide -8,447 (Figure 7.12B).
A DNase I protection assay (Figure 7.12 C and D) using the same probes
further delineated the boundaries of DNA-protein interaction. These
footprint reactions (as described in the methods) were done using either BSA
as a control or 5ug of a heparin agarose purified liver fraction or HeLa extract
from a 0.4M salt PH column step (a gift of X. Fu). For ANF site A the
footprinted region is depicted (somewhat split) in Figure 7.12C, and includes
the DNA sequence defined by the exoIII stop site (see Figure 7.13). The ANF
site B is protected as shown in Figure 7.12D by the region encompassed by the
black bar. Again, the exoIII stop site is included within this sequence. These
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Figure 7.13. Sequence of the functionally important portion of the albumin
enhancer negative region (-8.7 to -8.43kbp). The exonuclease stop sites from
both strands represented by the arrows, and the D N a s e I protected regions are
represented by the brackets. N o footprint has been obtained for the A N F site
B lower strand which represents the weaker binding site. A comparison of
the A N F A and B binding sites are s h o w n at bottom, indicating a 7/10
sequence match between the two protected regions.

156

•8,700
i

CAATAATTAT GAGCAGAATT ACTGACACTT CCATTTTATA CATTCTACTT GCTGATCTAT GAAACATAGA
GTTATTAATA CTCGTCTTAA TGACTGTGAA GGTAAAATAT GTAAGATGAA CGACTAGATA CnTGTAICT
0

ANF A

^

(-8,5611
Ase I

taAGCATGCA GGCAnCATC ATAGTTTTCT TTATCTQGAA1 AAACATTAAA TATGAAAGAA OQCATITAafr
ATTCGTACGT OCGTAAGTAG TATCAAAAGA AATAGACCTT TTjTGTAA'p'T, ATALTi'lL'iT GCGTAAATAA

•8,560
AATACAGTIT AGATGTGnT TCCGATCTIT TAATTTCITA AGAAATACTA AGCTGATCGA GCGTGAAGAGT
TTATGTCAAA TCTACACAAA AGGCTAGAAA ATCAAAGAAT TCTTTAIGAT TCGACTAGCT CGCACTTCACA

ANFB

-8,490

«.

*

TGTGTGAAAA GCAGTGGTGC AGbrTGGCTT GAACTOGTIC TOCAGCInGG GATCGAC
ACACACrnT CGACACCAGG TCGAACOGAA CTIGAGCAAG AGG1CGAACC CTAGCIG

CITIATCTOG

(ANF "A" -8,602 -+> -8,593)

OTX^AACIOG (ANF "B" -8,463 -•-8,454)

results are summarized in figure 7.13, and a comparison of the sequence
within the two protected regions revealed a 7 base pair identity within a 10
base pair sequence. The relative importance of these nucleotides for protein
binding will require further mutagenesis and functional studies.

The ability of the ANF sites to interfere with the TTR enhancer is
proportional to their affinity
Having identified these two ANF binding sites, a final experiment
compared the effectiveness of the two ANF sites in suppressing TTR gene
enhancer activity. Transient transfections were done using similar plasmid
constructs as described in Figure 7.9 with fragments containing the ANF A or
B binding sites now independently inserted between the TTR elements (all
constructs shown are in the + orientation). Following co-transfection into
HepG2 cells (50ug of TTR DNA) using a SV40 enhancer driven p-globin
plasmid (20 ug) as a control, both TTR and p-globin gene expression were
scored in the same reaction. The 93 nucleotide specific TTR signal (labeled 93
in Figure 7.14) can be evaluated after correcting for variations in transfection
efficiency and RNA extraction using the p- globin signal which here consists
of a summation of the 206 and 143 nucleotide bands, representing the second
and first exons respectively (labeled -206 and -143).
As shown in Figure 7.14, the ANF A containing fragment (-8.56 to
-8.7kbp) had about the same negative activity as the larger fragment
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Figure 7.14 The mouse albumin enhancer negative region sequences were
placed between the T T R enhancer and promoter as in Figure 7.9. For this
assay, however, both probes (for the T T R or the p-globin control) were assayed
in the same reaction. Again, the T T R promoter (TTR -202) and T T R promoterenhancer controls are shown (TTR -202 + T T R Enh). The coordinates of the
inserted albumin sequences are as marked and are all in the (+) orientation.
The 93 nucleotide band represents the specific T T R signal while the 143 and
206bp bands represent exons 1 and 2 of the p-globin gene.
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previously described (-8.43 to -8.7) while A N F B containing fragment (-8.43
to -8.56) had at best a slight negative effect. Recall that figure 7.9 showed that
the affinity of the ANF A site (-8.56 to -8.7, probe 1) was stronger than that for
site B (-8.56 to -8.43, probe 2). Thus, the apparent stronger binding of site A
correlates with the greater negative effect it has in transfection assays.
Therefore, this assay has served to locate the entire, functional negative effect
of region III to the ANF A site located on the -8.56 to -8.7Kb fragment. Due to
the close proximity of these sites, however, and the possibility that they each
might function in vivo, both will be included in the following discussion of
Region III. In any event, mutational analysis of these binding sites (ie. using
the technique of point mutagenesis) will be required to confirm the role of
ANF in albumin enhancer function.

Discussion
The experiments described in this chapter prove that the albumin
enhancer contains a functionally acting negative sequence between -8.43 and
-8.7Kb upstream of the albumin gene RNA start site. This sequence,
presumably acting through the newly described protein ANF, negates the
effect of the positive acting region of the albumin enhancer. A negative
action is also evident when the element is placed between the enhancer and
promoter of the mouse TTR gene. The negative element had no direct effect
on the mouse albumin promoter alone, nor was this element able to suppress
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the very strong p-globin activation by the SV40 enhancer of the p-globin
promoter in either HepG2 or HeLa cells.
Both the TTR enhancer-promoter and the albumin enhancerpromoter sequences have binding sites for many different proteins, including
four factors present more prominently in hepatocytes than in other cell types
(HNF1,3,4 and C/EBP) and the NLS1 protein described in chapter 6 (Cereghini
et al, 1987; Lichtsteiner et al; Courtois et al, 1988). In the albumin enhancer,
the ANF sites between -8.43 and -8.7kbp presumably negate the action of the
NLS1 factor that binds at ~10kbp. In the experimental constructs where Region
III divides the TTR elements, the negative element is presumably able to
prevent the action of one of the other site-specific DNA binding proteins
mentioned above.

A model for the tissue specificity of the mouse albumin enhancer
At this juncture, all three of the albumin enhancer regions have been
described, and it seems reasonable to discuss a working hypothesis to explain
how they might interact to generate tissue specific gene enhancement. The
three enhancer regions and the proteins which have been identified as
binding to them are shown in Figure 7.15. It has been demonstrated in the
preceding chapters that the NLS1 protein is responsible for the complete
positive action of this enhancer which can be negated by the action of the
ANF binding sites. The C/EBP protein, however, modulates the negative
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Figure 7.15 S u m m a r y of the DNA-protein interactions occurring on the
m o u s e albumin enhancer. The three regions of functional, importance
(identified as I, II and III) and the proteins that interact with them have been
identified and are shown schematically. Region I has two sites for the protein
C / E B P (see chapter 5). Region II was shown to interact with N L S 1 (chapter
6), and Region III contains two binding sites for A N F which have been
described in this chapter.
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effect and enables the enhancer to function. H o w then, does this overriding
mechanism insure that albumin transcription occurs in a liver specific
fashion?
The ANF binding activity is present ubiquitously, and while to date it
has only been shown to negate transcription in liver derived cell types
(HepG2 and SV1), assume for the purpose of this model that ANF is present
and able to negate albumin transcription in all cell types. Next consider
NLS1, a factor for which binding activity is present in all tissues but specific
modification (or an additional protein) is required for stimulatory function.
The results presented in this thesis have demonstrated that in the liver celltypes NLS1 is active, whereas in HeLa cells, although binding activity is
present, function is lacking. Furthermore, the results from the Palmiter
laboratory mentioned earlier strongly suggest (but of course don't prove) that
the NLS1 is functionally modified in other differentiated tissues (Pinkert et
al, 1987; e.g. spleen, lung, kidney). This is based on the fact that the albumin
enhancer sequences in the absence of the negative region (identified in this
thesis) could enhance albumin transcription in several non-liver tissues of
transgenic mice (a fragment from -10.4 to -9.3kbp produced this effect, and
NLS1 is the only identified positive acting element in this region). With
these facts as a backdrop several specific situations may now be examined.
In the hepatocyte, NLS1 is functionally active although the ANF is
present as well. However, the presence of C/EBP overrides the negative
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mechanism and enables the enhancer to function. O n the other hand, in a
non-liver tissue such as the spleen, NLS1 is also present and functionally
active (extrapolating from Pinkert et al, 1987) again in the presence of the
negative factor. In this case, however, C/EBP is lacking and therefore the
negative effect persists. The end result is no enhancement in this tissue.
Finally, in a HeLa cell a dual mechanism appears to keep enhancer directed
albumin transcription silent, for NLS1 is not functionally modified and
C/EBP is lacking. Hence, it would seem to be both the presence/absence of
C/EBP and the state of modification of the NLS1 which controls albumin
enhancer function.
In regard to the final point above, perhaps NLS1 is present and
functionally active exclusively in fully differentiated tissues (hence the
absence of function in the HeLa cells). It that event, C/EBP becomes the key
to enhancer function. C/EBP is a liver enriched factor and this model would
explain the lack of albumin transcription in most tissues. It could not,
however, account for regulation of the albumin enhancer in adipocytes,
which are known to produce significant levels of C/EBP (Birkenmeier et al,

1989). In this situation, perhaps the relative levels of all three different factor
are such that enhancement does not occur (ie. for example NLS1 is reduced or
only partially functional while C/EBP is at a less than optimal concentration).
Alternatively, it is possible that a low level of enhancer function does occur
in this tissue but its effect is not manifested due to the tissue specific nature
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the albumin promoter. This latter point is significant for as demonstrated in
this thesis, the albumin gene has a dual mechanism for insuring its
specificity: both a highly tissue specific promoter and enhancer element. It
should be keep in mind, however, that in vivo the above mechanism could
be secondary, for the factors might have already functionally altered the
chromatin structure during terminal differentiation of the cell. Hence, the
decision whether to express albumin may already be stored on the
chromosome.
The testing of the above model provides the basis for future functional
studies involving this enhancer element. A number of points must still be
examined: 1) the ability of the ANF to function in non-liver cell types; 2) The
ability of NLS1 to function in other differentiated tissues; 3) an analysis of
enhancer function in adipocytes. Probably, the best way to address these
questions in multiple cell-types would be to prepare transgenic mice
containing different combinations of these three regulatory regions. Now
that the binding sites have been delineated, this type of experiment is quite
feasible. Additionally, it has recently been found that the NLS1
oligonucleotide (described in chapter 6) can be oligmerized and used to
enhance p-globin expression in HepG2 cells. This same construct can now be
used to analyze NLS1 function in a host of differentiated cell types (including
adipocytes) by transfection. Finally, the negative element can be tested in
non-liver cell types by making it part of promoters known to be active in
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H e L a cells.

Molecular extinction suggested the existence of negative regulation
Somatic cell genetic studies have shown that when certain hepatoma
cells are fused with each other or with a variety cell types, suppression of
liver gene transcription occurs (Killary and Fournier, 1984, Petit et al, 1986;
Gourdeau et al, 1989). This extinction is subject to gene dosage effects and is
reversible, often following the loss of a particular chromosome in the
extinguishing parent. This has led to the conclusion that these
"extinguisher" genes act in a trans-dominant manner. Tse 1 (tissue-specific
extinguisher) was the first locus identified as a discrete genetic element
residing on mouse chromosome 11 or human chromosome 17. (Killary and
Fournier, 1984), and the product (s) encoded by this locus specifically
extinguishes tyrosine aminotransferase transcription in hepatoma x fibroblast
cell hybrids (Gourdeau et al, 1989). Extinguishers such as these have also
been found to be involved in the regulation of many other liver specific
genes including albumin. Petit et al (1986) have described cell fusion studies
of FaO rat hepatomas with microcells (which contain only a small number of
chromosomes) that extinguish albumin expression, and they have narrowed
this locus to a single unidentified chromosome (Petit et al, 1988).
Is ANF the factor involved in albumin extinction; the product of this
extinguishing locus? The answer to this question is no for several reasons.
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First of all, the A N F is present ubiquitously, including in liver cells and
hence is not acting in the same dominant fashion as the extinguishers
described above. Furthermore, Petit et al demonstrated that extinction
occurred upon a transfected albumin promoter containing only 400bp of
upstream sequence, and therefore this enhancer is not even necessary for that
process. It seems more likely that the extinguishing gene product is acting
indirectly to effect the activity of one of the factors involved in albumin
transcriptional regulation. For example, if it interfered with the regulation of
C/EBP production it could negate the enhancer (for C/EBP is required to
override the negative element) and severely restrict the activity of the
promoter. Likewise a decrease in the activity of any of the other factors
involved in albumin transcription would have a similar effect. It has recently
been suggested that the loss of HNF1 activity and the appearance of a nonfunctional variant (vHNFl; see introduction) might be involved in this
process (discussed in chapter 8).

Mechanisms of action of the negative element
The exact protein-protein interactions involved in manifesting the
negative effect of ANF is currently under study. The fact that the negative
element does not extinguish the basal level transcription from the albumin
promoter (-300 sequences) nor does it require its own promoter, suggests that
the ANF doesn't specifically inhibit initiation complex formation but rather
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blocks the enhancing activity of upstream factors (either by interfering with
their binding or by masking their activating functions). Perhaps the binding
of the ANF interferes with the binding of NLS1 in the absence C/EBP. There
is precedent for these types of protein interaction in several systems including
most prominently the yeast mating type genes where for example, the
MATal gene has been shown to change the oc2 protein in such a fashion that
it no longer recognizes a specific binding site (Goutte et al, 1988).
Alternatively, the ANF sites either independently or perhaps by interacting
with each other, might form a large complex or secondary structure that
prevents the enhancer from functioning .

The negative element resembles a yeast silencer
In many ways this albumin negative element resembles the silencers
of yeast in their ability to function in an orientation and distance free fashion
to block transcription (Brand et al, 1985, 1987 ). Like the yeast silencer, this
element is not promoter specific and works through a cis-acting sequence
known to bind cellular factors. As the SIR proteins and binding sites from
yeast and the ANF protein are better characterized a comparison will certainly
be warranted.

Conclusion
Future work will attempt to address the mechanism by which this
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negative region functions and by which the C / E B P overrides the effect. A s
each of the three albumin enhancer proteins are purified and cloned it will
become possible to explore the protein-protein interactions responsible for the
this intricate regulatory scheme. From this discussion, however, further
support is drawn for the conclusion that combinations of transcription factors
interact to produce regulated gene activity in differentiated cells. While at the
the present time not enough is known to suggest specific mechanisms of
action for these proteins, the first step in solving such interactions is the clear
delineation of DNA binding sites and the characterization of their cognate
proteins.
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Chapter 8

Transcriptional Regulation in Rat Hepatoma Cells

H e p a t o m a cells while useful recipients to test recombinant genes
transcribed specifically in hepatocytes, do not exhibit normal rates of
transcription (as compared to the rat liver) for an array of hepatocyte
expressed genes (Clayton et al, 1985; Friedman et al, 1987; chapter 1).
Additionally, numerous hepatoma cells lines have been isolated which have
dedifferentiated and lost the ability to manifest liver specific functions
completely (Descharette and Weiss, 1974). Since many genes, including
albumin, are differentially transcribed in these cell-types, they represent a
useful system for exploring the molecular mechanisms underlying gene
control. Using gel-shift analyses, the relative levels of known transcriptional
proteins can be probed in nuclear extracts from the different cell lines and
correlated with the transcription rates of their dependent genes.
Furthermore, with the availability of clones for several liver enriched
transcription factors, it is possible to measure their rates of transcription (the
factors) in each cell-type. This approach enables a beginning understanding of
the process by which the activity of the transcriptional regulators themselves
are controlled in a specific cell type.
Work in several laboratories has identified, characterized and now
cloned at least four nuclear protein factors, which have been shown to be
involved in hepatocyte specific gene expression (HNF1, C/EBP, HNF3, and
HNF4; chapter 1). These four liver enriched proteins, along with the factors
NLS1 and ANF (chapters 6 and 7), are known to be involved in the
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transcriptional

regulation of both the m o u s e albumin and transthyretin

(TTR) genes. A summary of the DNA-protein interactions that occur upon
the albumin and TTR regulatory regions is diagrammed in Figure 8.1.
With the availability of DNA clones for each of these genes and a set of
DNA oligonucleotides that each contains a binding site for one of these six
factors, a series of rat cell lines was examined (Figure 8.2; Deschatrette and
Weiss, 1974; Deschatrette et al, 1980) whose profile for hepatocyte-like
transcription has been described (Clayton et al, 1985; Friedman et al, 1987).
FaO cells represent the parent hepatoma cell line and are considered most
similar to hepatocytes; C2 is a variant of FaO that has simultaneously lost
gluconeogenic capacity and albumin production, and several other liver
specific functions; C2 rev7 is a revertant of C2 that has regained gluconeogenic
capacity and some ability to produce albumin. H5 is a variant of the cell line
H4II, which like C2 is dedifferentiated cell line that has lost liver-like
functions.

Nuclear run-on transcription rate analysis
To determine the transcription rate of various liver specific genes,
including the four transcription factors, nuclear run-on assays were
performed with nuclei from rat liver and the cell lines described above
(Figure 8.3; Table 8.1). Two genes encoding secreted serum proteins
transcribed at high rates: albumin and transthyretin show very different
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Figure 8.1. S u m m a r y of the DNA-protein interactions occurring in the
promoter/enhancer regions of the m o u s e albumin and T T R genes. This
figure is based on the results of functional analysis and in vitro binding
studies on the 5' flanking regions of these genes (albumin; this thesis and
references therein; TTR, Costa et al, 1986,1988a, 1989). The legend (bottom),
denotes the identity of the different factors.
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Figure 8.2. Origin of rat hepatoma cell clones (Deschatrette and Weiss, 1974;
Deschatrette et al, 1980). These clones are divided into two groups; the
albumin producing, differentiated cell lines (top) or the non-albumin
producing, dedifferentiated cell types (bottom). The arrows extends from the
parent of each cell line. These cell lines were selected based on the ability to
g r o w in the presence or absence of glucose. For a more thorough discussion
of these cell lines see text.
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transcription patterns in F a O cells. Albumin is transcribed in F a O cells at
about 18% the rate it is in liver but TTR transcription is transcribed at only 1%
that in rat liver. The transcription rate in C2 cells of the albumin gene was
barely above the baseline level and that for the TTR was undetectable. In
C2rev7, the hepatocyte-like revertant, a small but definite resumption of
transcription rate was observed both for the albumin and TTR genes, whereas
the H5 did not transcribe either of these genes. These results are quite similar
to those described earlier for these cell lines (Clayton et al, 1985; Friedman et
al, 1987). Therefore, while both albumin and TTR maintain identical

transcriptional specificity in the different cell lines (activated in liver, FaO and
C2rev7 and inactive in C2 and H5) their relative transcription rates vary
significantly.
The results of the nuclear run-on assays for the transcription factors are
more complex. The most striking, finding is the five-fold decrease in the
transcription of the C/EBP gene in FaO cells compared to liver and the 40-fold
decrease in FINF3 and HNF4 transcription. In contrast, to the HNF3, HNF4
and C/EBP genes, however, the transcription rate of the HNF1 gene is almost
the same in FaO cells as in liver and does not change significantly in any of
the other cell lines. C/EBP transcription is also similar (within a factor of 2)
in all the hepatoma cell lines (Figure 2; Table 1) while transcription of HNF3
and HNF4 is very low in FaO and C2rev7 cells and almost undetectable in C2
and H5 cells.
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Figure 8.3. Nuclear run-on transcription analysis of albumin (ALB),
Transthyretin (TTR) and the genes coding for H N F 1 , H N F 3 , H N F 4 and
C/EBP. Nuclei from rat liver tissue or the FaO, C2, C2rev7 and H 5 cells lines
were isolated and allowed to chain-elongate nascent R N A in the presence of
32P-dUTP as described previously (Weber et al., 1987; Hofer and Darnell 1981)
The R N A was extracted and hybridized to nitrocellulose filters containing
excess D N A affixed as dots. Unhybridized D N A was digested and washed
away leaving the hybridized R N A to be detected by autoradiography. Spotted
D N A s include: rat albumin (a 2400bp genomic fragment; rat B clone Sargent
et al, 1981), rat TTR (a 440 bp fragment of the rat TTR cDNA, Dickson et al,
1985); H N F 1 ( the 3052bp M 6 c D N A clone, Frain et al, 1989) C/EBP (500bp
pPstl fragment, Xanthopoulos et al, 1989). H N F 3 (655 nucleotides) and H N F 4
(972 nucleotides) were c D N A s in plasmids (Lai, Sladek and Darnell,
unpublished). A Chicken p-actin clone was used as a control (Cleveland et al,
1980).
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Normalized Nuclear Run-On Transcription Data

Liver

FaO

C2

C2Rev7

H5

Albumin 100 18 0.1 1.0

TTR 189 0.6 - 1.2

HNF1 2.0 1.8 1.9 2.0 1.7

C/EBP 92 26 18.5 19.5 16

HNF3 46 1.0 0.5 1.0 0.5

HNF4 39 0.6 - 0.6

Table 8.1. The results for the nuclear run on analysis were normalized based
on the size of the D N A probes and the actin transcription value. The albumin
transcription signal in the liver was arbitrarily given a values of 100 and
serves as the standard of reference. This table represents the averaged results
of two different experiments, one of which is shown in Figure 8.3.
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Gel-shift analysis of Nuclear Factors in Hepatoma Cell Lines
Having established the transcriptional patterns for these four factors,
the nuclear protein levels of these factors was established in the nuclei of the
different rat cell types to determine if transcriptional regulation accounted for
their control. Furthermore, this allowed an analysis of the NLS1 and ANF
factors for which clones are not yet available (Figure 8.4). Nuclear extracts of
rat liver cells and of the four cell lines were prepared. Each extract contained
about the same amount of protein capable of binding the AP-1 site of alantitrypsin (Figure 8.4A; oligonucleotide B, Grayson et al, 1988) indicating
that the method for obtaining factors was similarly effective in all cell types.
Surprisingly, the pattern for HNF1 binding activity in the cell lines
was very different from that of its transcription rate, which varied little
between the cell types. While FaO, C2rev7 and liver nuclear extracts
contained similar amounts of HNF1 DNA binding activity, C2 cells had at
least ten to twenty-fold less HNF1 binding activity, and. in H5 cells it was
undetectable (Figure 8.4B). Since the transcription rate of albumin is very low
in C2rev7 cells compared to FaO and liver cells, this result shows that HNF1
alone cannot insure high albumin transcription rates.
Another interesting result of the HNF1 shift assays is the appearance of
a faster moving DNA-protein species in the C2 and H5 nuclear extracts
(Figure 4B, bottom arrow; note that the H5 lanes represent a five fold longer
autoradiographic exposure indicating the low level of this complex). This
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Figure 8.4. Binding activities for API, H N F 1 , C/EBP, HNF3, H N F 4 and NLS1
in nuclear extracts prepared from the rat liver or from the hepatoma cell
lines FaO, C2, C2rev7 and H5. Oligonucleotide probes were prepared to
represent these binding sites and in Table 4.2, except for A N F which is the
same probe used in Figure 7.11. D N A probes were 3' end labeled and
incubated (lng) with lOfig of nuclear extract in a 20jxl binding reaction
containing 4u,g of poly (dI-dC):poly (dl-dC) in 2 0 m M HEPES p H 7.9, 4 0 m M
KC1, 2 m M MgCl 2 , I m M DTT, 0.5mM E G T A and 4 % ficoll, for 30min at room
temperature. Following incubation, 4ul of this mixture was electrophoresed
on 5 - 9% acrylamide gels run in 2 5 m M Tris-borate and 0.25mM EDTA, in the
absence (-) or presence (+) of homologous unlabeled D N A (50 fold molar
excess).
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activity has been observed by others, also in dedifferentiated, non-liver
expressing cells, and has been named variant HNF1 (vHNFl; Baumheuter et
al, 1988; Cereghini et al, 1988). The makeup of this vHNFl protein is far from
clear for it could be a modified form (either pre-or post-translational) of the
HNF1 gene or alternatively the product of a different gene. The function of
vHNFl (e.g. is it a positive or negative acting factor) is equally obscure
(Tronche et al, 1989), but it appears that it is the lack of HNF1 and not
necessarily the presence of vHNFl in the C2 and H5 cell types that is most
probably responsible for the lack of albumin and TTR gene transcription.
Reference to C/EBP binding activity is helpful in trying to interpret the
albumin and TTR transcriptional results (Figure 8.3C): FaO cells have
abundant C/EBP binding activity and both C2 and C2rev7 cells have less.
Therefore, unlike the case with HNF1, C/EBP binding activity better parallels
its transcription rate. Also, since both the albumin promoter and enhancer
elements contain functional C/EBP binding sites (Figure 8.1) , this lower
amount of C/EBP could partly explain the much reduced albumin
transcription rate in C2rev7 cells.
The results of the HNF3 binding activity were remarkably different
from both the HNF1 and C/EBP results (Figure 8.4D). HNF3 binding activity
is present at approximately equal amounts in all 4 hepatoma cell types tested
(Figure 8.4E), although it is not transcribed well in any of them, as compared
to the high rate observed in liver. These results suggest that post-

179

transcriptional events are involved in maintaining the level of this protein
in hepatoma cells (In animal tissues, however, HNF3 is regulated
transcriptionally not post-transcription, Xanthopoulos et al., unpublished.)
HNF4 binding activity is present in FaO cells at 10% the level of liver
cells, and this drop off corresponds to a transcriptional decrease.
Furthermore, a low amount of HNF4 binding activity is present in C2 and H5
cells where transcription is barely detectable as compared to liver cells.
However, the gel-shift pattern of this binding activity was not completely
normal. C2 extracts produce two HNF4 complexes (lower arrow figure 3E) but
lack the third slowest moving complex (upper arrow, Figure 3E). C2rev7
which regained some TTR transcriptional activity have at least some proteins
that form all three HNF4 complexes, but at a much reduced level (even
though its transcription rate is nearly identical to that in FaO cells). This is
similar to the situation observed for the vHNFl factor and suggests that
posttranslational modification might influence HNF4 function.

NLS1 and ANF protein levels
Lastly, the relative protein abundance was determined for the factors
NLS1 and ANF which confer the positive and negative actions of the
albumin enhancer. In the series of hepatoma derivatives tested here, only
FaO cells contain detectable amounts of the NLS1 binding protein (Figure
8.3F), although at a much lower level than that found in liver. This result
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correlates with the higher albumin transcription rate in F a O cells compared to
C2, H5 or C2rev7 and the reduced albumin transcription observed in FaO cells
compared to liver. Additionally, the levels of ANF (albumin negative factor)
were measured in the cell lines and shown to be fairly constant. Hence,
increased production of this negative factor does not seem to be involved in
turning albumin off in these cell types.

Discussion
These results contribute to two lines of inquiry about transcriptional
control in specialized cells: 1) the regulation of transcription factors
themselves and 2) how various factors combine to regulate transcription of
specific genes and specific cell types. First, certain hepatoma cells even
though they are markedly dedifferentiated, still transcribe some liverenriched transcription factors at rates comparable to their differentiated
parents. HNF1 and C/EBP are in this category. Two other factors HNF3 and
HNF4, originally described as proteins necessary for high rates of transcription
of TTR, are not transcribed well in hepatoma cells, at least under the cell
culture conditions used in this study. Despite this minimal level of HNF3
transcription, however, HNF3 DNA binding activity was abundant in all the
cells tested. This result is consistent with earlier studies which demonstrated
that in C2rev7 cells considerable albumin mRNA is present with very low
transcription rates (Jefferson et al, 1984; Clayton et al, 1985; Friedman et al.,
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1987), presumably resulting from posttranscriptional stabilization of the

mRNA.
Similarly, the HNF1 gene was transcribed well in C2 and H5 cells,
although little or no protein capable of DNA binding was found in these cell
extracts. In both cases a smaller amounts of the faster migrating bands were
evident. Again, whether these bands are derived from post-transcriptional
modifications of HNF1 or are the product of a distinct gene is not known. In
any case, the major event is the loss of the larger 80KD HNF1 protein that
produces the slower migrating band, and the role, if any, of this variant HNF1
remains to be established. Since the gel retardation assay scores DNA binding
activity and not amounts of protein, antibodies to the various transcription
factors will be needed to determine how much protein is actually present.
Then, it might be possible to decipher how much of the apparent posttranscriptional regulation is in fact, post-translational modification.

Correlation with Albumin and TTR gene expression
Can the transcriptional behavior of the genes for albumin and TTR,
two prototypical liver products, be explained by the transcriptional activity of
their transcription factor genes? Some correlations seem evident but
numerous questions remain. First, albumin transcription in FaO cells seems
to be the most easily explained. HNF1 and C/EBP are transcribed at a
relatively high rate and their DNA binding activities are equally abundant in
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F a O cells and in liver. Both factors are k n o w n to be important in transcription
from the albumin promoter (Figure 8.1). However, the protein level of NLS1,
the single known positive activator of the albumin enhancer (Chapter 6), is
decreased significantly in FaO cells as compared to liver. In the C2rev7 cells,
the lower level of NLS1 DNA binding activity could account for the further
decrease in the albumin gene transcription observed. Additionally, it appears
that C2 and H5 do not transcribe any albumin because they do not contain a
functional HNF1 protein. This implicates HNF1 as having the essential role
in determining the specificity of albumin transcription. It would seem that a
minimum level of HNF1 is required to allow a basal level of albumin
transcription to occur, and that the other factors work primarily to modulate
transcriptional rate.
Regarding the TTR ene, four of the factors assayed here are known to
have binding sites either in its upstream enhancer or in the promoter
proximal sequences (C/EBP, HNF1, HNF3 and HNF4; see Figure 8.1). While
the transcription rates for HNF3 and HNF4 in the cultured cells correlates
with that of the TTR gene (all decreased with respect to the liver) the levels of
DNA binding activities of these factors found in the nuclear extracts did not.
For example, HNF3 binding activity was the same in all extracts. These
results suggest that either these proteins can bind DNA in vitro but can't
activate transcription inside the cells or the decreased level of HNF4 alone
dictates the loss of TTR transcription. There have been other reported cases
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where

DNA

binding

activity in vitro has been disassociated

from

transcriptional activation in vivo (e.g. serum response factor levels in cells
not stimulated by serum or PDGF. (Treisman, 1986 Treisman et al, 1989). In
those cases, it is assumed that either some change in the factor or some other
protein is required to render the factor active in vivo. The possibility that
HNF4 concentration is critical, however, is made plausible by the results in
C2rev7 cells in which there is a small amount of HNF4 binding activity and a
low but detectable level of TTR transcription (as opposed to the rat liver).
Another obvious possibility is that several of the proteins apparently needed
for TTR expression are all present in lowered concentrations (ie. in the FaO
or C2rev7 cells) and therefore, cannot, under these circumstances, interact
properly in FaO cells to stimulate transcription.

Conclusions
Almost all genes studied thus far which are regulated in a cell-specific
fashion have multiple binding sites for a variety of proteins. Therefore, as
these experiments suggest, it is very likely the interaction between those
proteins that define a given level of transcription for a gene and not just the
presence or absence of individual factors. Hence, the transcriptional
variability inherent in these hepatoma cell systems is extremely useful for
sorting through this complicated task. Experiments can be planned in the not
too distant future where recombinant genes for these different factors can be
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introduced into a dedifferentiated hepatoma cell (ie. C2) to observe if the liverlike phenotype can be reestablished.
Lastly, these experiments demonstrate that the cell-type control of these
transcription factors is a complicated matter, with regulatory events occurring
at both the transcriptional and post transcriptional level. The ultimate
understanding of how these factors are differentially controlled in the cells
(including the elucidation of potential autoregulatory mechanisms) is
important for it will elevate the study of hepatocyte differentiation one step
up the regulatory cascade towards an understanding of the molecular events
which underlie cellular determination.
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Chapter 9

Conclusion

This thesis has analyzed the regulatory elements involved in the
control of the serum albumin gene, and through this process identified two
novel DNA binding activities (NLS1 and ANF). Having determined the
different proteins which interact with the albumin gene, their tissue
specificity and possible means of regulation, the mechanisms responsible for
albumin transcriptional control are now better understood. Another major
reason for studying albumin (an adult hepatocyte-expressed gene), however,
was to address the question of coordinate gene control in the maintenance of
the differentiated hepatocyte. In this regard, the concluding chapter of this
thesis will include both a recapitulation of the results obtained for the
albumin promoter and enhancer regions and a comparison of these elements
with the regulatory regions of Transthyretin (TTR; Costa et al, 1986, 1988a,
1989) and al-antitrypsin (Grayson et al, 1988a, 1988b), two additional serum
protein genes transcribed primarily in the liver (Figure 9.1). From the study
of these genes and the identification of their upstream transcription factors,
several general rules for the design and function of their regulatory regions
have emerged.

L Multiple sites of DNA-protein interaction are present on the regulatory
elements of hepatocyte-expressed genes.
The first and most obvious conclusion from observing Figure 9.1 is
that multiple proteins interact with the upstream regulatory sequences of all
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Figure 9.1. S u m m a r y of the k n o w n sites of DNA-protein interaction that
occur o n the m o u s e transthyretin (TTR), m o u s e al-antitrypsin and rat and
m o u s e albumin genes (the rat promoter a n d the m o u s e enhancer; as
described in this thesis the regulatory regions of the t w o genes are virtually
identical). At the bottom of the figure is a diagram representing each cellular
factor. This figure is based o n results from the following: T T R gene (Costa et
al, 1986,1988a, 1989) al-antitrypsin (Grayson et al, 1988a; Costa et al, 1989) and
albumin (this thesis; Babiss et al, 1987; Cereghini et al, 1987; Lichtsteiner et
al, 1987; Liu et al, 1988). For a m o r e detailed explanation of this figure see
text.
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three of these genes. This thesis has demonstrated the numerous protein
interactions that occur on the albumin enhancer (as many as 6) and promoter
(at least 5; note that the Figure 9.1 includes data generated by other research
groups studying the albumin promoter; Cereghini et al, 1987; Lichtsteiner et
al, 1987). In addition, Zaret and colleagues have recently reported yet another
C/EBP site to exist at -3.5kbp which is shown in the diagram (Liu et al, 1988).
Interestingly, this same degree of protein interaction is present on the other
two genes described here. For example, there are as many as 10 sites of DNAprotein contact on the mouse transthyretin gene upstream sequences and
eight on the mouse al antitrypsin regulatory regions. Therefore, these liver
specific genes have complicated genetic elements, containing many binding
sites for regulatory proteins.

IL Both Promoters and Enhancer elements exist
These sites of protein interaction can be found either within the first
100 or 200 nucleotides or as far as 10 kilobases upstream from the start site of
RNA synthesis. In all three of the cases shown in Figure 9.1, both a
hepatocyte specific promoter and enhancer element exist, and each is required
to achieve maximal rates of transcription. Furthermore, for some hepatocyteexpressed genes (ie. a-fetoprotein) several distinct enhancer elements have
been elucidated (Godbout et al, 1988a).
One intriguing aspect of these promoter and enhancer elements,
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however is the great similarity between them, for the same group of proteins
appears to interact with both. For example, multiple C/EBP binding sites are
found on both the albumin promoter and enhancer DNA sequences. This
same multiplicity of sites is observed for the two other genes under
discussion (see Figure 9.1). Additionally, HNF3 and HNF4 sites occur on both
elements of the TTR gene. This common link between these liver specific
enhancer and promoter elements is similar to the situation observed for the
immunoglobulin genes where for example, the octomer motif is found in
several places in the upstream regions (Sen and Baltimore, 1986; Lenardo et
al, 1987).
It is now known that several of these liver specific promoter elements
(including albumin and TTR; Heard et al, 1987; Costa et al, 1988a, 1989) can be
placed upstream of a heterologous promoter (in either orientation) where
they act to boost the rate of transcription in a fashion similar to classical
enhancer elements. Therefore, the above facts probably indicate that the
mechanisms by which promoter and enhancer elements activate
transcription are not very different, and perhaps enhancer elements work
simply by increasing the concentration of given trans-activating protein at the
RNA start site.
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III.

Both cell specific and ubiquitous factors are involved in liver specific
gene transcription

The factors involved in stimulating transcription of a particular liver
specific gene are a mixture of proteins that can be found in extracts of many
cells (ie. API, NF1 and CAAT binding proteins) and a limited number found
predominantly in hepatocytes or hepatoma cells and at low levels (or not at
all) in other tissues. The four cloned factors already described, HNF1, HNF3,
HNF4, C/EBP are examples of the latter group (Courtois et al., 1987; Frain et
al., 1989; Graves et al, 1986; Landshulz et al, 1988; Costa et al, 1989).
Furthermore, it is known that certain proteins can exist which might be
present in all cell-types but specifically "modified" only in certain situations.
NLS1 which was described in this thesis is a candidate for such a factor as are
AF-1 (the ApoCIII gene Leff et al, 1989) or (j)NFl (Lichtsteiner et al., 1987,
Paonessa et al., 1988). Alternatively, these proteins might represent members
of multigene families for which only the liver representative is active.
In any event, the above suggests a model in which the ubiquitous
factors act only to increase the magnitude of the transcriptional effect without
determining specificity. Instead, it is the presence of specific combinations of
liver enriched factors that generates tissue specific gene expression. This type
of regulation allows more variable control for no single activating switch
exists. That is, by possessing multiple sites for liver enriched proteins, the
genes can presumably be modulated by a larger number of different stimuli.
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IV.

Positive and negative regulatory factors exist

While most of the elements described so far appear to be positive acting
and additive, a smaller group of functionally negative acting DNA-regions
and proteins also exists Negative acting elements have been described for
several hepatocyte-expressed genes including apolipoprotein Oil, retinol
binding protein, human al-antitrypsin gene and a-fetoprotein (Muglia and
Rothman Denes, 1986; Reue et al, 1988; Colantuoni et al, 1987; D'onofrio et
al., 1989; Camper and Tilghman, 1989). In this thesis the albumin gene was
shown to have a negative element which contains two binding sites for a
negative acting protein, ANF (albumin negative factor). Whether ANF plays
a general role in liver regulation by interacting with other liver specific genes
remains to be explored. Naturally, the precise transcriptional arrangements
which exists upon the regulatory regions of liver specific genes
(positive/negative/both) are as varied as the different DNA-binding protein
combinations which can occur.

V. The liver enriched factors interact with multiple genes
Most all the liver enriched or modified factors identified so far interact
with more than one gene expressed chiefly in hepatocytes (Figure 9.1) This
suggests their involvement in coordinate control, simultaneously activating
several genes involved in maintaining the hepatocyte-like phenotype. For
example, the C/EBP and HNF1 and HNF3 proteins interact with all three of
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the genes under discussion. In a like fashion, it has recently been found that
NLS1 also binds to the constitutive activating region of the mouse
glutathione-s-transferase gene. While this gene is expressed at high levels
pericentrally in the liver, it is believed that the NLS1 interacts with the
promoter element of the gene which directs the basal level expression in all
hepatocytes (Paulson et al., In press). Hence, numerous genes transcribed
predominantly in the liver interact with the same group of liver enriched
regulatory proteins.

Perspectives
This thesis therefore suggests that hepatocyte specific gene expression
relies on the combinatorial action of several, different regulatory factors.
Through the interplay of these factors, only some of which are tissue specific,
a regulated differentiated cell phenotype is established. Importantly, this type
of model can account for the fact that certain liver genes are expressed in
other tissues. For example, TTR is transcribed in certain regions of the brain
(the choroid plexus) and al-antitrypsin in macrophages and the kidney (Costa
et al, 1989). It is therefore reasonable to assume that the ubiquitous factors or
reduced levels of one of the liver enriched factors combine with additional
factors in the alternate tissue to activate transcription (Costa et al, 1989). In
this way, regulation is achieved in each tissues through different but
overlapping subsets of regulatory molecules
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All the factors that have been identified and described in this thesis
represent the end stage of what is probably an autoregulatory, cascade of
factors which are initiated by the determinative events in the early embryo.
The process which dictates this regulatory network of transcription factors
and controls factor production in a given cell type, however, remains
unknown. The answers to this question can be obtained by working
backwards as described in this thesis; asking both how these transcription
factors interact to stimulate transcription and exploring the mechanism by
which they themselves are modulated. In this way, the molecular
mechanisms responsible for hepatocyte differentiation and development can
be further explored.
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